data_2mkw_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2mkw _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.469 ' HG ' ' H ' ' A' ' 27' ' ' GLY . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.469 ' H ' ' HG ' ' A' ' 26' ' ' SER . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 80.2 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.472 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' TYR . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-20 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.4 ' H ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 70' ' ' SER . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.422 ' N ' ' HG ' ' A' ' 69' ' ' SER . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 85' ' ' ASP . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 83' ' ' THR . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 102' ' ' PHE . 67.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 101' ' ' VAL . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 98' ' ' ASN . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 96' ' ' SER . 0.2 OUTLIER 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.49 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' MET . . . . . 0.588 ' H ' ' HG ' ' A' ' 25' ' ' SER . 57.5 mtt . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.0 p80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 3' ' ' MET . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 31' ' ' SER . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.409 ' C ' ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.446 ' HG ' ' H ' ' A' ' 28' ' ' SER . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.532 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.604 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 10.4 m120 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.438 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 66' ' ' SER . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 83' ' ' THR . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 97' ' ' SER . 35.8 m170 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 109' ' ' THR . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 28' ' ' SER . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.458 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 77.0 m-20 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.422 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.547 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.619 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HZ1' ' HG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.532 ' HG1' ' HZ1' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.436 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' SER . 7.6 m120 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 85' ' ' ASP . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.676 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.448 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.199 0.047 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 88' ' ' ASP . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.526 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.4 m120 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.609 ' HG ' ' N ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.609 ' N ' ' HG ' ' A' ' 66' ' ' SER . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 C--O 1.23 0.066 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.468 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.468 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.405 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.54 ' N ' ' HG ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.503 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . 9.4 m120 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.601 ' HE ' ' CG2' ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG2' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' THR . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 69' ' ' SER . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.423 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ASP . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.615 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.404 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.546 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 12.4 m120 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.49 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.723 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.523 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.723 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . 0.512 ' C ' ' HG1' ' A' ' 106' ' ' THR . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 105' ' ' GLY . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.439 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 109' ' ' THR . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.653 ' HG ' ' ND2' ' A' ' 32' ' ' ASN . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.653 ' ND2' ' HG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.586 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 85' ' ' ASP . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 11' ' ' SER . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 10' ' ' VAL . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.689 ' N ' ' HG ' ' A' ' 9' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 25' ' ' SER . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.533 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.459 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 9.0 m120 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.545 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.545 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 85' ' ' ASP . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.544 ' CG ' HH22 ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.23 0.048 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 50' ' ' TYR . 7.5 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 39' ' ' GLN . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.61 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.611 ' CE2' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 79.1 m-20 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.647 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' THR . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.402 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' N ' ' C ' ' A' ' 51' ' ' GLU . 2.4 m120 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.536 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.558 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 75' ' ' SER . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.646 ' HG ' ' N ' ' A' ' 70' ' ' SER . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 69' ' ' SER . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 66' ' ' SER . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.507 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.558 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' ASN . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.488 ' CB ' ' HD1' ' A' ' 99' ' ' HIS . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' SER . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.488 ' HD1' ' CB ' ' A' ' 97' ' ' SER . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 C--O 1.231 0.1 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.414 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.52 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.414 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 66' ' ' SER . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.652 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' SER . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' ALA . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.61 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CD1' ' NE2' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.546 ' CG2' ' HH ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.465 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m120 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.535 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.575 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 83' ' ' THR . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 37' ' ' TYR . 58.5 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' SER . . . . . 0.441 ' OG ' ' CG2' ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . 0.441 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 109' ' ' THR . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.584 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.404 ' OE1' ' CE1' ' A' ' 50' ' ' TYR . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' ' N ' ' A' ' 53' ' ' ASN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 14.2 m120 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.568 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.568 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.47 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.608 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.515 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.461 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.494 ' OG ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' OG ' ' A' ' 31' ' ' SER . 9.5 m-80 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 39' ' ' GLN . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.465 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.531 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 9.2 m120 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.2 OUTLIER 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 23.4 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.497 ' C ' ' H ' ' A' ' 97' ' ' SER . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.687 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.5 p80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 27' ' ' GLY . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 52' ' ' ASP . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . 0.4 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 40' ' ' ARG . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.406 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 75' ' ' SER . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.407 ' H ' ' HG ' ' A' ' 69' ' ' SER . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 66' ' ' SER . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.506 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.635 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . 0.471 ' C ' ' HG ' ' A' ' 9' ' ' SER . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.488 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.634 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.77 HD21 ' H ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 75' ' ' SER . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 66' ' ' SER . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.639 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.436 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.57 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 77' ' ' THR . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . 0.487 ' C ' ' HG ' ' A' ' 75' ' ' SER . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' SER . . . . . 0.487 ' HG ' ' C ' ' A' ' 74' ' ' ALA . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.434 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.435 ' O ' ' OG ' ' A' ' 11' ' ' SER . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . 0.574 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.506 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' THR . . . . . 0.506 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.407 ' C ' HD21 ' A' ' 53' ' ' ASN . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' A' ' 70' ' ' SER . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 69' ' ' SER . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 83' ' ' THR . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ILE . . . . . 0.433 HG23 HD11 ' A' ' 20' ' ' ILE . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' TRP . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 34' ' ' VAL . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ARG . . . . . 0.514 HH12 ' CG ' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' LEU . . . . . 0.477 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' ASN . . . . . 0.478 ' C ' ' HD1' ' A' ' 99' ' ' HIS . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' HIS . . . . . 0.478 ' HD1' ' C ' ' A' ' 98' ' ' ASN . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' LYS . . . . . 0.447 ' HZ2' ' HG1' ' A' ' 109' ' ' THR . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' THR . . . . . 0.447 ' HG1' ' HZ2' ' A' ' 107' ' ' LYS . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.509 ' CE1' ' OG ' ' A' ' 26' ' ' SER . 1.1 m-85 -150.72 117.21 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.579 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp -155.89 165.9 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.797 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.509 ' OG ' ' CE1' ' A' ' 2' ' ' PHE . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.469 ' H ' ' HG ' ' A' ' 26' ' ' SER . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 80.2 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.472 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.466 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.466 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.472 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.431 ' N ' ' O ' ' A' ' 50' ' ' TYR . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-20 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.4 ' H ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.422 ' HG ' ' N ' ' A' ' 70' ' ' SER . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.422 ' N ' ' HG ' ' A' ' 69' ' ' SER . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.441 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.423 ' CD1' ' C ' ' A' ' 81' ' ' LEU . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.435 ' O ' ' N ' ' A' ' 85' ' ' ASP . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.551 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.551 ' H ' ' C ' ' A' ' 83' ' ' THR . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 102' ' ' PHE . 67.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.437 ' O ' ' N ' ' A' ' 101' ' ' VAL . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.409 ' C ' ' H ' ' A' ' 98' ' ' ASN . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.409 ' H ' ' C ' ' A' ' 96' ' ' SER . 0.2 OUTLIER 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.468 ' CG1' ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.49 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.446 ' CZ ' ' OG ' ' A' ' 26' ' ' SER . 25.6 m-85 -98.99 134.76 41.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 179.034 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.588 ' H ' ' HG ' ' A' ' 25' ' ' SER . 57.5 mtt -152.41 161.12 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.502 179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.607 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.0 p80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.588 ' HG ' ' H ' ' A' ' 3' ' ' MET . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.462 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.446 ' H ' ' HG ' ' A' ' 31' ' ' SER . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.409 ' C ' ' CD1' ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.446 ' HG ' ' H ' ' A' ' 28' ' ' SER . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.532 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.532 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.604 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.604 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 10.4 m120 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.438 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.414 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.451 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.451 ' O ' ' OG ' ' A' ' 66' ' ' SER . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.43 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.525 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.525 ' H ' ' C ' ' A' ' 83' ' ' THR . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 97' ' ' SER . 35.8 m170 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.402 ' CZ ' ' OG ' ' A' ' 26' ' ' SER . 10.4 m-85 -128.69 128.93 45.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.439 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -143.79 159.37 42.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.476 ' OG ' ' O ' ' A' ' 109' ' ' THR . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.444 ' HG ' ' N ' ' A' ' 27' ' ' GLY . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.444 ' N ' ' HG ' ' A' ' 26' ' ' SER . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.492 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.546 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.492 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.404 ' OG ' ' O ' ' A' ' 28' ' ' SER . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.458 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.455 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.455 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 77.0 m-20 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.422 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.547 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.533 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.619 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.497 ' C ' ' H ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.547 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.532 ' HZ1' ' HG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.532 ' HG1' ' HZ1' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.436 HD13 ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.41 ' H1 ' ' H ' ' A' ' 2' ' ' PHE . 28.0 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.4 m-85 -86.03 174.7 9.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.7 168.29 27.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.89 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.448 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.615 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' SER . 7.6 m120 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.449 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.454 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.465 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.454 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.429 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.421 ' O ' ' N ' ' A' ' 85' ' ' ASP . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.558 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.558 ' H ' ' C ' ' A' ' 83' ' ' THR . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.436 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.676 ' N ' HD21 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.448 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 26.9 p90 -84.16 139.68 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.227 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt -155.99 171.2 20.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.903 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.518 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.518 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.402 ' CD ' ' O ' ' A' ' 88' ' ' ASP . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.526 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.526 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.4 m120 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.609 ' HG ' ' N ' ' A' ' 67' ' ' ILE . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.609 ' N ' ' HG ' ' A' ' 66' ' ' SER . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.415 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.546 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.51 ' C ' ' H ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.519 ' O ' ' N ' ' A' ' 98' ' ' ASN . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.519 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.674 ' ND2' ' H1 ' ' A' ' 1' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -155.22 122.21 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.043 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt -143.98 165.2 28.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.468 ' C ' ' HG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.468 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.405 ' CG2' ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.405 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.634 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.54 ' HG ' ' N ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.54 ' N ' ' HG ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.503 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.486 ' C ' ' H ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.486 ' H ' ' C ' ' A' ' 51' ' ' GLU . 9.4 m120 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.601 ' HE ' ' CG2' ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . 0.601 ' CG2' ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.421 ' O ' ' N ' ' A' ' 77' ' ' THR . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.494 ' H ' ' HG ' ' A' ' 69' ' ' SER . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.423 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.567 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.567 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.405 ' C ' ' O ' ' A' ' 85' ' ' ASP . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 18.9 p90 -162.32 133.56 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.077 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt -154.04 161.59 41.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.529 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.615 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.615 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.526 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.576 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.526 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.404 ' NE2' ' CE2' ' A' ' 89' ' ' TYR . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.546 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.546 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 12.4 m120 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.49 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.723 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.457 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.523 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.723 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.404 ' CE2' ' NE2' ' A' ' 38' ' ' GLN . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.512 ' C ' ' HG1' ' A' ' 106' ' ' THR . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.512 ' HG1' ' C ' ' A' ' 105' ' ' GLY . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.35 126.99 41.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.138 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm -154.92 172.47 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.439 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.439 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 109' ' ' THR . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.541 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.541 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.513 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.547 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.513 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.653 ' HG ' ' ND2' ' A' ' 32' ' ' ASN . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.653 ' ND2' ' HG ' ' A' ' 31' ' ' SER . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . 0.586 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.586 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.525 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.439 ' C ' ' H ' ' A' ' 85' ' ' ASP . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.433 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.426 ' O ' ' OG ' ' A' ' 11' ' ' SER . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' CD2' ' CB ' ' A' ' 26' ' ' SER . 2.3 t80 -131.76 119.22 20.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt -144.59 167.88 21.47 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 10' ' ' VAL . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.689 ' N ' ' HG ' ' A' ' 9' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' CD2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.615 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.59 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.533 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.533 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.459 ' OD1' ' ND2' ' A' ' 53' ' ' ASN . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 9.0 m120 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.545 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.516 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.545 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.542 ' C ' ' H ' ' A' ' 85' ' ' ASP . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.544 ' CG ' HH22 ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' N ' ' O ' ' A' ' 83' ' ' THR . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -108.1 121.49 44.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm -148.63 172.3 14.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.492 ' C ' ' HG ' ' A' ' 9' ' ' SER . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.492 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.42 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.434 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.42 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 50' ' ' TYR . 7.5 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.428 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.49 ' OE1' ' N ' ' A' ' 39' ' ' GLN . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.61 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.611 ' CE2' ' NE2' ' A' ' 35' ' ' GLN . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.511 ' H ' ' C ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 79.1 m-20 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.435 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.569 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.414 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.435 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.647 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.553 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.553 ' H ' ' C ' ' A' ' 83' ' ' THR . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.523 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.402 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.441 ' CD1' ' CG ' ' A' ' 95' ' ' ASP . 2.1 m-85 -96.64 112.3 24.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.661 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt -154.58 169.74 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.817 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.453 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.453 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' N ' ' C ' ' A' ' 51' ' ' GLU . 2.4 m120 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.536 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.536 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.469 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.558 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.446 ' OG ' ' O ' ' A' ' 75' ' ' SER . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.49 ' CD1' ' N ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.548 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.646 ' HG ' ' N ' ' A' ' 70' ' ' SER . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.646 ' N ' ' HG ' ' A' ' 69' ' ' SER . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.548 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.446 ' O ' ' OG ' ' A' ' 66' ' ' SER . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.507 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.558 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.528 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' CG ' ' CD1' ' A' ' 2' ' ' PHE . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.43 ' C ' ' H ' ' A' ' 98' ' ' ASN . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.488 ' CB ' ' HD1' ' A' ' 99' ' ' HIS . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.43 ' H ' ' C ' ' A' ' 96' ' ' SER . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.488 ' HD1' ' CB ' ' A' ' 97' ' ' SER . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 18.0 p90 -144.41 129.44 18.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt -152.96 169.03 23.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.537 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.414 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.52 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.496 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.496 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.499 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.502 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.414 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.429 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.429 ' O ' ' OG ' ' A' ' 66' ' ' SER . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.41 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.652 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.513 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.52 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.401 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.522 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.522 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.43 ' N ' ' O ' ' A' ' 93' ' ' SER . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.414 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.13 102.66 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp -150.86 172.06 16.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.563 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.563 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.439 ' C ' ' H ' ' A' ' 30' ' ' ALA . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.61 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.439 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CD1' ' NE2' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.546 ' CG2' ' HH ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.465 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.465 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m120 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.535 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . 0.524 ' CD1' ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.412 ' HA ' ' O ' ' A' ' 64' ' ' SER . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.575 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.575 ' H ' ' C ' ' A' ' 83' ' ' THR . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 37' ' ' TYR . 58.5 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' SER . . . . . 0.441 ' OG ' ' CG2' ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . 0.441 ' CG2' ' OG ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.534 ' CD1' ' N ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -81.58 178.04 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp -155.37 172.15 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.091 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 109' ' ' THR . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.479 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.584 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.479 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.451 ' O ' ' N ' ' A' ' 52' ' ' ASP . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.404 ' OE1' ' CE1' ' A' ' 50' ' ' TYR . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.515 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.458 ' C ' ' N ' ' A' ' 53' ' ' ASN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 14.2 m120 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.568 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.568 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.415 ' N ' ' O ' ' A' ' 22' ' ' CYS . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.47 ' O ' ' CD2' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.608 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.529 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.515 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . 0.461 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.461 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.4 ' O ' ' OG ' ' A' ' 11' ' ' SER . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.2 m120 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD2' ' OD1' ' A' ' 95' ' ' ASP . 8.1 m-85 -81.14 143.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.073 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp -151.02 165.24 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.494 ' OG ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' OG ' ' A' ' 31' ' ' SER . 9.5 m-80 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.534 ' OE1' ' N ' ' A' ' 39' ' ' GLN . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.465 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.531 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.531 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 9.2 m120 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.2 OUTLIER 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.427 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.449 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 23.4 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 2' ' ' PHE . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.497 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 14.5 t80 -103.94 109.86 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.851 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -149.64 168.43 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.214 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.687 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.5 p80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.415 ' C ' ' H ' ' A' ' 27' ' ' GLY . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.415 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.491 ' O ' ' N ' ' A' ' 52' ' ' ASP . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . 0.4 ' O ' ' OG ' ' A' ' 43' ' ' SER . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' O ' ' A' ' 40' ' ' ARG . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.598 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.598 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.406 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.402 ' OG ' ' O ' ' A' ' 75' ' ' SER . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.455 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.407 ' H ' ' HG ' ' A' ' 69' ' ' SER . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.455 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.402 ' O ' ' OG ' ' A' ' 66' ' ' SER . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.506 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.635 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.635 ' H ' ' C ' ' A' ' 83' ' ' THR . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.4 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.6 174.22 7.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -156.14 170.12 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.729 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.469 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . 0.471 ' C ' ' HG ' ' A' ' 9' ' ' SER . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' SER . . . . . 0.471 ' HG ' ' C ' ' A' ' 8' ' ' HIS . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.488 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.488 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.481 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . 0.411 ' CD1' ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.481 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.411 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.634 ' CG2' ' H ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.634 ' H ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.77 HD21 ' H ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' SER . . . . . 0.466 ' OG ' ' O ' ' A' ' 75' ' ' SER . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.466 ' O ' ' OG ' ' A' ' 66' ' ' SER . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.44 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.491 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.532 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . 0.469 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.639 ' CD1' ' H ' ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.468 ' C ' ' SD ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -95.34 109.85 21.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' MET . . . . . 0.468 ' SD ' ' C ' ' A' ' 2' ' ' PHE . 2.1 mpt? -154.61 167.28 30.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.92 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.436 ' CG2' ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.436 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.473 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . 0.473 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.421 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.57 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.443 ' O ' ' N ' ' A' ' 77' ' ' THR . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . 0.487 ' C ' ' HG ' ' A' ' 75' ' ' SER . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' SER . . . . . 0.487 ' HG ' ' C ' ' A' ' 74' ' ' ALA . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.434 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' THR . . . . . 0.443 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.422 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.57 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . 0.491 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' THR . . . . . 0.438 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.435 ' O ' ' OG ' ' A' ' 11' ' ' SER . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 20.4 p90 -98.12 125.7 43.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.07 169.59 24.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.797 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.636 ' HG ' ' N ' ' A' ' 26' ' ' SER . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.636 ' N ' ' HG ' ' A' ' 25' ' ' SER . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . 0.574 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.506 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' THR . . . . . 0.506 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.427 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.457 ' CD1' ' N ' ' A' ' 51' ' ' GLU . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.407 ' C ' HD21 ' A' ' 53' ' ' ASN . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.515 ' HG ' ' N ' ' A' ' 70' ' ' SER . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' SER . . . . . 0.515 ' N ' ' HG ' ' A' ' 69' ' ' SER . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.407 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.539 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.539 ' H ' ' C ' ' A' ' 83' ' ' THR . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . 0.478 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 26' ' ' SER . 22.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 5.7 m-85 -147.54 116.11 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt -148.89 163.91 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ILE . . . . . 0.433 HG23 HD11 ' A' ' 20' ' ' ILE . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ILE . . . . . . . . . . . . . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TYR . . . . . 0.487 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . 0.518 ' N ' ' O ' ' A' ' 36' ' ' TRP . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ASP . . . . . 0.538 ' N ' ' O ' ' A' ' 34' ' ' VAL . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ARG . . . . . 0.514 HH12 ' CG ' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . 0.413 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . 0.553 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ASN . . . . . 0.553 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' LEU . . . . . 0.477 ' CD2' ' C ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.572 ' H ' ' CD2' ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 7.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD2' ' CG ' ' A' ' 2' ' ' PHE . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' ASN . . . . . 0.478 ' C ' ' HD1' ' A' ' 99' ' ' HIS . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' HIS . . . . . 0.478 ' HD1' ' C ' ' A' ' 98' ' ' ASN . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' LYS . . . . . 0.447 ' HZ2' ' HG1' ' A' ' 109' ' ' THR . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' THR . . . . . 0.447 ' HG1' ' HZ2' ' A' ' 107' ' ' LYS . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.5 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 10' ' ' VAL . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.637 ' O ' HD21 ' A' ' 81' ' ' LEU . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' HD23 ' A' ' 81' ' ' LEU . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' CE1' ' A' ' 50' ' ' TYR . 23.6 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.46 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.523 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 67' ' ' ILE . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 18.7 m120 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.862 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 56' ' ' PRO . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 52' ' ' ASP . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 81' ' ' LEU . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.471 ' OE1' ' CE2' ' A' ' 102' ' ' PHE . 18.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 4' ' ' LEU . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 101' ' ' VAL . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.909 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' MET . . . . . 0.47 ' N ' ' HG ' ' A' ' 25' ' ' SER . 57.5 mtt . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 79' ' ' SER . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 26' ' ' SER . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.401 ' CB ' ' OD1' ' A' ' 72' ' ' ASN . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.614 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.471 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 49' ' ' ILE . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' N ' HG22 ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 96.3 m-20 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 64' ' ' SER . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.437 HG13 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.581 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.489 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mt-30 -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 11' ' ' SER . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 79' ' ' SER . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.524 HE22 ' HE1' ' A' ' 94' ' ' TYR . 3.7 mp0 -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 63' ' ' PHE . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' N ' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.456 ' N ' ' C ' ' A' ' 51' ' ' GLU . 31.4 m120 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' HH12 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.986 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 29' ' ' ILE . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.403 HD12 HD21 ' A' ' 76' ' ' LEU . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.407 ' C ' ' N ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HE1' HE22 ' A' ' 35' ' ' GLN . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 102' ' ' PHE . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 101' ' ' VAL . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.465 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.825 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 11' ' ' SER . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 81' ' ' LEU . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 61' ' ' ASP . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.473 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 29' ' ' ILE . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 18' ' ' VAL . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' A' ' 98' ' ' ASN . 1.3 m-20 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.199 0.047 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.481 HD23 ' CA ' ' A' ' 24' ' ' GLY . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 81' ' ' LEU . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 4' ' ' LEU . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.607 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' THR . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 59.3 m-20 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 59' ' ' VAL . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 77' ' ' THR . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.879 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' SER . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG13 HD21 ' A' ' 76' ' ' LEU . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.867 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 97' ' ' SER . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 100' ' ' VAL . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 102' ' ' PHE . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 C--O 1.23 0.066 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 5' ' ' THR . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 76' ' ' LEU . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.617 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.748 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 83.3 m-20 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.64 ' HE ' HG23 ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.913 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 100' ' ' VAL . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.636 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.682 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 94.6 m-20 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLN . . . . . 0.406 ' HA ' HH22 ' A' ' 55' ' ' ARG . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' NH2' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' HD11 ' A' ' 29' ' ' ILE . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.588 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.743 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.673 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.651 HD23 ' HA2' ' A' ' 24' ' ' GLY . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 10' ' ' VAL . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.6 ' O ' HD23 ' A' ' 81' ' ' LEU . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.57 HG13 ' CG ' ' A' ' 63' ' ' PHE . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' OD2' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 56' ' ' PRO . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CG ' HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' OD2' ' A' ' 52' ' ' ASP . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.923 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.464 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 13' ' ' SER . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' GLU . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.563 HD12 ' OXT' ' A' ' 111' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.555 HD23 ' HA2' ' A' ' 24' ' ' GLY . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 11' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 10' ' ' VAL . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 79' ' ' SER . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' LEU . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 25' ' ' SER . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.792 HE22 ' HB3' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' OD1' HD12 ' A' ' 67' ' ' ILE . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.9 m-20 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.572 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.471 HD12 ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.555 HD12 HD21 ' A' ' 76' ' ' LEU . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 17' ' ' THR . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.572 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 86' ' ' GLU . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE1' HG23 ' A' ' 100' ' ' VAL . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.23 0.048 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.649 HD23 ' HA2' ' A' ' 24' ' ' GLY . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.689 HG23 HD13 ' A' ' 81' ' ' LEU . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.649 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' OE1' ' CE2' ' A' ' 50' ' ' TYR . 5.6 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.593 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG12 HG13 ' A' ' 49' ' ' ILE . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.712 HG22 ' N ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.712 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 51' ' ' GLU . 32.1 m120 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.445 HH11 HG12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CD1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' HD11 ' A' ' 29' ' ' ILE . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.433 ' HB3' HD11 ' A' ' 4' ' ' LEU . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.612 HD23 ' HA2' ' A' ' 24' ' ' GLY . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 81' ' ' LEU . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.557 HG22 ' HA ' ' A' ' 79' ' ' SER . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.425 ' N ' ' C ' ' A' ' 51' ' ' GLU . 36.0 m-20 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.608 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' HD11 ' A' ' 4' ' ' LEU . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 100' ' ' VAL . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 10' ' ' VAL . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 C--O 1.231 0.1 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.486 HD23 ' HA2' ' A' ' 24' ' ' GLY . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 79' ' ' SER . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 81' ' ' LEU . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 92' ' ' GLN . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 37' ' ' TYR . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 56' ' ' PRO . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.975 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 34' ' ' VAL . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 102' ' ' PHE . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.541 ' N ' HG12 ' A' ' 101' ' ' VAL . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 79' ' ' SER . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 81' ' ' LEU . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' ' OE1' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 88' ' ' ASP . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' HE ' ' A' ' 55' ' ' ARG . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' C ' ' N ' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 51' ' ' GLU . 65.3 m-20 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' PRO . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.626 HH22 ' CG ' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 1.0 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 76' ' ' LEU . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.531 ' HA ' HG22 ' A' ' 17' ' ' THR . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 18' ' ' VAL . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.626 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.427 ' OE1' ' CD1' ' A' ' 37' ' ' TYR . 17.1 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 100' ' ' VAL . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 83' ' ' THR . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.88 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.613 HD23 ' HA2' ' A' ' 24' ' ' GLY . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 20' ' ' ILE . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 5' ' ' THR . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.613 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 92' ' ' GLN . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 47' ' ' THR . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 37' ' ' TYR . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 63' ' ' PHE . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 90.4 m-20 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.637 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.667 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' HD11 ' A' ' 29' ' ' ILE . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 29' ' ' ILE . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 17' ' ' THR . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.868 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.615 HG22 ' HA ' ' A' ' 79' ' ' SER . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG23 HD22 ' A' ' 81' ' ' LEU . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 31' ' ' SER . 8.4 m120 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.461 ' CD1' ' CD ' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.705 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 49' ' ' ILE . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.601 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 98.1 m-20 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 56' ' ' PRO . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.529 ' HA ' HD11 ' A' ' 29' ' ' ILE . 40.2 t-20 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.615 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.713 HD22 HG23 ' A' ' 18' ' ' VAL . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.461 ' CD ' ' CD1' ' A' ' 37' ' ' TYR . 73.8 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 93' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 4' ' ' LEU . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 97' ' ' SER . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 10' ' ' VAL . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 79' ' ' SER . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 81' ' ' LEU . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 5' ' ' THR . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 92' ' ' GLN . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.62 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 46' ' ' THR . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' N ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.643 ' N ' HG22 ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.548 HH22 ' CG ' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.764 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 18' ' ' VAL . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 81' ' ' LEU . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.74 ' O ' HG13 ' A' ' 34' ' ' VAL . 56.6 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 109' ' ' THR . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' THR . . . . . 0.407 ' N ' HD12 ' A' ' 108' ' ' LEU . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.52 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' HD23 ' A' ' 81' ' ' LEU . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG23 HD22 ' A' ' 81' ' ' LEU . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.2 m-80 -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLN . . . . . 0.464 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 50' ' ' TYR . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.693 HG22 ' N ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.693 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' GLU . 23.5 p-10 -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 77' ' ' THR . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 29' ' ' ILE . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG13 HD21 ' A' ' 76' ' ' LEU . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.693 HD22 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' CYS . . . . . 0.52 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 1.055 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.573 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 40' ' ' ARG . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.464 ' HA ' HH21 ' A' ' 55' ' ' ARG . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.62 HG13 HD21 ' A' ' 76' ' ' LEU . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 102' ' ' PHE . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.496 ' N ' HG12 ' A' ' 101' ' ' VAL . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' LEU . . . . . 0.661 HD23 ' HA2' ' A' ' 24' ' ' GLY . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' O ' HD23 ' A' ' 81' ' ' LEU . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 81' ' ' LEU . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' GLY . . . . . 0.661 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.571 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.551 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' THR . . . . . 0.439 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 50' ' ' TYR . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' N ' HG22 ' A' ' 49' ' ' ILE . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASN . . . . . 0.431 ' ND2' ' OE1' ' A' ' 51' ' ' GLU . 9.1 m-20 -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' ALA . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' ALA . . . . . 0.551 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 102' ' ' PHE . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 102' ' ' PHE . . . . . 0.442 ' N ' HG12 ' A' ' 101' ' ' VAL . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.426 HD12 HG13 ' A' ' 10' ' ' VAL . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 111' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 108' ' ' LEU . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG23 HD13 ' A' ' 81' ' ' LEU . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 HD22 ' A' ' 76' ' ' LEU . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 37' ' ' TYR . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ASP . . . . . 0.857 ' OD2' HG23 ' A' ' 67' ' ' ILE . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' ILE . . . . . 0.857 HG23 ' OD2' ' A' ' 52' ' ' ASP . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HZ2' ' A' ' 36' ' ' TRP . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' SER . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ILE . . . . . 0.629 HG13 HD21 ' A' ' 76' ' ' LEU . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.837 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 34' ' ' VAL . 29.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 99' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 10' ' ' VAL . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' CE1' ' OG ' ' A' ' 26' ' ' SER . 1.1 m-85 -150.72 117.21 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.579 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp -155.89 165.9 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.797 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.5 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 10' ' ' VAL . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.637 ' O ' HD21 ' A' ' 81' ' ' LEU . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' HD23 ' A' ' 81' ' ' LEU . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.425 ' OG ' ' CE1' ' A' ' 2' ' ' PHE . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 3.0 m-80 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.452 ' OE1' ' CE1' ' A' ' 50' ' ' TYR . 23.6 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.46 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.523 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 67' ' ' ILE . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 18.7 m120 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.862 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 56' ' ' PRO . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 52' ' ' ASP . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.848 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 81' ' ' LEU . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.471 ' OE1' ' CE2' ' A' ' 102' ' ' PHE . 18.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 4' ' ' LEU . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.521 ' N ' HG12 ' A' ' 101' ' ' VAL . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.909 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -98.99 134.76 41.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.5 mtt -152.41 161.12 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.502 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 5.5 p-80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 79' ' ' SER . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 26' ' ' SER . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.401 ' CB ' ' OD1' ' A' ' 72' ' ' ASN . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.471 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 49' ' ' ILE . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' N ' HG22 ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 96.3 m-20 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.868 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 64' ' ' SER . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.437 HG13 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.581 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.489 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -128.69 128.93 45.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -143.79 159.37 42.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 1.8 mt-30 -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 11' ' ' SER . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 79' ' ' SER . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.524 HE22 ' HE1' ' A' ' 94' ' ' TYR . 3.7 mp0 -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' C ' ' CD1' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 63' ' ' PHE . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.456 ' C ' ' N ' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.456 ' N ' ' C ' ' A' ' 51' ' ' GLU . 31.4 m120 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.8 pt20 -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' HH12 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.986 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 29' ' ' ILE . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.811 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.403 HD12 HD21 ' A' ' 76' ' ' LEU . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.905 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.407 ' C ' ' N ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.524 ' HE1' HE22 ' A' ' 35' ' ' GLN . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 102' ' ' PHE . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 101' ' ' VAL . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.465 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.825 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.0 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.532 ' N ' ' CD1' ' A' ' 2' ' ' PHE . 1.4 m-85 -86.03 174.7 9.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.7 168.29 27.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.89 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 11' ' ' SER . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 81' ' ' LEU . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 28.7 m-20 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 61' ' ' ASP . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.473 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 29' ' ' ILE . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.875 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 18' ' ' VAL . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.458 ' N ' ' OD1' ' A' ' 98' ' ' ASN . 1.3 m-20 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.484 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 26.9 p90 -84.16 139.68 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.227 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt -155.99 171.2 20.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.903 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.481 HD23 ' CA ' ' A' ' 24' ' ' GLY . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 81' ' ' LEU . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 4' ' ' LEU . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.607 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.469 HG23 ' O ' ' A' ' 47' ' ' THR . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 59.3 m-20 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 59' ' ' VAL . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 77' ' ' THR . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.516 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.879 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' SER . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG13 HD21 ' A' ' 76' ' ' LEU . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.867 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 97' ' ' SER . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 58.7 t-80 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.475 ' O ' HG13 ' A' ' 100' ' ' VAL . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 102' ' ' PHE . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 1.6 m120 . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -155.22 122.21 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.043 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt -143.98 165.2 28.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 5' ' ' THR . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 76' ' ' LEU . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.617 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.748 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 83.3 m-20 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.64 ' HE ' HG23 ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.913 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 100' ' ' VAL . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 18.9 p90 -162.32 133.56 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.077 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt -154.04 161.59 41.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.529 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.636 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.682 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 8.4 mp0 -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 94.6 m-20 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' HA ' HH22 ' A' ' 55' ' ' ARG . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' NH2' ' H ' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' HD11 ' A' ' 29' ' ' ILE . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.909 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.588 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.656 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.743 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.673 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.35 126.99 41.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.138 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm -154.92 172.47 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.651 HD23 ' HA2' ' A' ' 24' ' ' GLY . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 10' ' ' VAL . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.6 ' O ' HD23 ' A' ' 81' ' ' LEU . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.652 HD13 ' N ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.57 HG13 ' CG ' ' A' ' 63' ' ' PHE . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' OD2' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 56' ' ' PRO . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CG ' HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' OD2' ' A' ' 52' ' ' ASP . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.923 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.464 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 13' ' ' SER . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' GLU . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.565 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.465 ' O ' HG13 ' A' ' 100' ' ' VAL . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.563 HD12 ' OXT' ' A' ' 111' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 33.9 t30 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' CD2' ' CB ' ' A' ' 26' ' ' SER . 2.3 t80 -131.76 119.22 20.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt -144.59 167.88 21.47 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD23 ' HA2' ' A' ' 24' ' ' GLY . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 11' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 10' ' ' VAL . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 79' ' ' SER . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' LEU . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' CD2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.548 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.792 HE22 ' HB3' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.604 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' OD1' HD12 ' A' ' 67' ' ' ILE . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 84.9 m-20 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.572 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.576 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.471 HD12 ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.519 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.863 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.555 HD12 HD21 ' A' ' 76' ' ' LEU . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 17' ' ' THR . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.646 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.572 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 86' ' ' GLU . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE1' HG23 ' A' ' 100' ' ' VAL . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -108.1 121.49 44.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm -148.63 172.3 14.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.649 HD23 ' HA2' ' A' ' 24' ' ' GLY . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.689 HG23 HD13 ' A' ' 81' ' ' LEU . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.649 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.612 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' OE1' ' CE2' ' A' ' 50' ' ' TYR . 5.6 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.593 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG12 HG13 ' A' ' 49' ' ' ILE . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.712 HG22 ' N ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.712 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.428 ' O ' ' N ' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.428 ' N ' ' O ' ' A' ' 51' ' ' GLU . 32.1 m120 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.445 HH11 HG12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CD1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' HD11 ' A' ' 29' ' ' ILE . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.737 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.987 HD23 ' H ' ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.433 ' HB3' HD11 ' A' ' 4' ' ' LEU . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 60.8 t30 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.441 ' CD1' ' CG ' ' A' ' 95' ' ' ASP . 2.1 m-85 -96.64 112.3 24.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.661 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt -154.58 169.74 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.817 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD23 ' HA2' ' A' ' 24' ' ' GLY . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 81' ' ' LEU . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.557 HG22 ' HA ' ' A' ' 79' ' ' SER . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.544 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 51.1 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.425 ' N ' ' C ' ' A' ' 51' ' ' GLU . 36.0 m-20 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.608 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.767 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' HD11 ' A' ' 4' ' ' LEU . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 100' ' ' VAL . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' CG ' ' CD1' ' A' ' 2' ' ' PHE . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 10' ' ' VAL . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.529 ' O ' ' CD1' ' A' ' 2' ' ' PHE . 18.0 p90 -144.41 129.44 18.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt -152.96 169.03 23.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.537 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD23 ' HA2' ' A' ' 24' ' ' GLY . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 79' ' ' SER . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 81' ' ' LEU . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 92' ' ' GLN . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 37' ' ' TYR . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 75.4 m-20 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 56' ' ' PRO . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.905 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.975 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 34' ' ' VAL . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 102' ' ' PHE . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.541 ' N ' HG12 ' A' ' 101' ' ' VAL . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.13 102.66 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp -150.86 172.06 16.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 79' ' ' SER . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 81' ' ' LEU . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.427 ' CD1' ' OE1' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 88' ' ' ASP . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' HE ' ' A' ' 55' ' ' ARG . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' C ' ' N ' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' N ' ' C ' ' A' ' 51' ' ' GLU . 65.3 m-20 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' PRO . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.626 HH22 ' CG ' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 1.0 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.798 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 76' ' ' LEU . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.531 ' HA ' HG22 ' A' ' 17' ' ' THR . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 18' ' ' VAL . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.626 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.427 ' OE1' ' CD1' ' A' ' 37' ' ' TYR . 17.1 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.56 ' O ' HG13 ' A' ' 100' ' ' VAL . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 83' ' ' THR . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.88 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -81.58 178.04 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp -155.37 172.15 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.091 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.613 HD23 ' HA2' ' A' ' 24' ' ' GLY . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 20' ' ' ILE . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.538 HD12 ' N ' ' A' ' 20' ' ' ILE . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 5' ' ' THR . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.613 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 92' ' ' GLN . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 47' ' ' THR . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 37' ' ' TYR . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 63' ' ' PHE . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 90.4 m-20 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.637 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.667 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' HD11 ' A' ' 29' ' ' ILE . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.537 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 29' ' ' ILE . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.891 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 17' ' ' THR . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.868 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.499 ' O ' HG13 ' A' ' 100' ' ' VAL . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.2 m120 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD2' ' OD1' ' A' ' 95' ' ' ASP . 8.1 m-85 -81.14 143.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.073 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp -151.02 165.24 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.615 HG22 ' HA ' ' A' ' 79' ' ' SER . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG23 HD22 ' A' ' 81' ' ' LEU . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.592 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.51 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 31' ' ' SER . 8.4 m120 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.481 ' CD ' ' N ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.461 ' CD1' ' CD ' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.705 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 49' ' ' ILE . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.601 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 98.1 m-20 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 56' ' ' PRO . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.529 ' HA ' HD11 ' A' ' 29' ' ' ILE . 40.2 t-20 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.841 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.615 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.713 HD22 HG23 ' A' ' 18' ' ' VAL . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.461 ' CD ' ' CD1' ' A' ' 37' ' ' TYR . 73.8 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 93' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 4' ' ' LEU . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 2' ' ' PHE . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 26.6 m-20 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 14.5 t80 -103.94 109.86 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.851 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -149.64 168.43 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.214 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 1.4 p-80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 10' ' ' VAL . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 79' ' ' SER . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 81' ' ' LEU . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 5' ' ' THR . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 92' ' ' GLN . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' CD ' ' N ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.62 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 46' ' ' THR . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' N ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.643 ' N ' HG22 ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.9 pt20 -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.548 HH22 ' CG ' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.764 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 18' ' ' VAL . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 81' ' ' LEU . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.594 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.74 ' O ' HG13 ' A' ' 34' ' ' VAL . 56.6 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.505 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 109' ' ' THR . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' THR . . . . . 0.407 ' N ' HD12 ' A' ' 108' ' ' LEU . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.6 174.22 7.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -156.14 170.12 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.729 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.52 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' HD23 ' A' ' 81' ' ' LEU . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG23 HD22 ' A' ' 81' ' ' LEU . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 1.2 m-80 -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLN . . . . . 0.464 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 50' ' ' TYR . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.693 HG22 ' N ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.693 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' O ' ' A' ' 51' ' ' GLU . 23.5 p-10 -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.9 pt20 -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 77' ' ' THR . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 29' ' ' ILE . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.827 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG13 HD21 ' A' ' 76' ' ' LEU . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.693 HD22 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.605 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' CYS . . . . . 0.52 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 2.1 t60 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 100' ' ' VAL . . . . . 0.484 ' O ' HG13 ' A' ' 100' ' ' VAL . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 1.055 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 42.4 m-20 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.468 ' C ' ' SD ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -95.34 109.85 21.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 3' ' ' MET . . . . . 0.468 ' SD ' ' C ' ' A' ' 2' ' ' PHE . 2.1 mpt? -154.61 167.28 30.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.92 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.573 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 40' ' ' ARG . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.464 ' HA ' HH21 ' A' ' 55' ' ' ARG . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.886 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.62 HG13 HD21 ' A' ' 76' ' ' LEU . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.6 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 102' ' ' PHE . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.496 ' N ' HG12 ' A' ' 101' ' ' VAL . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 20.4 p90 -98.12 125.7 43.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.07 169.59 24.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.797 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' LEU . . . . . 0.661 HD23 ' HA2' ' A' ' 24' ' ' GLY . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' O ' HD23 ' A' ' 81' ' ' LEU . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 81' ' ' LEU . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' GLY . . . . . 0.661 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.551 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' THR . . . . . 0.439 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 50' ' ' TYR . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' N ' HG22 ' A' ' 49' ' ' ILE . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLU . . . . . 0.457 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASN . . . . . 0.431 ' ND2' ' OE1' ' A' ' 51' ' ' GLU . 9.1 m-20 -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 5.1 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.839 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' ALA . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' ALA . . . . . 0.551 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 102' ' ' PHE . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' PHE . . . . . 0.442 ' N ' HG12 ' A' ' 101' ' ' VAL . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.426 HD12 HG13 ' A' ' 10' ' ' VAL . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 26' ' ' SER . 22.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 5.7 m-85 -147.54 116.11 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt -148.89 163.91 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 108' ' ' LEU . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG23 HD13 ' A' ' 81' ' ' LEU . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 HD22 ' A' ' 76' ' ' LEU . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 23.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 37' ' ' TYR . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ASP . . . . . 0.857 ' OD2' HG23 ' A' ' 67' ' ' ILE . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' N ' ' CD1' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ILE . . . . . 0.857 HG23 ' OD2' ' A' ' 52' ' ' ASP . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HZ2' ' A' ' 36' ' ' TRP . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' LEU . . . . . 0.779 HD23 ' O ' ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' SER . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ILE . . . . . 0.629 HG13 HD21 ' A' ' 76' ' ' LEU . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.837 HD23 ' H ' ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' N ' ' OD1' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 34' ' ' VAL . 29.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD2' ' CG ' ' A' ' 2' ' ' PHE . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 99' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 10' ' ' VAL . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp . . . . . 0 N--CA 1.457 -0.08 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.5 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 10' ' ' VAL . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.637 ' O ' HD21 ' A' ' 81' ' ' LEU . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' HD23 ' A' ' 81' ' ' LEU . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 80.2 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.46 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 67' ' ' ILE . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-20 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.862 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 56' ' ' PRO . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 52' ' ' ASP . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 81' ' ' LEU . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 102' ' ' PHE . 67.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 4' ' ' LEU . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.909 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . 0.47 ' N ' ' HG ' ' A' ' 25' ' ' SER . 57.5 mtt . . . . . 0 C--O 1.231 0.122 0 N-CA-C 110.502 -0.184 . . . . 0.0 110.502 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.7 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.0 p80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 79' ' ' SER . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 26' ' ' SER . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.401 ' CB ' ' OD1' ' A' ' 72' ' ' ASN . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.614 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.471 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 49' ' ' ILE . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.656 ' N ' HG22 ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 10.4 m120 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.868 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 64' ' ' SER . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.437 HG13 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.581 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.489 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 97' ' ' SER . 35.8 m170 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm . . . . . 0 C--O 1.231 0.111 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 11' ' ' SER . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 79' ' ' SER . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 63' ' ' PHE . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 77.0 m-20 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.496 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' HH12 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.986 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 29' ' ' ILE . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.811 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.403 HD12 HD21 ' A' ' 76' ' ' LEU . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.905 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.407 ' C ' ' N ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 102' ' ' PHE . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 101' ' ' VAL . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.465 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.465 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.825 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--O 1.231 0.107 0 N-CA-C 109.89 -0.411 . . . . 0.0 109.89 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 11' ' ' SER . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 81' ' ' LEU . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' SER . 7.6 m120 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 61' ' ' ASP . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.473 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 29' ' ' ILE . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.488 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.875 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 18' ' ' VAL . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.473 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.74 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.446 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.199 0.047 . . . . 0.0 110.903 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.481 HD23 ' CA ' ' A' ' 24' ' ' GLY . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 81' ' ' LEU . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 4' ' ' LEU . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.607 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' THR . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.4 m120 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 59' ' ' VAL . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 77' ' ' THR . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.879 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' SER . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.457 HG13 HD21 ' A' ' 76' ' ' LEU . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.867 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 97' ' ' SER . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 102' ' ' PHE . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt . . . . . 0 C--O 1.23 0.066 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 5' ' ' THR . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 76' ' ' LEU . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.617 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.748 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 9.4 m120 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.64 ' HE ' HG23 ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.913 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 100' ' ' VAL . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt . . . . . 0 CA--C 1.529 0.142 0 N-CA-C 110.529 -0.175 . . . . 0.0 110.529 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.636 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.682 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 12.4 m120 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.406 ' HA ' HH22 ' A' ' 55' ' ' ARG . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.518 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' HD11 ' A' ' 29' ' ' ILE . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.588 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.743 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.673 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm . . . . . 0 C--O 1.231 0.092 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.651 HD23 ' HA2' ' A' ' 24' ' ' GLY . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 10' ' ' VAL . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.6 ' O ' HD23 ' A' ' 81' ' ' LEU . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.57 HG13 ' CG ' ' A' ' 63' ' ' PHE . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.468 ' OD2' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 56' ' ' PRO . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CG ' HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' OD2' ' A' ' 52' ' ' ASP . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.923 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.464 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 13' ' ' SER . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' GLU . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.563 HD12 ' OXT' ' A' ' 111' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt . . . . . 0 C--O 1.232 0.164 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.555 HD23 ' HA2' ' A' ' 24' ' ' GLY . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 11' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 10' ' ' VAL . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 79' ' ' SER . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' LEU . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.473 ' CB ' ' O ' ' A' ' 25' ' ' SER . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.792 HE22 ' HB3' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.618 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.471 ' OD1' HD12 ' A' ' 67' ' ' ILE . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.459 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 9.0 m120 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.572 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.471 HD12 ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.555 HD12 HD21 ' A' ' 76' ' ' LEU . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 17' ' ' THR . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.572 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 86' ' ' GLU . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE1' HG23 ' A' ' 100' ' ' VAL . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm . . . . . 0 C--O 1.23 0.048 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.649 HD23 ' HA2' ' A' ' 24' ' ' GLY . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.689 HG23 HD13 ' A' ' 81' ' ' LEU . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.649 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 50' ' ' TYR . 7.5 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.593 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.585 HG12 HG13 ' A' ' 49' ' ' ILE . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.712 HG22 ' N ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.712 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 79.1 m-20 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.445 HH11 HG12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CD1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' HD11 ' A' ' 29' ' ' ILE . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.987 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.434 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.433 ' HB3' HD11 ' A' ' 4' ' ' LEU . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt . . . . . 0 C--O 1.232 0.18 0 N-CA-C 109.817 -0.438 . . . . 0.0 109.817 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.612 HD23 ' HA2' ' A' ' 24' ' ' GLY . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 81' ' ' LEU . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.557 HG22 ' HA ' ' A' ' 79' ' ' SER . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.429 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.429 HD22 ' C ' ' A' ' 52' ' ' ASP . 2.4 m120 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.554 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.608 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.767 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' HD11 ' A' ' 4' ' ' LEU . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 100' ' ' VAL . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 10' ' ' VAL . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt . . . . . 0 C--O 1.231 0.1 0 N-CA-C 110.537 -0.171 . . . . 0.0 110.537 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.486 HD23 ' HA2' ' A' ' 24' ' ' GLY . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 79' ' ' SER . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 81' ' ' LEU . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 92' ' ' GLN . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 37' ' ' TYR . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 56' ' ' PRO . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.905 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.975 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 34' ' ' VAL . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 102' ' ' PHE . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.541 ' N ' HG12 ' A' ' 101' ' ' VAL . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp . . . . . 0 C--O 1.231 0.123 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 79' ' ' SER . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 81' ' ' LEU . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CD1' ' NE2' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 88' ' ' ASP . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' HE ' ' A' ' 55' ' ' ARG . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.469 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m120 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' PRO . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.626 HH22 ' CG ' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 1.0 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 76' ' ' LEU . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.531 ' HA ' HG22 ' A' ' 17' ' ' THR . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 18' ' ' VAL . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.626 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 37' ' ' TYR . 58.5 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 100' ' ' VAL . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 83' ' ' THR . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.88 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp . . . . . 0 C--O 1.231 0.111 0 N-CA-C 110.091 -0.337 . . . . 0.0 110.091 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.613 HD23 ' HA2' ' A' ' 24' ' ' GLY . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 20' ' ' ILE . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 5' ' ' THR . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.613 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 92' ' ' GLN . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 47' ' ' THR . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 37' ' ' TYR . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 63' ' ' PHE . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 14.2 m120 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.637 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.667 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.637 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' HD11 ' A' ' 29' ' ' ILE . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 29' ' ' ILE . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.891 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 17' ' ' THR . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.868 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 100' ' ' VAL . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp . . . . . 0 C--O 1.231 0.087 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.615 HG22 ' HA ' ' A' ' 79' ' ' SER . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.713 HG23 HD22 ' A' ' 81' ' ' LEU . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.494 ' OG ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' OG ' ' A' ' 31' ' ' SER . 9.5 m-80 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.705 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 49' ' ' ILE . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.601 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 9.2 m120 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 56' ' ' PRO . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.576 ' C ' HD22 ' A' ' 72' ' ' ASN . 0.2 OUTLIER 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.841 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.615 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.713 HD22 HG23 ' A' ' 18' ' ' VAL . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 23.4 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 4' ' ' LEU . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.459 ' C ' ' H ' ' A' ' 97' ' ' SER . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.231 0.095 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.762 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.5 p80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 10' ' ' VAL . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 79' ' ' SER . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 81' ' ' LEU . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 5' ' ' THR . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.616 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 92' ' ' GLN . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.62 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 46' ' ' THR . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' N ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.643 ' N ' HG22 ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.548 HH22 ' CG ' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.764 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 18' ' ' VAL . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 81' ' ' LEU . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.74 ' O ' HG13 ' A' ' 34' ' ' VAL . 18.4 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 109' ' ' THR . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . 0.407 ' N ' HD12 ' A' ' 108' ' ' LEU . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.143 0 N-CA-C 110.729 -0.101 . . . . 0.0 110.729 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.52 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' HD23 ' A' ' 81' ' ' LEU . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.693 HG23 HD22 ' A' ' 81' ' ' LEU . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . 0.464 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 50' ' ' TYR . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.693 HG22 ' N ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.693 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.941 HD22 ' H ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . 0.426 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 77' ' ' THR . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 29' ' ' ILE . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.827 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.412 HG13 HD21 ' A' ' 76' ' ' LEU . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.693 HD22 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . 0.52 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 1.055 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.1 mpt? . . . . . 0 C--O 1.231 0.098 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.573 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 40' ' ' ARG . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.464 ' HA ' HH21 ' A' ' 55' ' ' ARG . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.886 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.62 HG13 HD21 ' A' ' 76' ' ' LEU . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 102' ' ' PHE . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.496 ' N ' HG12 ' A' ' 101' ' ' VAL . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.111 0 N-CA-C 109.797 -0.445 . . . . 0.0 109.797 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . 0.661 HD23 ' HA2' ' A' ' 24' ' ' GLY . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . 0.602 ' O ' HD23 ' A' ' 81' ' ' LEU . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 81' ' ' LEU . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . 0.661 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.571 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . 0.606 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.551 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . 0.439 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 50' ' ' TYR . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.463 ' N ' HG22 ' A' ' 49' ' ' ILE . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.448 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.839 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' ALA . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . 0.551 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 102' ' ' PHE . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . 0.442 ' N ' HG12 ' A' ' 101' ' ' VAL . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.426 HD12 HG13 ' A' ' 10' ' ' VAL . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt . . . . . 0 C--O 1.231 0.127 0 N-CA-C 109.856 -0.424 . . . . 0.0 109.856 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 108' ' ' LEU . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' VAL . . . . . 0.478 HG23 HD13 ' A' ' 81' ' ' LEU . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 HD22 ' A' ' 76' ' ' LEU . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 37' ' ' TYR . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ASP . . . . . 0.857 ' OD2' HG23 ' A' ' 67' ' ' ILE . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ARG . . . . . 0.513 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' ILE . . . . . 0.857 HG23 ' OD2' ' A' ' 52' ' ' ASP . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HZ2' ' A' ' 36' ' ' TRP . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' SER . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ILE . . . . . 0.629 HG13 HD21 ' A' ' 76' ' ' LEU . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 10' ' ' VAL . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m-80 . . . . . 0 N--CA 1.49 1.55 0 N-CA-C 108.795 -0.817 . . . . 0.0 108.795 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.425 ' CE1' ' OG ' ' A' ' 26' ' ' SER . 1.1 m-85 -150.72 117.21 5.73 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.682 -0.69 . . . . 0.0 109.579 177.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 55.8 mtp -155.89 165.9 35.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.745 -0.662 . . . . 0.0 109.797 178.745 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.5 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.5 mt -116.95 149.04 40.84 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 121.131 0.491 . . . . 0.0 110.013 179.52 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.4 m -123.77 125.18 44.27 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.79 178.28 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.53 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -129.77 -176.43 0.54 Allowed Pre-proline 0 C--N 1.33 -0.258 0 CA-C-N 115.452 -0.795 . . . . 0.0 109.189 -179.578 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.7 Cg_exo -74.69 147.89 36.01 Favored 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.363 2.042 . . . . 0.0 111.885 177.017 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 94.5 m-70 -70.54 -40.84 73.19 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 0.0 110.853 178.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -164.51 145.72 8.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.02 -0.536 . . . . 0.0 110.086 -177.469 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.435 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -154.59 154.49 6.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-O 120.952 0.406 . . . . 0.0 110.534 -179.691 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.435 ' N ' HG22 ' A' ' 10' ' ' VAL . 38.8 m -133.88 160.6 37.15 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.436 -179.02 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.4 tp10 -156.15 143.06 18.88 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.174 -0.466 . . . . 0.0 110.813 -179.643 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.637 ' O ' HD21 ' A' ' 81' ' ' LEU . 19.2 m -86.33 154.7 57.17 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.634 -178.762 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.92 156.32 34.04 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 121.751 1.634 . . . . 0.0 111.49 -178.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 87.77 -35.38 3.52 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.612 -0.995 . . . . 0.0 110.612 177.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.522 ' O ' HD23 ' A' ' 81' ' ' LEU . 42.0 mmtm -77.77 177.11 8.42 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.93 0.395 . . . . 0.0 110.746 179.777 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 62.3 p -98.73 166.25 11.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.712 179.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 40.1 t -118.99 130.38 73.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 121.424 0.63 . . . . 0.0 109.412 176.511 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 50.9 m -118.3 123.96 46.64 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.038 -0.726 . . . . 0.0 109.038 179.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.468 ' CD1' ' CD2' ' A' ' 89' ' ' TYR . 65.4 mt -114.26 115.12 48.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.978 175.727 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 13.4 t -106.86 125.02 50.46 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.522 -0.308 . . . . 0.0 110.261 179.137 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.53 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.5 m -120.73 116.47 25.32 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 179.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 34.3 m -94.27 138.71 31.96 Favored 'General case' 0 N--CA 1.463 0.22 0 O-C-N 121.989 -0.444 . . . . 0.0 110.185 -178.451 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.5 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -100.35 127.75 9.35 Favored Glycine 0 CA--C 1.523 0.571 0 N-CA-C 111.504 -0.639 . . . . 0.0 111.504 179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 2.2 t -100.48 89.32 3.9 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 110.491 -0.188 . . . . 0.0 110.491 178.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.425 ' OG ' ' CE1' ' A' ' 2' ' ' PHE . 3.6 p 167.03 -79.25 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.09 -178.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -133.39 -173.53 13.28 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.525 -1.03 . . . . 0.0 110.525 -177.156 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 9.9 p -60.38 133.65 56.3 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.067 175.448 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.62 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.3 pp -76.11 -4.35 6.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.742 -179.137 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.62 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -94.12 -11.08 31.28 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.451 -177.22 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 85.8 p -77.06 -8.99 58.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.898 177.039 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.6 m120 -139.46 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.103 179.542 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.3 OUTLIER -81.88 146.92 29.58 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 108.91 -0.774 . . . . 0.0 108.91 -177.501 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 91.7 t -121.28 136.61 57.66 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 N-CA-C 109.868 -0.419 . . . . 0.0 109.868 -179.199 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.607 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 80.2 mt-30 -119.51 160.1 23.05 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.27 -0.641 . . . . 0.0 109.27 -179.13 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 10.6 m95 -126.84 147.13 50.05 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.898 0.38 . . . . 0.0 110.609 -177.739 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.46 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 29.2 m-85 -140.31 154.4 46.78 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 109.642 -177.463 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.601 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.6 mm100 -132.35 139.09 48.0 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 109.03 -0.73 . . . . 0.0 109.03 178.362 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -121.13 103.85 9.32 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.734 -0.666 . . . . 0.0 110.008 -179.88 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.6 mtm180 -80.95 148.88 65.69 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.322 177.112 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.61 130.6 41.09 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.902 1.734 . . . . 0.0 111.224 178.302 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.13 -13.5 3.38 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.907 -0.877 . . . . 0.0 110.907 176.935 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.433 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.1 OUTLIER -100.76 175.58 5.59 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.884 -0.413 . . . . 0.0 109.884 -179.153 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -100.41 172.82 4.18 Favored Pre-proline 0 C--N 1.33 -0.263 0 N-CA-C 109.548 -0.538 . . . . 0.0 109.548 -178.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -68.35 148.55 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.64 0 C-N-CA 122.117 1.878 . . . . 0.0 112.084 178.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 51.1 p -138.63 134.89 34.3 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.417 -0.356 . . . . 0.0 110.761 175.411 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.46 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 96.9 m -69.7 128.3 35.96 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 177.406 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.415 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 20.3 t -96.61 -39.48 9.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.354 179.557 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.523 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 14.8 mt -141.86 166.26 17.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 175.933 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.607 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 22.0 t80 -137.02 146.97 45.91 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.774 -0.648 . . . . 0.0 111.425 -179.221 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.432 ' C ' ' N ' ' A' ' 53' ' ' ASN . 21.3 mm-40 43.79 21.34 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.335 -0.848 . . . . 0.0 111.349 -178.884 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.465 ' OD2' HG23 ' A' ' 67' ' ' ILE . 8.3 t70 46.11 18.95 0.06 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.403 -0.362 . . . . 0.0 110.15 178.097 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.432 ' N ' ' C ' ' A' ' 51' ' ' GLU . 72.0 m-20 -112.69 -20.85 11.51 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 120.703 0.287 . . . . 0.0 111.081 -177.648 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 177.52 -175.61 0.15 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.225 -177.629 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 20.4 ptt-85 -135.28 154.95 79.05 Favored Pre-proline 0 C--N 1.33 -0.259 0 CA-C-N 116.066 -0.516 . . . . 0.0 110.458 -178.996 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.862 ' O ' HG12 ' A' ' 59' ' ' VAL . 2.4 Cg_endo -55.67 142.77 81.89 Favored 'Trans proline' 0 C--N 1.307 -1.609 0 C-N-CA 121.733 1.622 . . . . 0.0 110.835 -177.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -62.2 134.29 56.34 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 119.378 -0.929 . . . . 0.0 109.48 179.78 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 107.42 -26.31 18.79 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 175.294 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.862 HG12 ' O ' ' A' ' 56' ' ' PRO . 11.4 p -75.25 143.67 77.17 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 178.747 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -55.86 148.54 56.02 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 CA-C-N 119.996 1.034 . . . . 0.0 110.53 -175.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -105.22 41.44 1.36 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.874 0.369 . . . . 0.0 110.406 -176.823 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.506 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 8.5 ptm180 -94.97 6.61 48.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.404 -0.362 . . . . 0.0 111.059 177.235 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.415 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.2 OUTLIER -120.4 150.88 40.08 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 110.282 -0.266 . . . . 0.0 110.282 178.075 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 7.7 t -150.48 119.06 6.49 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.338 177.56 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.82 140.36 14.99 Favored Glycine 0 CA--C 1.526 0.742 0 N-CA-C 111.368 -0.693 . . . . 0.0 111.368 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -138.33 144.46 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.082 -0.34 . . . . 0.0 110.082 179.598 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.465 HG23 ' OD2' ' A' ' 52' ' ' ASP . 9.8 pt -118.89 134.03 63.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 120.709 0.29 . . . . 0.0 111.119 179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.451 ' O ' HD11 ' A' ' 29' ' ' ILE . 39.7 m-20 -116.2 95.15 4.95 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.091 -178.245 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 48.6 p -60.55 -39.3 87.42 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 121.057 0.456 . . . . 0.0 110.229 178.424 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 16.0 m -62.38 -51.13 68.82 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.099 -178.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.1 t -81.97 -7.1 59.59 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.088 -0.506 . . . . 0.0 109.953 -178.757 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.459 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 0.6 OUTLIER 58.48 36.42 25.28 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.685 177.821 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 53.4 p -151.03 162.18 41.34 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.59 -179.864 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -110.63 149.63 30.16 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.144 -0.688 . . . . 0.0 109.144 -176.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -145.99 116.99 7.77 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.76 -176.864 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.848 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -96.87 138.26 34.7 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.092 0.472 . . . . 0.0 110.179 178.236 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 25.4 m -110.76 120.15 41.44 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.753 -0.658 . . . . 0.0 110.366 175.594 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 1.9 mt -111.19 145.75 17.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.63 -0.507 . . . . 0.0 109.63 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -116.88 164.49 14.6 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-O 121.038 0.447 . . . . 0.0 110.817 177.063 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 44.25 70.15 0.61 Allowed Glycine 0 CA--C 1.525 0.718 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.617 176.741 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.766 HD12 ' N ' ' A' ' 82' ' ' LYS . 0.2 OUTLIER -79.27 147.15 32.63 Favored 'General case' 0 C--N 1.33 -0.253 0 O-C-N 122.662 -0.317 . . . . 0.0 110.472 -179.136 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.766 ' N ' HD12 ' A' ' 81' ' ' LEU . 53.0 mttp -152.96 167.7 28.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.843 0.354 . . . . 0.0 111.163 173.323 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.477 ' C ' ' H ' ' A' ' 85' ' ' ASP . 63.4 p -48.53 -28.68 3.54 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.955 -0.566 . . . . 0.0 111.065 -178.722 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -54.83 -8.71 0.27 Allowed 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.601 175.635 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.506 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 15.5 m-20 -95.0 -31.49 13.59 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.669 178.346 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.8 tt0 -42.84 96.94 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.178 0 C-N-CA 120.284 -0.567 . . . . 0.0 111.232 -179.796 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.441 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.7 -177.62 1.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.767 -0.373 . . . . 0.0 110.828 -179.416 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.455 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 1.1 m-20 -96.33 134.4 39.52 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.148 178.266 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.601 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 17.9 m-85 -101.04 156.82 17.19 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.716 -0.675 . . . . 0.0 109.638 179.085 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.4 m-85 -139.59 143.5 37.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.553 -0.748 . . . . 0.0 109.706 -179.051 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 72.5 m -117.88 150.08 39.79 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.597 -1.26 . . . . 0.0 107.597 179.249 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.618 ' NE2' ' CE2' ' A' ' 102' ' ' PHE . 67.2 mt-30 -142.21 151.18 41.9 Favored 'General case' 0 C--N 1.331 -0.232 0 O-C-N 122.076 -0.39 . . . . 0.0 110.648 174.834 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.481 ' OG ' HD11 ' A' ' 4' ' ' LEU . 23.0 p -143.73 167.07 23.15 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.641 -178.481 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -118.24 140.9 49.11 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.963 0.411 . . . . 0.0 110.197 -179.819 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 70.8 m-20 -92.61 174.14 7.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.287 179.498 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 5.1 t -54.4 -37.2 64.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.132 178.908 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.9 p -75.36 9.27 2.2 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.59 -0.732 . . . . 0.0 110.33 -179.031 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 59.71 45.61 12.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.836 -0.62 . . . . 0.0 110.052 179.072 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 7.4 t-80 -113.1 129.14 56.6 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.241 -0.436 . . . . 0.0 109.898 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.5 p -63.12 139.7 20.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.01 -0.541 . . . . 0.0 110.655 -178.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.521 HG12 ' N ' ' A' ' 102' ' ' PHE . 65.1 t -127.66 161.09 36.13 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.399 179.032 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.618 ' CE2' ' NE2' ' A' ' 92' ' ' GLN . 16.8 m-85 -128.34 157.7 40.27 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.872 -0.604 . . . . 0.0 110.379 -178.876 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -111.45 175.0 17.2 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.642 -0.583 . . . . 0.0 111.642 179.483 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.92 -31.89 80.08 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.858 -0.897 . . . . 0.0 110.858 -178.438 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.67 176.84 33.97 Favored Glycine 0 CA--C 1.525 0.691 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.377 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.7 m -150.23 138.97 20.77 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.581 0.229 . . . . 0.0 110.481 178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 69.9 tttt -99.57 106.68 18.69 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.792 0.329 . . . . 0.0 110.544 179.373 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 15.1 tp -89.94 117.9 29.1 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.388 177.047 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 54.7 m -112.7 123.24 49.85 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.409 179.113 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 44.7 t -108.5 138.44 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 115.961 -0.563 . . . . 0.0 109.905 -179.524 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.909 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.214 -0.773 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -176.329 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.9 m-20 . . . . . 0 N--CA 1.49 1.551 0 N-CA-C 108.962 -0.755 . . . . 0.0 108.962 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 25.6 m-85 -98.99 134.76 41.37 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.371 179.034 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 57.5 mtt -152.41 161.12 43.05 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.502 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 4.5 mt -124.36 131.07 53.5 Favored 'General case' 0 C--N 1.334 -0.1 0 N-CA-C 109.854 -0.424 . . . . 0.0 109.854 -178.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 25.4 m -103.52 125.14 49.9 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.795 -0.639 . . . . 0.0 110.355 -179.605 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -139.68 161.25 57.53 Favored Pre-proline 0 C--N 1.33 -0.259 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.1 Cg_endo -55.75 156.25 19.49 Favored 'Trans proline' 0 C--N 1.307 -1.634 0 C-N-CA 122.071 1.847 . . . . 0.0 111.5 -179.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.7 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 3.0 p80 -82.33 -37.19 26.1 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.09 -0.504 . . . . 0.0 110.57 -179.819 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 1.4 m -162.0 154.68 19.98 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.626 -0.429 . . . . 0.0 110.646 -178.073 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.7 p -165.05 149.93 2.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.733 -179.666 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.3 t -141.16 164.28 30.69 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.237 -179.678 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 37.8 tp10 -156.2 155.91 33.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.245 -178.401 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 8.1 m -88.48 153.09 50.44 Favored Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.618 -0.264 . . . . 0.0 110.514 179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.8 Cg_exo -57.14 140.42 92.7 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.888 1.725 . . . . 0.0 110.839 -179.218 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 94.46 -31.14 7.0 Favored Glycine 0 CA--C 1.526 0.751 0 N-CA-C 111.224 -0.75 . . . . 0.0 111.224 176.256 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 2.6 tptt -72.3 -162.15 0.09 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.805 0.336 . . . . 0.0 110.218 179.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.581 HG22 ' HA ' ' A' ' 79' ' ' SER . 23.2 p -127.83 162.38 26.8 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.982 -0.554 . . . . 0.0 111.14 178.565 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 11.1 t -126.28 136.94 59.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.096 177.801 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 66.0 m -118.31 118.49 31.96 Favored 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.433 -0.58 . . . . 0.0 109.433 178.049 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 33.1 mm -113.3 121.1 64.84 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.188 177.379 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.0 m -103.55 136.71 42.76 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.48 -0.193 . . . . 0.0 110.48 179.989 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -123.35 116.95 24.15 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 107.923 -1.14 . . . . 0.0 107.923 177.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 25.3 m -111.71 132.6 54.51 Favored 'General case' 0 N--CA 1.465 0.292 0 O-C-N 121.543 -0.723 . . . . 0.0 110.07 -177.198 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.56 172.16 24.75 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.891 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.511 ' OG ' ' N ' ' A' ' 26' ' ' SER . 96.0 p -107.34 -95.97 0.37 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.96 0.41 . . . . 0.0 110.395 -178.474 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.511 ' N ' ' OG ' ' A' ' 25' ' ' SER . 5.4 t -64.67 -48.17 75.74 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.816 -179.13 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -84.99 144.82 21.22 Favored Glycine 0 CA--C 1.524 0.622 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -179.622 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.401 ' CB ' ' OD1' ' A' ' 72' ' ' ASN . 46.8 t -95.0 143.86 26.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.816 0.341 . . . . 0.0 110.334 178.459 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.614 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.4 pp -68.77 -0.78 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.494 -179.147 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.602 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.93 -25.81 11.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.453 -0.34 . . . . 0.0 110.094 179.172 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 86.6 p -71.63 -11.46 60.85 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.38 178.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -151.65 166.16 32.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.044 -179.371 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 8.3 m-85 -84.88 149.13 25.89 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.5 -0.318 . . . . 0.0 110.358 -179.719 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 68.0 t -124.89 137.86 56.11 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 CA-C-O 120.873 0.368 . . . . 0.0 110.097 -178.773 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 67.2 mt-30 -120.95 163.55 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.878 -0.416 . . . . 0.0 109.878 179.765 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.438 ' CD1' ' N ' ' A' ' 36' ' ' TRP . 37.6 m95 -121.36 149.42 42.98 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.206 -0.452 . . . . 0.0 110.778 -177.361 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.471 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 6.7 m-85 -144.37 154.52 43.08 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.938 -0.574 . . . . 0.0 109.792 -176.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.432 ' OE1' ' O ' ' A' ' 88' ' ' ASP . 1.8 mm-40 -131.55 132.46 44.17 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 108.574 -0.898 . . . . 0.0 108.574 178.065 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -118.99 97.95 5.94 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.311 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.482 ' NH2' ' O ' ' A' ' 84' ' ' GLU . 3.3 mtt180 -87.15 136.46 33.73 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.305 -0.861 . . . . 0.0 111.066 179.855 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.5 Cg_exo -58.58 143.21 98.52 Favored 'Trans proline' 0 C--N 1.31 -1.496 0 C-N-CA 121.142 1.228 . . . . 0.0 110.778 -179.688 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 81.98 -11.98 45.36 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 110.865 -0.894 . . . . 0.0 110.865 177.269 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 3.8 m -133.52 159.09 41.44 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.748 0.308 . . . . 0.0 110.229 -179.819 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -76.65 178.01 2.25 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-N 116.152 -0.476 . . . . 0.0 109.916 -178.097 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -75.03 156.11 42.81 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 122.377 2.051 . . . . 0.0 112.108 178.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 19.9 p -138.43 131.83 30.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.576 177.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.471 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 81.6 m -62.48 123.71 19.02 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.253 -0.43 . . . . 0.0 110.562 178.828 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.544 HG12 HG13 ' A' ' 49' ' ' ILE . 96.3 t -90.29 -43.05 14.45 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-N 115.956 -0.565 . . . . 0.0 109.833 179.705 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.656 HG22 ' N ' ' A' ' 50' ' ' TYR . 70.2 mt -144.37 170.59 7.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.975 -0.38 . . . . 0.0 109.975 178.099 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.656 ' N ' HG22 ' A' ' 49' ' ' ILE . 59.2 t80 -137.13 148.1 46.42 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.193 0.52 . . . . 0.0 111.138 -178.463 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.423 ' O ' ' N ' ' A' ' 53' ' ' ASN . 12.6 tt0 45.64 21.33 0.08 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.41 -0.814 . . . . 0.0 111.806 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 1.6 t0 46.55 19.15 0.07 Allowed 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.275 -0.421 . . . . 0.0 110.266 179.382 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.423 ' N ' ' O ' ' A' ' 51' ' ' GLU . 10.4 m120 -112.71 -20.72 11.56 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.889 -0.141 . . . . 0.0 111.06 -179.266 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER 168.94 169.3 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.096 -0.502 . . . . 0.0 109.939 -177.448 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.446 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -105.68 154.08 39.49 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 115.825 -0.625 . . . . 0.0 109.873 -178.667 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -56.81 156.14 24.52 Favored 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.249 1.299 . . . . 0.0 110.44 179.439 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -70.91 136.07 48.36 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.42 -0.512 . . . . 0.0 110.209 176.316 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.81 -38.86 3.09 Favored Glycine 0 CA--C 1.526 0.764 0 N-CA-C 111.237 -0.745 . . . . 0.0 111.237 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.427 HG22 ' H ' ' A' ' 59' ' ' VAL . 15.6 m -75.5 155.27 85.65 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 117.27 0.535 . . . . 0.0 110.628 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.1 166.28 2.32 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.958 1.772 . . . . 0.0 111.828 -177.595 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.545 ' O ' ' CD2' ' A' ' 63' ' ' PHE . 30.2 t70 -99.02 -115.12 0.15 Allowed 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.394 -0.367 . . . . 0.0 110.589 176.657 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.489 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 53.4 mtp180 64.97 -64.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.268 0 O-C-N 123.097 0.248 . . . . 0.0 110.377 177.677 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.545 ' CD2' ' O ' ' A' ' 61' ' ' ASP . 0.2 OUTLIER -70.63 136.93 49.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-O 121.221 0.534 . . . . 0.0 109.755 179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.453 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 4.2 t -139.48 127.37 22.13 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.44 -0.8 . . . . 0.0 109.921 178.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.423 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.09 145.24 17.69 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.382 -1.087 . . . . 0.0 110.382 -178.158 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.5 p -143.59 152.47 41.45 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 109.644 -0.502 . . . . 0.0 109.644 178.047 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.2 pp -125.59 143.55 38.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.221 0 CA-C-O 121.479 0.657 . . . . 0.0 110.817 -179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.46 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.8 m-20 -124.11 83.44 2.15 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.13 -0.941 . . . . 0.0 110.335 177.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 41.9 p -53.79 -34.57 59.52 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.034 -0.53 . . . . 0.0 110.59 179.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 44.2 m -64.54 -51.12 64.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.95 178.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.1 t -83.03 -7.84 59.61 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.239 -179.242 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.46 ' N ' ' O ' ' A' ' 68' ' ' ASP . 5.6 t30 59.39 36.89 23.39 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.359 -0.536 . . . . 0.0 110.442 178.399 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.7 p -149.64 154.07 38.03 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 115.855 -0.611 . . . . 0.0 110.204 -177.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.08 149.06 28.01 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 -175.249 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 68.9 m -141.22 116.86 10.28 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.859 -0.61 . . . . 0.0 110.866 -177.2 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.868 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -97.82 135.68 39.23 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 120.896 0.379 . . . . 0.0 110.244 179.365 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.414 ' N ' ' O ' ' A' ' 64' ' ' SER . 11.0 m -109.47 117.81 34.98 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.521 176.37 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.437 HG13 HD21 ' A' ' 76' ' ' LEU . 3.2 mt -103.57 131.63 51.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.361 -0.607 . . . . 0.0 109.361 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.581 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.5 OUTLIER -123.9 121.83 36.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.974 -0.557 . . . . 0.0 109.967 177.032 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 85.79 56.26 2.38 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 176.821 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 2.1 pp -75.03 151.5 38.72 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.727 0.299 . . . . 0.0 110.817 -178.664 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 18.3 mmtt -147.64 173.62 12.56 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.433 ' C ' ' H ' ' A' ' 85' ' ' ASP . 77.3 p -61.19 -30.37 70.37 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.275 0.559 . . . . 0.0 110.784 176.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.482 ' O ' ' NH2' ' A' ' 40' ' ' ARG . 95.8 mt-10 -54.86 -8.91 0.29 Allowed 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 115.09 -0.959 . . . . 0.0 110.016 177.776 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.489 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 89.9 m-20 -109.04 -22.52 12.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.0 178.176 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -40.24 97.32 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.774 -0.37 . . . . 0.0 111.405 178.613 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.416 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -178.97 -170.77 0.19 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.943 0.401 . . . . 0.0 111.137 -175.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.6 m-20 -93.81 148.29 22.27 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.534 -0.757 . . . . 0.0 111.392 -179.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -114.99 140.02 49.37 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.588 -0.733 . . . . 0.0 109.641 178.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 16.6 m-85 -122.74 153.89 38.87 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.25 179.493 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 2.3 m -117.96 146.3 44.08 Favored 'General case' 0 CA--C 1.532 0.284 0 N-CA-C 107.503 -1.295 . . . . 0.0 107.503 178.698 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 8.2 mt-30 -130.59 127.91 39.97 Favored 'General case' 0 N--CA 1.464 0.233 0 O-C-N 121.689 -0.632 . . . . 0.0 110.561 175.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 14.4 p -128.26 158.7 37.43 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.625 0.25 . . . . 0.0 110.748 -179.711 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -124.12 148.61 47.03 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.677 179.132 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 33.7 m-20 -109.46 175.49 5.43 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.279 -0.418 . . . . 0.0 110.339 179.992 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.8 m -63.63 -17.92 63.4 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.571 -179.775 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.453 ' O ' ' CD2' ' A' ' 99' ' ' HIS . 82.7 p -85.69 16.54 3.89 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.432 -0.349 . . . . 0.0 110.946 -178.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 9.4 m120 51.96 39.89 27.06 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.515 -0.311 . . . . 0.0 110.62 -179.255 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.453 ' CD2' ' O ' ' A' ' 97' ' ' SER . 35.8 m170 -113.25 144.84 42.03 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.947 -0.39 . . . . 0.0 109.947 -179.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.43 HG12 ' H ' ' A' ' 100' ' ' VAL . 1.0 OUTLIER -89.56 138.71 18.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 178.577 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 70.4 t -125.32 150.14 30.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.114 -0.493 . . . . 0.0 109.891 178.603 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 44.8 m-85 -116.48 135.67 53.63 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.841 178.848 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.51 174.92 45.38 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 110.896 -0.881 . . . . 0.0 110.896 -179.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.77 -26.99 69.29 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 111.029 -0.829 . . . . 0.0 111.029 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 68.23 153.4 0.47 Allowed Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 -177.33 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.4 m -124.89 151.35 45.46 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.749 0.309 . . . . 0.0 110.519 -179.868 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 72.6 tttt -92.78 128.44 38.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.637 178.065 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 28.4 tp -108.65 129.66 55.34 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.363 -0.38 . . . . 0.0 110.704 175.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 71.3 m -121.34 137.82 54.53 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.397 179.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 86.2 t -117.72 138.27 48.94 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.187 -178.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 7.4 mt . . . . . 0 C--O 1.221 -0.398 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.409 -178.27 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 N--CA 1.491 1.58 0 N-CA-C 108.694 -0.854 . . . . 0.0 108.694 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 10.4 m-85 -128.69 128.93 45.05 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 177.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.1 mtm -143.79 159.37 42.64 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -124.63 146.45 49.08 Favored 'General case' 0 C--N 1.333 -0.152 0 N-CA-C 109.188 -0.671 . . . . 0.0 109.188 178.108 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 52.9 m -120.76 122.3 40.08 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.977 -179.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.474 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -136.63 -179.23 1.01 Allowed Pre-proline 0 C--N 1.331 -0.206 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 -177.266 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.416 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 5.3 Cg_exo -72.5 144.87 41.28 Favored 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.34 2.027 . . . . 0.0 111.516 175.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.616 ' ND1' ' N ' ' A' ' 8' ' ' HIS . 0.1 OUTLIER -67.49 -39.08 85.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 178.805 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 45.7 t -167.5 162.04 14.2 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.187 -176.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.448 HG22 ' N ' ' A' ' 11' ' ' SER . 6.3 p -163.79 157.95 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 N-CA-C 109.892 -0.411 . . . . 0.0 109.892 -179.43 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.448 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.6 t -140.18 150.7 44.51 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 110.274 -0.269 . . . . 0.0 110.274 -179.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.564 ' OE1' ' N ' ' A' ' 13' ' ' SER . 2.0 tm-20 -156.24 156.32 33.9 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.329 -0.396 . . . . 0.0 110.265 -179.222 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.564 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.5 OUTLIER -88.84 148.77 42.22 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 119.45 -0.309 . . . . 0.0 110.525 178.249 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.3 Cg_exo -59.63 151.9 66.41 Favored 'Trans proline' 0 C--N 1.309 -1.535 0 C-N-CA 121.605 1.537 . . . . 0.0 111.51 178.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.71 -28.45 15.02 Favored Glycine 0 CA--C 1.525 0.707 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 176.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 12.0 mmtt -87.66 -160.84 0.65 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.795 0.331 . . . . 0.0 110.141 178.594 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.428 HG22 ' HA ' ' A' ' 79' ' ' SER . 35.5 p -126.71 156.68 40.72 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.799 -0.637 . . . . 0.0 110.994 179.09 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 6.9 t -123.49 136.23 60.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 115.549 -0.751 . . . . 0.0 109.555 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.2 m -121.23 116.57 25.14 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 178.129 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 61.9 mt -107.01 116.37 50.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.716 177.15 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 36.6 m -102.58 125.66 49.38 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 179.806 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.474 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 14.7 m -113.63 116.04 28.86 Favored 'General case' 0 CA--C 1.533 0.289 0 N-CA-C 106.621 -1.622 . . . . 0.0 106.621 -179.71 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.5 m -102.13 126.67 49.15 Favored 'General case' 0 N--CA 1.464 0.272 0 O-C-N 121.735 -0.603 . . . . 0.0 110.162 -177.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -87.82 150.31 22.24 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 111.029 -0.828 . . . . 0.0 111.029 -179.019 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 4.2 t -115.36 60.37 0.7 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.136 -0.532 . . . . 0.0 110.301 -178.586 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.1 t 176.24 -69.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.547 176.649 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -107.52 -179.64 22.25 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 110.642 -0.983 . . . . 0.0 110.642 179.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.455 ' C ' ' H ' ' A' ' 30' ' ' ALA . 1.8 t -95.32 143.82 26.39 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 121.054 0.454 . . . . 0.0 110.592 178.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -64.92 2.8 0.41 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.357 -0.838 . . . . 0.0 110.952 -179.248 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.455 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -109.66 -23.9 11.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.132 178.51 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 5.4 p -73.49 -8.21 54.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.933 -179.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -146.11 166.03 27.34 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.924 -0.398 . . . . 0.0 109.924 -178.233 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 21.4 m-85 -86.09 140.05 30.58 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 178.227 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.502 ' O ' ' N ' ' A' ' 52' ' ' ASP . 4.4 t -130.1 140.34 49.16 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 CA-C-O 120.9 0.381 . . . . 0.0 110.072 -178.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.487 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -126.25 160.27 30.78 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.974 179.173 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.616 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 13.9 m95 -124.69 155.1 39.78 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.122 0.487 . . . . 0.0 110.905 179.463 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.496 ' CD1' ' C ' ' A' ' 37' ' ' TYR . 2.8 p90 -158.28 154.83 27.8 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.414 -0.812 . . . . 0.0 109.828 -178.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.527 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.6 mm-40 -117.31 143.36 46.02 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 108.634 -0.876 . . . . 0.0 108.634 -177.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.6 tt0 -116.21 100.27 7.8 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -178.601 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.8 mtt180 -83.77 142.74 42.62 Favored Pre-proline 0 C--N 1.329 -0.31 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 176.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.415 ' C ' ' H ' ' A' ' 43' ' ' SER . 2.2 Cg_endo -54.74 133.17 55.86 Favored 'Trans proline' 0 C--N 1.309 -1.525 0 C-N-CA 121.405 1.404 . . . . 0.0 110.95 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 78.61 -29.09 2.04 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.93 -0.868 . . . . 0.0 110.93 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.415 ' H ' ' C ' ' A' ' 41' ' ' PRO . 6.8 t -86.98 162.92 17.38 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.754 0.311 . . . . 0.0 110.988 177.369 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.427 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -89.26 -179.12 1.16 Allowed Pre-proline 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.32 178.225 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.427 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.9 Cg_exo -67.89 131.05 23.07 Favored 'Trans proline' 0 C--N 1.308 -1.589 0 C-N-CA 122.096 1.864 . . . . 0.0 111.478 178.373 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 68.5 p -112.1 110.83 21.33 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.583 -0.281 . . . . 0.0 110.252 177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 6.9 m -47.81 122.92 5.38 Favored 'General case' 0 C--N 1.33 -0.276 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 177.734 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.438 HG13 ' CG ' ' A' ' 63' ' ' PHE . 9.8 t -95.11 -42.65 12.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 115.537 -0.756 . . . . 0.0 109.448 179.999 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.573 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.42 173.01 10.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.781 -0.451 . . . . 0.0 109.781 179.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.573 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 13.6 t80 -136.58 132.54 35.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 114.628 -1.169 . . . . 0.0 110.707 175.42 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.536 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 0.4 OUTLIER 63.78 21.21 12.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 113.746 -1.57 . . . . 0.0 110.571 176.364 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 34' ' ' VAL . 6.8 t70 46.35 18.78 0.06 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.941 177.848 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 77.0 m-20 -112.53 -42.31 3.68 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.659 -178.101 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -160.11 -171.0 3.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.954 -0.567 . . . . 0.0 109.885 -178.15 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.539 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -131.2 152.86 81.33 Favored Pre-proline 0 C--N 1.331 -0.231 0 N-CA-C 109.471 -0.566 . . . . 0.0 109.471 -179.451 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -55.9 155.86 21.51 Favored 'Trans proline' 0 C--N 1.307 -1.652 0 C-N-CA 121.301 1.334 . . . . 0.0 110.974 -178.404 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.85 140.23 53.19 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.261 177.177 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.66 -36.42 4.31 Favored Glycine 0 CA--C 1.526 0.721 0 N-CA-C 111.177 -0.769 . . . . 0.0 111.177 174.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.41 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.2 m -71.43 157.19 90.47 Favored Pre-proline 0 C--N 1.33 -0.267 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.246 179.809 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.23 154.18 54.02 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.334 1.356 . . . . 0.0 111.199 -176.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.496 ' CB ' HH21 ' A' ' 55' ' ' ARG . 0.1 OUTLIER -107.89 28.97 7.69 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.767 179.402 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.446 HH12 ' CG ' ' A' ' 85' ' ' ASP . 51.0 mtm180 -71.89 -21.39 61.65 Favored 'General case' 0 C--N 1.329 -0.305 0 C-N-CA 120.818 -0.353 . . . . 0.0 111.122 -179.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.539 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.2 OUTLIER -117.34 152.58 34.62 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 123.184 0.302 . . . . 0.0 110.329 -177.257 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.413 ' HA ' HH12 ' A' ' 55' ' ' ARG . 0.5 OUTLIER -143.28 149.81 38.38 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.913 -179.703 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -116.32 143.76 18.18 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.814 -0.914 . . . . 0.0 110.814 -178.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 75' ' ' SER . 8.7 t -147.5 148.37 31.14 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.976 0.417 . . . . 0.0 110.362 179.12 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.986 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -126.09 145.08 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 115.729 -0.669 . . . . 0.0 110.404 -177.542 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.0 m-20 -124.18 85.47 2.42 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.787 -178.604 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -52.74 -26.7 14.93 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.417 -0.513 . . . . 0.0 110.341 179.568 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 2.1 m -86.11 -51.06 6.55 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.067 -0.515 . . . . 0.0 111.325 -178.565 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -76.93 -0.62 24.95 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.588 -0.523 . . . . 0.0 109.588 -175.591 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 5.4 t30 48.14 36.7 6.94 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 114.94 -1.027 . . . . 0.0 110.647 179.748 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . 0.514 ' N ' HD12 ' A' ' 29' ' ' ILE . 6.6 p -145.77 149.57 34.62 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.583 -0.28 . . . . 0.0 110.772 179.083 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -103.47 148.37 26.02 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 -177.628 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.506 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.8 m -143.32 132.61 23.28 Favored 'General case' 0 C--N 1.331 -0.236 0 O-C-N 123.177 0.298 . . . . 0.0 111.122 -176.73 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.811 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -111.7 133.86 53.66 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.088 178.195 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 9.2 m -105.07 125.74 51.31 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.84 0.352 . . . . 0.0 110.815 175.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.403 HD12 HD21 ' A' ' 76' ' ' LEU . 6.7 mt -111.65 144.31 19.75 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.224 0 CA-C-N 115.985 -0.552 . . . . 0.0 109.988 179.887 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.428 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.8 OUTLIER -137.44 150.7 47.81 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.598 178.008 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.47 39.4 90.62 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 111.185 -0.766 . . . . 0.0 111.185 176.294 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.905 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.1 pt? -74.25 146.3 43.37 Favored 'General case' 0 C--N 1.329 -0.313 0 C-N-CA 120.869 -0.332 . . . . 0.0 110.705 -177.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 36.9 mtmt -138.93 170.37 16.11 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.371 -0.603 . . . . 0.0 109.371 -179.287 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.407 ' C ' ' N ' ' A' ' 85' ' ' ASP . 67.0 p -47.97 -27.43 2.2 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.124 0.488 . . . . 0.0 110.932 179.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 49.5 tt0 -54.96 -12.06 0.76 Allowed 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.403 -0.817 . . . . 0.0 109.818 178.648 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.446 ' CG ' HH12 ' A' ' 62' ' ' ARG . 35.7 m-20 -104.33 -26.97 12.25 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.834 177.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.407 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 73.8 tt0 -39.45 102.92 0.03 OUTLIER 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.915 -0.314 . . . . 0.0 111.395 178.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.407 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 175.07 -167.81 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.433 -0.348 . . . . 0.0 110.777 -176.92 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.433 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 2.5 m-20 -92.47 140.73 29.27 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.606 -179.199 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.527 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-85 -111.77 160.26 17.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.786 179.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.48 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 38.1 m-85 -154.41 159.28 41.01 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.096 -0.502 . . . . 0.0 111.611 -178.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.616 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 77.3 m -123.5 141.76 51.68 Favored 'General case' 0 CA--C 1.531 0.245 0 N-CA-C 107.449 -1.315 . . . . 0.0 107.449 179.188 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 42.0 mt-30 -121.55 136.48 54.95 Favored 'General case' 0 N--CA 1.463 0.217 0 O-C-N 121.52 -0.737 . . . . 0.0 109.723 175.155 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 23.2 p -135.09 165.47 25.3 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.693 0.282 . . . . 0.0 110.443 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 17.1 m-85 -120.24 136.01 54.8 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.587 -0.523 . . . . 0.0 109.587 178.658 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 22.2 p30 -94.86 175.86 6.49 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.292 179.918 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.5 p -61.53 -28.85 69.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.548 -179.458 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 8.3 p -71.33 1.06 6.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.619 -179.757 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER 65.0 31.5 11.18 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.143 179.587 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 22.7 m80 -113.32 134.53 54.57 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.8 -0.444 . . . . 0.0 109.8 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 4.8 p -68.73 145.96 13.1 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.316 -179.349 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.411 HG12 ' N ' ' A' ' 102' ' ' PHE . 55.0 t -133.25 157.06 42.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 N-CA-C 109.858 -0.423 . . . . 0.0 109.858 179.573 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.411 ' N ' HG12 ' A' ' 101' ' ' VAL . 47.6 p90 -121.06 153.18 37.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.448 179.781 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.08 170.34 24.81 Favored Glycine 0 CA--C 1.525 0.705 0 N-CA-C 110.881 -0.888 . . . . 0.0 110.881 -179.966 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.32 -34.0 83.0 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 -177.445 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 101.98 177.77 27.93 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 111.304 -0.718 . . . . 0.0 111.304 179.072 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 88.8 m -154.88 121.13 5.27 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.717 0.294 . . . . 0.0 110.59 179.206 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.465 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 54.5 tttm -79.01 116.52 19.36 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.445 178.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 17.7 tp -101.98 122.58 44.33 Favored 'General case' 0 C--N 1.33 -0.239 0 N-CA-C 109.15 -0.685 . . . . 0.0 109.15 179.814 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.465 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 52.4 m -110.3 117.6 34.07 Favored 'General case' 0 C--N 1.332 -0.176 0 N-CA-C 110.34 -0.244 . . . . 0.0 110.34 178.639 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 22.9 t -108.67 124.7 65.38 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.226 0 O-C-N 121.945 -0.472 . . . . 0.0 110.147 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.825 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.208 -1.09 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 -177.59 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 28.0 m120 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.532 ' CD1' ' N ' ' A' ' 2' ' ' PHE . 1.4 m-85 -86.03 174.7 9.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.856 -179.623 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.9 OUTLIER -154.7 168.29 27.34 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.89 -179.704 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 5.2 mt -121.95 139.98 53.01 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 121.089 0.471 . . . . 0.0 110.003 -179.192 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 123.16 47.46 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.67 -0.696 . . . . 0.0 109.723 179.708 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.491 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.03 159.9 51.37 Favored Pre-proline 0 C--N 1.33 -0.249 0 N-CA-C 109.25 -0.648 . . . . 0.0 109.25 179.125 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -55.17 139.62 80.64 Favored 'Trans proline' 0 C--N 1.306 -1.687 0 C-N-CA 121.932 1.754 . . . . 0.0 111.159 -179.022 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 35.7 t-80 -67.92 -34.01 75.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.361 177.552 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 23.9 t -170.94 148.28 2.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.063 -178.179 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.411 HG22 ' N ' ' A' ' 11' ' ' SER . 4.4 p -149.62 154.99 8.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.207 -0.451 . . . . 0.0 109.965 -177.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 109' ' ' THR . 10.9 t -141.14 154.61 45.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.912 -177.263 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.609 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.3 tm-20 -156.15 148.85 23.91 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.338 179.63 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.609 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 28.3 t -79.41 150.05 73.05 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.618 177.359 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.97 134.39 59.76 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.267 1.311 . . . . 0.0 110.913 -177.85 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 113.63 -32.33 6.11 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 22.5 mmtp -79.64 -157.37 0.13 Allowed 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.633 -0.333 . . . . 0.0 110.404 -178.608 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 73.1 p -132.08 161.31 33.56 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 121.005 0.431 . . . . 0.0 111.077 179.155 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.541 HG23 HD22 ' A' ' 81' ' ' LEU . 6.8 t -125.79 134.49 66.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.457 176.958 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.97 118.93 33.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 114.842 -1.072 . . . . 0.0 110.558 177.199 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.5 mt -108.37 116.33 51.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.109 -0.496 . . . . 0.0 109.987 178.026 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.7 p -103.77 126.72 51.1 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.553 -0.294 . . . . 0.0 110.42 179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.491 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -113.94 116.94 30.04 Favored 'General case' 0 N--CA 1.466 0.328 0 N-CA-C 107.527 -1.286 . . . . 0.0 107.527 178.561 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 27.0 m -112.98 131.27 55.82 Favored 'General case' 0 N--CA 1.463 0.204 0 O-C-N 122.077 -0.39 . . . . 0.0 110.023 -179.255 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -106.09 153.94 16.99 Favored Glycine 0 CA--C 1.525 0.662 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 -177.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.47 ' O ' ' CB ' ' A' ' 26' ' ' SER . 21.8 t -109.82 54.53 0.66 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.668 0.27 . . . . 0.0 110.951 -177.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.0 OUTLIER 161.73 -52.94 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.269 -0.423 . . . . 0.0 110.295 177.824 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -86.84 142.56 18.52 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.704 -0.958 . . . . 0.0 110.704 -179.133 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -93.64 141.38 28.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.194 0.521 . . . . 0.0 109.785 177.124 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.879 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.2 OUTLIER -75.05 1.67 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 115.529 -0.76 . . . . 0.0 110.569 -178.761 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -113.88 -27.18 7.85 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.611 179.134 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.46 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 82.4 p -81.14 -12.4 59.23 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.326 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.46 ' ND2' ' O ' ' A' ' 31' ' ' SER . 7.6 m120 -140.65 166.75 23.88 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 110.153 -0.314 . . . . 0.0 110.153 -177.755 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 14.2 m-85 -85.41 138.87 31.97 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.795 -0.446 . . . . 0.0 109.795 -179.82 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 27.2 t -122.39 134.96 64.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 121.348 0.594 . . . . 0.0 109.577 178.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.585 ' NE2' ' CZ ' ' A' ' 50' ' ' TYR . 74.5 mt-30 -124.64 150.79 45.66 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.979 -178.158 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.4 m95 -112.06 146.74 37.4 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.367 -176.273 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.522 ' CE1' ' OE1' ' A' ' 92' ' ' GLN . 52.9 m-85 -137.6 154.36 49.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.621 -0.718 . . . . 0.0 109.687 -178.061 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.555 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.7 mm-40 -129.93 143.57 50.87 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 179.553 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.469 ' CD ' ' CE1' ' A' ' 90' ' ' TYR . 7.5 mt-30 -117.42 97.87 6.11 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 179.875 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 6.5 ttm180 -87.14 120.04 71.23 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.662 -0.699 . . . . 0.0 110.326 178.723 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -56.85 124.73 16.95 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 CA-C-N 120.059 1.057 . . . . 0.0 110.771 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 107.14 -15.1 39.95 Favored Glycine 0 CA--C 1.526 0.771 0 N-CA-C 111.52 -0.632 . . . . 0.0 111.52 177.836 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.5 p -135.92 175.05 9.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 117.044 0.422 . . . . 0.0 110.812 -178.351 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.432 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.7 OUTLIER -77.53 -178.76 1.07 Allowed Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.968 -0.56 . . . . 0.0 110.138 -177.158 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.432 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 6.1 Cg_exo -71.22 154.03 61.88 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.511 2.141 . . . . 0.0 111.855 176.708 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 53.1 m -135.62 128.5 31.26 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.592 178.366 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 57.6 p -65.05 128.48 35.95 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.372 -0.376 . . . . 0.0 110.4 176.007 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 3.2 t -97.0 -39.77 9.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.204 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.434 -177.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.494 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 6.1 mt -145.17 162.4 12.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.141 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.585 ' CZ ' ' NE2' ' A' ' 35' ' ' GLN . 0.1 OUTLIER -130.5 153.35 48.91 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.372 -179.195 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.524 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 34.7 mm-40 44.06 21.62 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.567 -0.742 . . . . 0.0 110.624 -178.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.482 ' N ' ' O ' ' A' ' 50' ' ' TYR . 5.4 t0 46.58 19.67 0.09 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.771 -0.65 . . . . 0.0 110.816 178.063 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.524 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 47.4 m-80 -112.01 -31.25 6.97 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.844 -0.428 . . . . 0.0 109.844 -178.453 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -179.02 174.9 1.03 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.406 -179.61 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.445 ' HE ' ' HA ' ' A' ' 61' ' ' ASP . 5.4 ptt-85 -104.7 157.19 34.68 Favored Pre-proline 0 C--N 1.329 -0.292 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 -178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.41 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.5 Cg_endo -56.3 156.3 21.69 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.233 1.288 . . . . 0.0 110.716 -179.664 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 11.2 m -70.92 138.3 49.97 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 120.334 -0.546 . . . . 0.0 110.462 177.926 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.07 -37.07 3.99 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.431 -0.668 . . . . 0.0 111.431 174.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.422 ' H ' HG22 ' A' ' 59' ' ' VAL . 11.4 m -74.08 155.54 88.26 Favored Pre-proline 0 C--N 1.33 -0.245 0 C-N-CA 120.451 -0.5 . . . . 0.0 110.258 -178.539 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -51.22 164.11 0.8 Allowed 'Trans proline' 0 C--N 1.307 -1.612 0 C-N-CA 121.615 1.543 . . . . 0.0 110.844 -176.605 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 63' ' ' PHE . 46.8 m-20 -101.73 -115.41 0.19 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.585 177.518 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.473 HH22 ' CG ' ' A' ' 85' ' ' ASP . 24.4 mtm105 63.35 -58.83 0.17 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.091 -0.504 . . . . 0.0 111.054 178.159 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.478 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.4 OUTLIER -80.07 138.32 36.95 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.175 0.512 . . . . 0.0 110.577 -178.415 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.6 t -139.26 136.86 35.37 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.422 -0.808 . . . . 0.0 110.838 176.18 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.494 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.81 147.93 18.84 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.372 -0.691 . . . . 0.0 111.372 -179.415 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.27 152.81 41.31 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 110.214 -0.291 . . . . 0.0 110.214 176.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 23.2 pt -129.83 142.74 43.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-O 121.028 0.442 . . . . 0.0 110.849 -179.569 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' HD11 ' A' ' 29' ' ' ILE . 74.3 m-20 -122.86 85.76 2.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.452 -0.794 . . . . 0.0 110.519 -176.164 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 91.0 p -48.83 -27.24 2.88 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.196 177.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.8 m -86.08 -51.31 6.4 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.121 -0.491 . . . . 0.0 111.63 -177.393 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 4.6 t -77.33 0.87 20.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.144 0.497 . . . . 0.0 109.724 -176.471 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.488 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.1 t30 49.39 32.9 4.91 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.237 -0.892 . . . . 0.0 110.326 178.989 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -146.43 155.77 42.81 Favored 'General case' 0 C--N 1.331 -0.21 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.296 -179.32 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -111.25 125.27 53.64 Favored 'General case' 0 C--N 1.33 -0.261 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 -176.13 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 9.4 m -118.46 126.77 52.76 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.758 -174.813 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.875 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -102.47 138.06 39.89 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.851 177.303 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 95.4 m -106.74 120.87 43.13 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.265 0.555 . . . . 0.0 110.784 175.028 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.5 mt -105.27 136.45 39.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 N-CA-C 109.44 -0.578 . . . . 0.0 109.44 178.444 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -120.53 133.74 55.36 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.583 178.601 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 66.4 63.53 3.88 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 177.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.541 HD22 HG23 ' A' ' 18' ' ' VAL . 2.0 pp -79.39 128.92 33.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.976 0.417 . . . . 0.0 111.124 179.211 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 41.7 mtpt -136.94 172.51 12.91 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 109.719 -0.475 . . . . 0.0 109.719 -178.148 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.461 ' C ' ' H ' ' A' ' 85' ' ' ASP . 12.9 p -48.76 -34.77 12.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.193 0.521 . . . . 0.0 110.975 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 97.0 mt-10 -54.98 -7.64 0.2 Allowed 'General case' 0 C--N 1.326 -0.431 0 CA-C-N 115.132 -0.94 . . . . 0.0 110.372 176.213 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.473 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.0 OUTLIER -106.23 -27.52 10.99 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 178.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.446 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 29.4 tt0 -41.53 95.44 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.812 -0.355 . . . . 0.0 111.431 -179.534 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.555 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -172.94 -169.33 0.55 Allowed 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.951 -178.592 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 78.2 m-20 -100.05 144.17 29.4 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.028 179.137 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.454 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 5.1 m-85 -110.99 159.92 17.29 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 115.833 -0.621 . . . . 0.0 109.644 -179.451 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.469 ' CE1' ' CD ' ' A' ' 39' ' ' GLN . 18.6 m-85 -150.54 150.45 31.26 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.687 -178.844 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 0.4 OUTLIER -134.24 141.68 47.09 Favored 'General case' 0 N--CA 1.464 0.227 0 N-CA-C 109.294 -0.632 . . . . 0.0 109.294 -178.155 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.522 ' OE1' ' CE1' ' A' ' 37' ' ' TYR . 61.2 mt-30 -130.48 136.17 48.71 Favored 'General case' 0 N--CA 1.462 0.159 0 O-C-N 121.684 -0.635 . . . . 0.0 110.819 -177.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.1 p -119.07 166.57 12.73 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.242 -0.436 . . . . 0.0 110.552 179.228 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -126.42 143.12 51.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.055 0.455 . . . . 0.0 110.532 179.467 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 43.5 m-20 -97.12 -175.5 3.26 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.696 -0.683 . . . . 0.0 110.573 179.294 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.495 ' O ' ' ND2' ' A' ' 98' ' ' ASN . 5.4 m -71.41 -32.15 68.08 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.762 179.413 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 81.3 p -75.43 6.74 4.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.495 -179.629 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.74 ' N ' HD22 ' A' ' 98' ' ' ASN . 0.6 OUTLIER 60.8 46.1 9.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.705 -179.868 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.5 t-80 -113.1 132.71 55.33 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.364 178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 3.3 p -67.07 142.42 16.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.507 -179.465 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 89.4 t -134.05 140.63 45.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 178.314 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.407 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 20.6 p90 -123.49 144.79 49.31 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.925 0.393 . . . . 0.0 110.695 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.76 175.18 27.47 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 111.158 -0.777 . . . . 0.0 111.158 -179.578 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.73 -34.14 80.85 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.743 -0.943 . . . . 0.0 110.743 179.503 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.42 -163.67 24.08 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 179.505 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 55.4 m -156.51 143.67 18.92 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.277 -0.268 . . . . 0.0 110.277 -178.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.3 tttm -104.79 113.69 27.44 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.894 0.378 . . . . 0.0 111.474 -179.915 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.2 tp -93.91 118.88 32.07 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.789 176.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.412 ' O ' ' OG ' ' A' ' 11' ' ' SER . 61.9 m -110.28 119.06 38.03 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.522 177.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.446 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 43.6 t -93.81 129.02 44.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.938 0.399 . . . . 0.0 110.459 179.866 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 6.9 mt . . . . . 0 C--O 1.22 -0.477 0 CA-C-O 117.849 -1.072 . . . . 0.0 109.941 -175.458 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 18.4 m120 . . . . . 0 N--CA 1.49 1.547 0 N-CA-C 109.387 -0.597 . . . . 0.0 109.387 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.484 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 26.9 p90 -84.16 139.68 32.25 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.227 179.165 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 2.3 ttt -155.99 171.2 20.5 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.75 -0.38 . . . . 0.0 110.903 176.845 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.481 HD23 ' CA ' ' A' ' 24' ' ' GLY . 10.2 mt -118.66 140.49 49.83 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.923 0.392 . . . . 0.0 111.393 179.794 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 t -129.01 132.88 47.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.731 -179.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.586 ' OE1' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -145.68 164.29 26.69 Favored Pre-proline 0 C--N 1.33 -0.27 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 -177.371 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -52.74 136.86 59.48 Favored 'Trans proline' 0 C--N 1.306 -1.667 0 C-N-CA 122.23 1.953 . . . . 0.0 111.031 -177.683 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -36.41 73.46 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.33 -0.395 . . . . 0.0 110.125 179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 42.3 t -166.87 153.4 8.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.916 0.389 . . . . 0.0 110.98 -177.729 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 3.3 p -163.15 151.8 3.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.561 -178.761 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 25.0 m -127.7 152.83 47.22 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.319 -0.4 . . . . 0.0 110.307 -178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 35.4 tp10 -156.18 149.52 24.56 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.836 -177.823 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.8 t -100.85 153.94 37.44 Favored Pre-proline 0 C--N 1.331 -0.232 0 O-C-N 122.382 -0.199 . . . . 0.0 110.845 -179.956 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_exo -58.28 157.97 24.14 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 121.636 1.557 . . . . 0.0 111.106 -178.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 97.79 -33.47 5.88 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.736 -0.946 . . . . 0.0 110.736 177.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 16.8 mmtt -88.33 -164.48 1.13 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.884 0.373 . . . . 0.0 110.487 -179.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.627 HG22 ' HA ' ' A' ' 79' ' ' SER . 30.2 p -127.19 160.98 29.62 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.747 -0.661 . . . . 0.0 110.933 175.314 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.455 ' CG2' HD13 ' A' ' 81' ' ' LEU . 73.6 t -123.81 124.23 68.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 115.32 -0.855 . . . . 0.0 109.426 178.0 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 56.3 m -118.86 114.89 23.33 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 176.294 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 20.6 mt -102.19 133.6 45.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 N-CA-C 108.896 -0.779 . . . . 0.0 108.896 177.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 26.4 t -108.85 125.35 51.89 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 177.226 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 7.9 m -113.55 116.73 30.0 Favored 'General case' 0 CA--C 1.533 0.322 0 N-CA-C 106.878 -1.527 . . . . 0.0 106.878 174.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 80.8 m -112.93 142.92 45.05 Favored 'General case' 0 N--CA 1.465 0.321 0 O-C-N 121.669 -0.645 . . . . 0.0 110.557 -174.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.481 ' CA ' HD23 ' A' ' 4' ' ' LEU . . . -119.92 158.89 15.14 Favored Glycine 0 CA--C 1.524 0.655 0 N-CA-C 111.395 -0.682 . . . . 0.0 111.395 -179.171 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.505 ' C ' ' H ' ' A' ' 27' ' ' GLY . 4.1 t -118.13 143.66 46.3 Favored 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -179.351 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 59.83 -0.95 0.19 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.435 178.518 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.505 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -128.93 151.95 19.24 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.506 -1.038 . . . . 0.0 110.506 -177.377 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -103.39 143.68 32.37 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 121.101 0.477 . . . . 0.0 110.092 178.328 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.678 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -97.72 -14.74 7.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.936 -0.574 . . . . 0.0 110.434 179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.678 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -96.3 -17.01 21.01 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.832 -0.432 . . . . 0.0 109.832 179.478 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.9 m -83.09 -13.94 54.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.009 177.734 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 15.5 m120 -134.04 163.75 28.87 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.33 -178.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.7 m-85 -89.88 145.22 25.3 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.241 -177.856 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 95.5 t -124.27 141.94 42.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.18 0 N-CA-C 109.663 -0.495 . . . . 0.0 109.663 -177.227 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.471 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 62.5 mt-30 -123.75 153.88 40.29 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 178.344 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 75.5 m95 -112.67 144.73 41.67 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.441 -0.345 . . . . 0.0 110.369 -178.185 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -136.14 154.26 51.03 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.719 -178.367 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.607 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.2 tm0? -135.62 137.07 41.53 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 21.7 tt0 -119.63 97.8 5.81 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.433 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.0 OUTLIER -86.06 132.22 44.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 115.6 -0.727 . . . . 0.0 109.956 -179.426 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -57.44 135.52 70.37 Favored 'Trans proline' 0 C--N 1.309 -1.545 0 C-N-CA 120.998 1.132 . . . . 0.0 110.639 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 93.44 -8.07 74.92 Favored Glycine 0 CA--C 1.526 0.729 0 N-CA-C 111.477 -0.649 . . . . 0.0 111.477 177.782 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 74.5 m -136.72 176.35 8.78 Favored 'General case' 0 C--N 1.33 -0.244 0 O-C-N 122.527 -0.396 . . . . 0.0 110.27 178.278 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -92.74 174.31 4.17 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 -177.252 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -72.32 145.54 43.51 Favored 'Trans proline' 0 C--N 1.309 -1.547 0 C-N-CA 122.279 1.986 . . . . 0.0 111.764 178.086 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 54.9 m -137.21 134.84 36.71 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.223 177.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.469 ' O ' HG23 ' A' ' 47' ' ' THR . 11.7 t -60.53 133.13 55.8 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.753 176.76 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 14.4 t -96.97 -42.84 12.17 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.743 -178.887 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.561 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.8 mt -138.78 168.25 19.62 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 N-CA-C 109.675 -0.491 . . . . 0.0 109.675 177.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.561 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.3 OUTLIER -133.48 145.14 49.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.764 0.792 . . . . 0.0 111.073 -179.583 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.525 ' O ' ' N ' ' A' ' 53' ' ' ASN . 44.6 mt-10 44.08 21.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 114.722 -1.126 . . . . 0.0 111.349 -179.789 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.405 ' N ' ' C ' ' A' ' 50' ' ' TYR . 2.8 p30 45.86 18.77 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.018 -0.537 . . . . 0.0 109.723 175.261 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.525 ' N ' ' O ' ' A' ' 51' ' ' GLU . 3.4 m120 -112.91 -19.4 11.96 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.51 -178.493 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER 175.99 164.5 0.38 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.892 -177.184 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.429 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -108.77 154.57 41.68 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.232 178.962 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.411 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -57.06 156.48 24.23 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.433 1.422 . . . . 0.0 110.865 179.949 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.75 137.52 47.76 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 120.547 -0.461 . . . . 0.0 110.207 177.765 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.11 -36.26 4.45 Favored Glycine 0 CA--C 1.526 0.744 0 N-CA-C 110.882 -0.887 . . . . 0.0 110.882 175.249 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.435 ' H ' HG22 ' A' ' 59' ' ' VAL . 3.6 m -74.35 157.95 85.86 Favored Pre-proline 0 C--N 1.329 -0.285 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.204 -178.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_exo -55.64 161.37 7.93 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 121.694 1.596 . . . . 0.0 111.13 -176.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.429 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.7 OUTLIER -128.63 30.76 5.08 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.579 -0.282 . . . . 0.0 111.107 -179.818 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.539 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 7.9 mtm105 -78.14 -13.03 60.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.406 -0.361 . . . . 0.0 111.098 179.399 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.429 ' O ' ' NH1' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -118.21 155.37 30.64 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.02 0.438 . . . . 0.0 110.536 -178.678 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.434 ' O ' ' N ' ' A' ' 77' ' ' THR . 11.1 t -142.32 131.49 23.35 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.4 179.098 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -95.34 145.2 17.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 179.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.96 162.38 37.93 Favored 'General case' 0 C--N 1.331 -0.196 0 O-C-N 122.393 -0.475 . . . . 0.0 110.845 177.947 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 26.3 pt -129.08 139.87 50.73 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.176 0 CA-C-N 116.384 -0.371 . . . . 0.0 111.148 -179.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.522 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 0.4 OUTLIER -120.72 86.87 2.65 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.722 -178.16 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.9 p -61.06 -33.48 73.39 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.549 -0.461 . . . . 0.0 110.625 -179.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.9 m -62.86 -51.15 68.13 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.706 178.705 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.1 t -85.23 -8.61 58.47 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.974 -179.034 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.516 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 4.0 t30 59.84 28.6 18.11 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.614 -0.721 . . . . 0.0 110.717 -179.807 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.4 p -133.43 148.31 51.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.195 -179.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.76 142.58 35.25 Favored 'General case' 0 C--N 1.329 -0.306 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 -177.731 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -141.92 140.88 32.92 Favored 'General case' 0 C--N 1.329 -0.32 0 C-N-CA 120.445 -0.502 . . . . 0.0 110.698 -175.355 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.879 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.36 134.17 50.82 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.92 175.92 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.434 ' N ' ' O ' ' A' ' 64' ' ' SER . 8.5 m -105.43 118.57 36.89 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.579 178.492 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.457 HG13 HD21 ' A' ' 76' ' ' LEU . 3.3 mt -105.85 142.44 18.87 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 N-CA-C 109.331 -0.618 . . . . 0.0 109.331 178.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.627 ' HA ' HG22 ' A' ' 17' ' ' THR . 0.9 OUTLIER -120.28 136.26 54.73 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.11 -0.495 . . . . 0.0 110.167 179.363 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 45.3 71.61 0.47 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.606 -0.598 . . . . 0.0 111.606 176.539 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.867 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -77.82 165.14 24.52 Favored 'General case' 0 C--N 1.33 -0.276 0 O-C-N 122.65 -0.323 . . . . 0.0 111.628 178.176 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 28.1 mtpt -139.8 -174.11 3.82 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.48 173.666 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.412 ' C ' ' N ' ' A' ' 85' ' ' ASP . 3.7 m -61.68 -32.74 72.95 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 119.81 -0.756 . . . . 0.0 110.373 -179.721 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 76.6 mm-40 -54.95 -10.05 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.048 -178.136 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.539 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 1.2 m-20 -95.61 -9.26 32.64 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.312 -0.404 . . . . 0.0 110.219 176.685 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.449 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 77.6 tt0 -58.81 101.38 0.09 Allowed 'General case' 0 C--N 1.329 -0.287 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.767 179.279 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.607 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 176.82 -168.79 0.06 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.795 0.331 . . . . 0.0 110.738 179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.402 ' O ' ' CD ' ' A' ' 38' ' ' GLN . 25.6 m-20 -95.38 154.73 17.05 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.222 -0.444 . . . . 0.0 111.374 -179.528 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -123.84 142.99 50.61 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.852 -0.613 . . . . 0.0 109.894 179.333 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 60.7 m-85 -135.79 146.2 47.34 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.676 -0.693 . . . . 0.0 110.079 176.434 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.586 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -117.36 145.0 44.34 Favored 'General case' 0 N--CA 1.466 0.367 0 N-CA-C 106.83 -1.545 . . . . 0.0 106.83 179.397 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 82.0 mt-30 -124.34 134.14 53.24 Favored 'General case' 0 N--CA 1.463 0.198 0 O-C-N 121.879 -0.513 . . . . 0.0 110.788 176.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 8.9 p -118.28 160.33 21.82 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.489 179.025 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.1 m-85 -125.07 136.48 53.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.924 -0.58 . . . . 0.0 109.997 176.961 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.463 ' O ' ' N ' ' A' ' 97' ' ' SER . 3.6 m-20 -106.44 158.15 17.12 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.053 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 61.0 m -45.34 -18.38 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.718 -178.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.463 ' N ' ' O ' ' A' ' 95' ' ' ASP . 93.0 p -77.58 1.28 20.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.975 0.417 . . . . 0.0 110.648 179.683 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 0.4 OUTLIER 58.77 35.47 24.34 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.539 -179.458 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.6 t60 -113.24 134.31 54.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.847 0.356 . . . . 0.0 110.596 179.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.475 HG13 ' O ' ' A' ' 100' ' ' VAL . 10.5 p -76.63 129.56 37.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.984 179.804 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.47 HG12 ' N ' ' A' ' 102' ' ' PHE . 77.4 t -119.42 158.01 21.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 179.241 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.47 ' N ' HG12 ' A' ' 101' ' ' VAL . 1.5 m-85 -117.21 148.14 41.88 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 121.028 0.442 . . . . 0.0 110.029 -177.106 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -87.67 174.98 45.17 Favored Glycine 0 CA--C 1.524 0.618 0 N-CA-C 111.487 -0.645 . . . . 0.0 111.487 179.437 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.47 -34.2 88.69 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.893 -0.883 . . . . 0.0 110.893 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 94.51 174.24 38.53 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.284 -0.726 . . . . 0.0 111.284 -179.271 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 62.4 m -158.56 131.47 7.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.698 0.285 . . . . 0.0 110.413 -178.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 23.6 tttp -90.81 95.04 9.93 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.161 178.748 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 18.2 tp -81.32 129.63 34.69 Favored 'General case' 0 C--N 1.33 -0.261 0 C-N-CA 120.778 -0.369 . . . . 0.0 110.167 176.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 20.1 m -126.26 137.53 53.53 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.718 176.648 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 60.9 t -106.69 144.09 16.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.242 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.963 -179.804 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.219 -0.503 0 CA-C-O 118.071 -0.966 . . . . 0.0 110.289 -178.168 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.54 ' N ' ' ND2' ' A' ' 1' ' ' ASN . 0.2 OUTLIER . . . . . 0 N--CA 1.49 1.542 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 . . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -155.22 122.21 5.46 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.043 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 11.7 mmt -143.98 165.2 28.42 Favored 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 177.147 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 16.4 mt -121.74 129.31 52.6 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 121.146 0.498 . . . . 0.0 110.429 178.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 5' ' ' THR . 11.3 t -111.46 125.71 54.18 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.62 -0.718 . . . . 0.0 110.53 178.672 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.544 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.54 158.87 67.56 Favored Pre-proline 0 C--N 1.331 -0.235 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 -176.256 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -56.64 147.86 68.17 Favored 'Trans proline' 0 C--N 1.306 -1.677 0 C-N-CA 121.485 1.457 . . . . 0.0 111.016 -179.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' O ' ' OG ' ' A' ' 9' ' ' SER . 7.2 m80 -67.4 -42.0 84.03 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.407 -0.361 . . . . 0.0 110.394 -178.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.406 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 25.1 m -165.65 162.45 18.87 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.261 -0.575 . . . . 0.0 110.586 -178.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.481 HG22 ' N ' ' A' ' 11' ' ' SER . 5.6 p -163.86 158.24 1.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.14 -0.482 . . . . 0.0 109.848 -178.743 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.481 ' N ' HG22 ' A' ' 10' ' ' VAL . 3.8 t -140.88 156.76 46.04 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.391 179.654 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 24.7 tp10 -154.4 142.29 20.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.602 -179.325 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -87.47 151.45 50.74 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.974 -178.113 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.1 Cg_exo -58.33 152.93 50.29 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.576 1.517 . . . . 0.0 111.242 -178.581 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.43 -30.32 10.17 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 178.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 17.6 mmtm -88.85 -158.82 0.52 Allowed 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 110.086 -0.339 . . . . 0.0 110.086 -179.682 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 44.1 p -131.98 163.03 29.28 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.737 177.781 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 24.8 t -119.25 136.75 55.42 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-O 121.362 0.601 . . . . 0.0 110.217 177.572 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 23.9 m -127.32 115.78 19.51 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.24 -0.891 . . . . 0.0 109.348 175.807 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.425 HD12 HD22 ' A' ' 76' ' ' LEU . 70.5 mt -101.02 129.21 52.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 109.574 -0.528 . . . . 0.0 109.574 178.314 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -106.02 115.91 31.03 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 179.271 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.544 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.9 OUTLIER -113.67 116.24 29.13 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 176.141 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 7.4 m -113.4 143.01 45.2 Favored 'General case' 0 N--CA 1.463 0.213 0 O-C-N 122.064 -0.398 . . . . 0.0 110.762 -179.874 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -103.2 161.48 16.32 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.307 -0.717 . . . . 0.0 111.307 -179.324 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 27.0 t -129.12 145.26 51.33 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.749 0.309 . . . . 0.0 110.674 -177.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 28.6 t 56.01 14.7 1.5 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.604 179.098 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -159.55 168.41 35.39 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 -178.641 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.9 m -102.66 144.06 31.53 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.032 0.444 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.617 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -89.47 -9.07 10.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.295 -179.483 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.617 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.93 13.82 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.81 0.338 . . . . 0.0 110.618 -179.298 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.5 p -73.41 -7.12 50.36 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.896 177.84 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -138.95 161.25 37.8 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.808 -0.441 . . . . 0.0 109.808 -179.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -88.97 133.9 34.16 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.591 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 39.4 t -112.58 140.79 30.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 N-CA-C 109.918 -0.401 . . . . 0.0 109.918 -179.235 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 55.0 mt-30 -124.64 143.79 50.54 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 178.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 67.9 m95 -102.97 142.4 34.12 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 109.985 -0.376 . . . . 0.0 109.985 -177.508 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.4 m-85 -133.71 154.26 51.08 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.79 -0.448 . . . . 0.0 109.79 -178.472 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.748 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.5 tm0? -133.2 141.94 48.33 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 179.768 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.407 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -121.69 98.52 6.0 Favored 'General case' 0 C--N 1.333 -0.145 0 CA-C-O 120.918 0.39 . . . . 0.0 110.144 -179.705 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -87.33 148.9 45.74 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.645 178.446 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -54.81 133.66 58.73 Favored 'Trans proline' 0 C--N 1.309 -1.534 0 C-N-CA 121.525 1.483 . . . . 0.0 111.007 -177.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.42 -16.21 6.42 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 111.048 -0.821 . . . . 0.0 111.048 179.372 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.2 t -101.17 178.08 4.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.76 0.314 . . . . 0.0 110.499 -179.24 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.442 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.8 OUTLIER -113.28 178.0 1.06 Allowed Pre-proline 0 C--N 1.33 -0.24 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.062 179.777 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.442 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -64.82 134.18 39.34 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 122.236 1.958 . . . . 0.0 111.582 177.338 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 4.8 t -134.23 129.63 35.97 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.873 0.368 . . . . 0.0 110.344 177.43 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.433 ' H ' HG22 ' A' ' 47' ' ' THR . 0.0 OUTLIER -59.44 123.88 18.23 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.044 -0.526 . . . . 0.0 110.397 179.631 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 19.4 t -96.25 -34.81 5.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.707 -178.177 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 9.6 mt -140.8 163.73 21.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.784 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -131.57 156.97 44.82 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.598 179.989 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 89.8 mt-10 43.92 21.56 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.616 -176.741 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.453 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.1 OUTLIER 46.29 19.37 0.07 Allowed 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.506 -0.553 . . . . 0.0 109.506 176.839 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.449 ' N ' ' O ' ' A' ' 51' ' ' GLU . 9.4 m120 -112.38 -52.34 2.79 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.53 178.624 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -151.19 168.61 24.17 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -175.497 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.64 ' HE ' HG23 ' A' ' 59' ' ' VAL . 7.5 ptm85 -104.99 163.63 16.77 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.138 -179.854 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.8 Cg_endo -57.7 159.87 16.09 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.284 1.322 . . . . 0.0 111.417 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -72.02 134.1 45.68 Favored 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.377 -0.529 . . . . 0.0 110.312 178.729 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.84 -39.11 2.99 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 111.15 -0.78 . . . . 0.0 111.15 173.328 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.64 HG23 ' HE ' ' A' ' 55' ' ' ARG . 0.4 OUTLIER -74.15 159.91 82.8 Favored Pre-proline 0 C--N 1.33 -0.272 0 C-N-CA 120.587 -0.445 . . . . 0.0 110.062 -177.826 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.497 ' O ' ' CD ' ' A' ' 55' ' ' ARG . 5.0 Cg_exo -58.38 140.92 96.36 Favored 'Trans proline' 0 C--N 1.307 -1.635 0 C-N-CA 121.72 1.613 . . . . 0.0 110.995 -176.692 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 13.2 m-20 -104.57 20.76 18.0 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.625 -0.262 . . . . 0.0 110.989 -179.507 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.548 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 0.0 OUTLIER -70.97 -9.05 57.25 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.57 -0.452 . . . . 0.0 110.288 177.6 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 -108.9 147.83 31.58 Favored 'General case' 0 C--N 1.331 -0.216 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 178.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.43 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 7.4 t -144.39 127.68 16.77 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.028 -0.669 . . . . 0.0 110.369 177.724 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.479 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.2 147.5 18.63 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 111.218 -0.753 . . . . 0.0 111.218 178.674 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.41 159.59 43.18 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.708 0.29 . . . . 0.0 110.34 178.341 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -137.13 143.58 34.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.864 0.364 . . . . 0.0 110.377 -177.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.406 ' O ' ' N ' ' A' ' 72' ' ' ASN . 96.5 m-20 -120.33 87.26 2.71 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.164 179.182 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 m -57.37 -26.15 60.58 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.447 179.77 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 5.4 m -79.37 -51.21 9.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.018 -0.537 . . . . 0.0 110.815 -178.673 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 7.8 t -80.23 -6.49 57.94 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.901 -0.59 . . . . 0.0 109.882 -179.226 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.506 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.4 t30 59.25 33.57 22.68 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.692 -0.685 . . . . 0.0 110.647 179.437 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 8.8 p -137.57 158.81 43.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.967 0.413 . . . . 0.0 110.909 -178.679 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.79 144.74 44.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.142 -0.481 . . . . 0.0 109.762 -177.789 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 14.6 m -146.11 133.22 20.39 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.859 -176.4 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.913 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -108.87 134.44 51.55 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.212 177.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.421 ' N ' ' O ' ' A' ' 64' ' ' SER . 15.2 m -106.08 121.8 44.88 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.075 0.464 . . . . 0.0 110.752 176.102 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.49 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -108.13 136.35 43.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 N-CA-C 109.148 -0.686 . . . . 0.0 109.148 179.016 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 99.9 p -109.49 137.13 47.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.908 0.385 . . . . 0.0 110.719 178.152 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.03 76.33 0.19 Allowed Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.247 -0.741 . . . . 0.0 111.247 177.631 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.5 pp -74.59 154.16 38.69 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.601 0.238 . . . . 0.0 111.011 179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 32.5 mttp -151.64 168.42 25.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.934 0.397 . . . . 0.0 111.147 177.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 85' ' ' ASP . 60.7 p -60.86 -32.3 71.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.95 -0.568 . . . . 0.0 111.138 -177.734 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 3.0 pt-20 -55.01 -5.32 0.09 Allowed 'General case' 0 C--N 1.327 -0.408 0 CA-C-N 115.388 -0.824 . . . . 0.0 109.865 176.23 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 0.8 OUTLIER -107.82 -28.65 9.52 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-N 116.581 -0.281 . . . . 0.0 110.609 179.344 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.488 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 54.1 tt0 -35.77 109.21 0.08 Allowed 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.839 -0.344 . . . . 0.0 111.348 179.17 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.748 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 172.96 -173.2 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.305 0 O-C-N 123.406 0.441 . . . . 0.0 110.818 -179.473 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.449 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 73.5 m-20 -93.08 152.02 19.52 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.102 0.477 . . . . 0.0 110.82 -178.344 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.634 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.1 m-85 -118.29 133.19 56.1 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.529 178.67 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 15.3 m-85 -118.8 152.25 36.56 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.225 -0.443 . . . . 0.0 109.904 178.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 89.0 m -120.56 142.29 49.49 Favored 'General case' 0 CA--C 1.532 0.267 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -179.696 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 18.1 mt-30 -128.06 136.9 51.86 Favored 'General case' 0 N--CA 1.464 0.23 0 O-C-N 121.536 -0.727 . . . . 0.0 110.675 176.842 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 77.6 p -136.15 164.11 28.8 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.587 0.232 . . . . 0.0 110.778 -178.266 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -123.19 150.82 42.88 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.788 0.328 . . . . 0.0 110.557 -179.265 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t0 -109.77 -172.0 1.95 Allowed 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.288 179.882 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -70.27 -14.26 62.52 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.579 179.377 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.464 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 3.2 p -91.54 7.15 42.74 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.539 -179.429 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 57.76 40.45 26.26 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.492 -0.322 . . . . 0.0 110.882 -179.541 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.464 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.1 m80 -113.17 130.44 56.2 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 121.173 0.511 . . . . 0.0 110.197 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.464 ' H ' HG12 ' A' ' 100' ' ' VAL . 1.4 p -73.42 124.78 31.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.54 179.157 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 40.8 t -116.63 147.14 20.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.267 -0.424 . . . . 0.0 109.863 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 1.6 p90 -115.75 153.11 31.99 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.992 0.425 . . . . 0.0 110.528 -179.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.26 175.04 26.77 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 111.003 -0.839 . . . . 0.0 111.003 179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.67 -34.58 90.02 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.978 -0.849 . . . . 0.0 110.978 179.258 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.94 158.71 34.5 Favored Glycine 0 CA--C 1.525 0.711 0 N-CA-C 110.71 -0.956 . . . . 0.0 110.71 179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 93.5 m -125.42 131.68 52.87 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.941 0.4 . . . . 0.0 110.475 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -81.31 126.89 32.12 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.484 178.102 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 27.7 tp -110.98 129.19 55.97 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 175.155 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 40.4 m -120.55 132.91 55.39 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.244 0.545 . . . . 0.0 110.203 178.49 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.1 t -112.93 132.24 62.29 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.238 -0.437 . . . . 0.0 109.826 -179.149 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.2 mt . . . . . 0 C--O 1.215 -0.736 0 CA-C-O 117.874 -1.06 . . . . 0.0 109.858 -176.744 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 41.5 m-80 . . . . . 0 N--CA 1.49 1.563 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.53 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 18.9 p90 -162.32 133.56 5.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.077 178.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 32.7 mtt -154.04 161.59 41.82 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 120.918 -0.313 . . . . 0.0 110.529 176.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.2 mt -104.91 141.57 36.31 Favored 'General case' 0 C--N 1.333 -0.127 0 O-C-N 122.036 -0.415 . . . . 0.0 110.257 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.4 m -122.42 130.21 52.85 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.62 -0.511 . . . . 0.0 109.62 -179.6 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.03 -179.4 1.06 Allowed Pre-proline 0 C--N 1.331 -0.226 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.253 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_exo -69.87 149.92 66.85 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.968 1.778 . . . . 0.0 111.302 177.291 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 16.2 m-70 -64.88 -42.76 94.56 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.466 176.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 41.7 t -175.57 159.6 2.39 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.472 -0.566 . . . . 0.0 109.472 -178.373 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.88 151.68 6.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-O 120.98 0.419 . . . . 0.0 110.433 -177.334 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 56.7 m -140.44 152.3 45.57 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.216 -178.762 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' O ' HD12 ' A' ' 111' ' ' LEU . 1.5 mm-40 -156.07 161.63 40.38 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 179.486 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -99.16 153.87 37.58 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.34 -179.131 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_endo -57.66 140.98 95.25 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.348 1.366 . . . . 0.0 110.726 -179.749 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 99.42 -30.12 10.57 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.243 -0.743 . . . . 0.0 111.243 179.844 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 13.7 mptt -75.88 -166.52 0.59 Allowed 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.263 -0.643 . . . . 0.0 109.263 177.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 75.1 p -127.09 166.66 17.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.378 176.29 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 13.7 t -136.17 140.83 43.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.378 0.608 . . . . 0.0 109.55 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.7 m -127.99 115.37 18.41 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.311 -0.859 . . . . 0.0 109.014 177.487 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.8 mt -105.19 130.35 56.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 N-CA-C 110.088 -0.338 . . . . 0.0 110.088 178.519 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -106.72 126.0 51.72 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 -178.371 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -117.54 116.77 27.77 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.223 -1.399 . . . . 0.0 107.223 176.306 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 50.6 m -110.6 140.76 44.63 Favored 'General case' 0 N--CA 1.464 0.236 0 O-C-N 121.528 -0.733 . . . . 0.0 109.76 -177.189 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -118.39 155.51 16.06 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.934 -0.866 . . . . 0.0 110.934 -176.576 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.636 ' C ' ' H ' ' A' ' 27' ' ' GLY . 5.0 t -122.97 144.37 49.29 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.346 -0.242 . . . . 0.0 110.346 178.35 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER 61.58 -15.02 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.505 -0.316 . . . . 0.0 111.054 -177.913 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.636 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -133.71 132.97 6.68 Favored Glycine 0 CA--C 1.524 0.627 0 N-CA-C 109.829 -1.309 . . . . 0.0 109.829 178.363 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.506 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.7 m -97.0 137.0 36.76 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.402 0.62 . . . . 0.0 110.195 -177.879 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.682 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -66.11 12.09 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-N 115.263 -0.881 . . . . 0.0 111.542 179.37 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.506 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -117.36 -29.85 5.73 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.597 -0.274 . . . . 0.0 111.135 178.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.3 m -65.02 -19.76 66.16 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.142 -179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 67.5 m-80 -145.73 167.16 23.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.238 -178.136 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 11.3 m-85 -82.08 146.24 29.75 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 0.0 110.006 -176.683 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.411 ' O ' ' N ' ' A' ' 52' ' ' ASP . 72.1 t -126.54 140.13 49.72 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 N-CA-C 109.462 -0.57 . . . . 0.0 109.462 179.511 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.17 151.42 44.05 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.915 0.388 . . . . 0.0 110.105 -178.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.517 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 88.2 m95 -104.99 140.41 38.23 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.971 -178.672 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 24.8 m-85 -139.28 154.31 47.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.73 -0.668 . . . . 0.0 109.524 -178.675 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . . . . . . . . . 6.5 tp-100 -126.92 147.35 50.09 Favored 'General case' 0 C--N 1.328 -0.328 0 N-CA-C 108.323 -0.991 . . . . 0.0 108.323 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -118.16 98.48 6.33 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 -179.238 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 38.7 mtm180 -78.93 140.73 58.22 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.949 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -57.59 126.78 22.93 Favored 'Trans proline' 0 C--N 1.308 -1.582 0 C-N-CA 121.383 1.389 . . . . 0.0 110.961 -177.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 73.24 -2.92 33.75 Favored Glycine 0 CA--C 1.526 0.732 0 N-CA-C 111.188 -0.765 . . . . 0.0 111.188 176.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 2.2 m -119.66 138.76 53.06 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 120.962 0.411 . . . . 0.0 110.59 -179.488 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.1 p -55.81 175.48 0.21 Allowed Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.707 -0.679 . . . . 0.0 110.226 179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 1.1 Cg_endo -71.89 159.52 50.22 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 122.218 1.945 . . . . 0.0 112.111 179.372 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 7.5 m -138.94 114.66 9.94 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.04 -0.527 . . . . 0.0 110.307 178.742 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 1.3 t -49.77 127.89 16.97 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.44 -0.345 . . . . 0.0 110.43 178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.439 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 43.2 t -100.47 -42.79 10.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.251 -0.431 . . . . 0.0 109.959 -176.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.576 HG22 ' N ' ' A' ' 50' ' ' TYR . 46.5 mt -142.84 169.19 12.77 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 173.805 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.576 ' N ' HG22 ' A' ' 49' ' ' ILE . 17.8 t80 -125.88 147.01 49.59 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.458 -177.322 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.434 ' C ' ' N ' ' A' ' 53' ' ' ASN . 92.4 mt-10 44.66 21.72 0.05 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.705 -0.679 . . . . 0.0 111.481 -179.41 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.517 ' OD1' ' CD1' ' A' ' 36' ' ' TRP . 0.7 OUTLIER 46.69 19.75 0.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 178.142 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.434 ' N ' ' C ' ' A' ' 51' ' ' GLU . 12.4 m120 -112.05 -34.35 5.99 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.972 0.415 . . . . 0.0 110.145 -177.643 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.406 ' HA ' HH22 ' A' ' 55' ' ' ARG . 1.5 pt20 -177.63 172.64 1.73 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.309 -179.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.518 ' H ' ' NH2' ' A' ' 55' ' ' ARG . 0.0 OUTLIER -108.28 152.03 41.74 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.786 -179.85 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.3 Cg_endo -56.32 144.32 82.83 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.215 1.277 . . . . 0.0 110.343 -179.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -52.58 141.07 21.41 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.127 -0.629 . . . . 0.0 109.611 179.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.68 -30.77 9.06 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.064 -0.814 . . . . 0.0 111.064 175.922 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -72.56 147.68 89.78 Favored Pre-proline 0 C--N 1.33 -0.281 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 179.838 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_exo -60.43 152.33 68.36 Favored 'Trans proline' 0 C--N 1.31 -1.463 0 C-N-CA 121.024 1.149 . . . . 0.0 110.687 -178.552 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' OD1' ' N ' ' A' ' 61' ' ' ASP . 0.3 OUTLIER -108.03 38.17 2.27 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.55 0.214 . . . . 0.0 110.59 -179.74 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.743 HH12 ' H ' ' A' ' 82' ' ' LYS . 23.8 mtm105 -73.22 -20.92 60.76 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.409 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.439 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -117.94 151.53 37.24 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.153 -0.476 . . . . 0.0 109.768 179.38 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -140.93 125.46 17.77 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 119.095 -0.478 . . . . 0.0 109.723 177.754 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -94.86 144.8 17.39 Favored Glycine 0 CA--C 1.524 0.647 0 N-CA-C 111.111 -0.796 . . . . 0.0 111.111 -178.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -144.66 144.61 31.33 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.871 0.367 . . . . 0.0 110.325 177.778 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.5 pp -122.14 145.22 29.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.47 179.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.404 ' O ' HD11 ' A' ' 29' ' ' ILE . 28.3 m-20 -122.95 96.45 5.02 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.759 179.603 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 t -63.23 -25.03 68.14 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.718 175.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 3.2 m -83.0 -51.16 7.82 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.152 -179.378 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.0 t -80.34 -7.02 58.89 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.264 0.554 . . . . 0.0 109.925 -177.799 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.406 ' O ' ' ND2' ' A' ' 72' ' ' ASN . 4.3 t30 55.47 30.85 15.84 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.271 -0.877 . . . . 0.0 110.699 177.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 9.4 p -143.07 150.0 38.95 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.817 0.341 . . . . 0.0 110.345 176.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.73 149.46 26.4 Favored 'General case' 0 C--N 1.33 -0.279 0 N-CA-C 109.249 -0.648 . . . . 0.0 109.249 -175.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 41.1 m -145.1 131.43 19.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.468 -176.193 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.909 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -109.06 130.25 55.48 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.128 -0.487 . . . . 0.0 110.458 178.432 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.457 ' N ' ' O ' ' A' ' 64' ' ' SER . 20.4 m -102.1 127.48 48.99 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 121.017 0.437 . . . . 0.0 110.677 175.459 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.588 ' CD1' HD21 ' A' ' 76' ' ' LEU . 6.1 mt -110.62 127.32 67.73 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 121.336 0.588 . . . . 0.0 110.256 179.417 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -102.42 124.49 48.08 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.104 -0.953 . . . . 0.0 110.176 178.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 52.35 66.65 2.5 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.836 -0.906 . . . . 0.0 110.836 177.077 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.656 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.2 pt? -58.9 155.99 12.26 Favored 'General case' 0 C--N 1.328 -0.337 0 C-N-CA 120.685 -0.406 . . . . 0.0 110.594 178.328 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.743 ' H ' HH12 ' A' ' 62' ' ' ARG . 13.1 mmtp -131.38 152.94 50.17 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.265 -0.642 . . . . 0.0 109.265 176.929 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 1.2 m -45.98 -29.51 1.47 Allowed 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.195 0.522 . . . . 0.0 110.461 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 70.8 mt-10 -54.87 -18.15 4.52 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.304 -0.862 . . . . 0.0 110.378 -179.448 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.54 ' OD2' ' NH1' ' A' ' 62' ' ' ARG . 35.6 m-20 -86.37 -19.71 29.34 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 110.05 -0.352 . . . . 0.0 110.05 176.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 1.7 tt0 -47.92 95.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.375 178.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.456 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -176.62 -176.29 0.72 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.475 -0.33 . . . . 0.0 110.489 179.536 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.06 140.24 29.75 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 177.737 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -105.07 134.61 47.88 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 109.439 -0.578 . . . . 0.0 109.439 -177.009 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.0 m-85 -124.59 153.76 41.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.147 -0.478 . . . . 0.0 109.784 178.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 26.2 m -119.8 142.5 48.54 Favored 'General case' 0 CA--C 1.533 0.301 0 N-CA-C 107.403 -1.332 . . . . 0.0 107.403 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 78.2 mt-30 -125.49 115.04 19.59 Favored 'General case' 0 N--CA 1.464 0.264 0 O-C-N 121.651 -0.656 . . . . 0.0 110.423 176.361 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 67.1 p -115.72 165.12 13.41 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 120.731 0.3 . . . . 0.0 110.615 -178.805 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 7.4 m-85 -129.99 144.06 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 -178.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.453 ' OD2' ' OG ' ' A' ' 97' ' ' SER . 17.6 p-10 -109.37 179.52 4.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.504 -0.316 . . . . 0.0 110.604 177.843 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 59.7 p -60.99 -31.94 71.53 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.911 -178.27 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.453 ' OG ' ' OD2' ' A' ' 95' ' ' ASP . 88.4 p -79.34 13.46 1.91 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.755 0.312 . . . . 0.0 110.902 -177.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 19.0 m120 53.99 44.21 29.67 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.616 -0.434 . . . . 0.0 110.229 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -107.98 122.92 47.83 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 109.685 -0.487 . . . . 0.0 109.685 179.286 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 13.9 p -69.76 133.01 32.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.136 177.77 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 43.3 t -123.86 148.46 27.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 109.465 -0.568 . . . . 0.0 109.465 -178.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.6 m-85 -120.15 131.31 54.97 Favored 'General case' 0 C--N 1.33 -0.252 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.715 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -83.49 169.38 47.24 Favored Glycine 0 CA--C 1.525 0.664 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 -179.615 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -62.39 -25.77 67.23 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.717 -0.953 . . . . 0.0 110.717 -178.839 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.76 -176.84 53.43 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.383 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 70.4 m -154.33 134.38 13.13 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 110.048 -0.352 . . . . 0.0 110.048 -178.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.1 tttt -80.27 105.64 11.69 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.621 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 47.6 tp -93.99 129.47 40.46 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 109.54 -0.541 . . . . 0.0 109.54 176.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 90.6 m -125.09 136.37 53.59 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.362 -0.381 . . . . 0.0 110.289 178.463 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 45.9 t -115.82 128.5 73.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.673 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.205 -1.27 0 N-CA-C 109.216 -0.661 . . . . 0.0 109.216 -179.026 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 N--CA 1.489 1.524 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 18.3 m-85 -96.35 126.99 41.94 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.423 -0.353 . . . . 0.0 110.138 177.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 15.3 mtm -154.92 172.47 18.0 Favored 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 110.054 -0.35 . . . . 0.0 110.054 177.528 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.651 HD23 ' HA2' ' A' ' 24' ' ' GLY . 39.1 mt -121.38 146.06 47.26 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-O 121.026 0.441 . . . . 0.0 110.003 177.344 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 18.6 m -110.41 114.47 27.94 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.086 178.6 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -132.09 155.52 81.23 Favored Pre-proline 0 C--N 1.331 -0.202 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.422 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -58.17 149.63 71.05 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 121.46 1.44 . . . . 0.0 110.869 -179.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.426 ' O ' ' OG ' ' A' ' 9' ' ' SER . 0.0 OUTLIER -66.3 -40.33 89.95 Favored 'General case' 0 C--N 1.328 -0.336 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 179.071 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.426 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 19.9 m -166.64 155.5 10.68 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.993 0.425 . . . . 0.0 110.405 -179.365 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.46 HG22 ' N ' ' A' ' 11' ' ' SER . 7.3 p -164.18 155.91 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.851 -0.613 . . . . 0.0 109.847 -179.878 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.46 ' N ' HG22 ' A' ' 10' ' ' VAL . 5.6 t -136.27 160.27 39.22 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.143 0.497 . . . . 0.0 111.058 -178.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 40.4 tp10 -156.17 142.22 18.15 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.614 -0.721 . . . . 0.0 109.879 -177.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.6 ' O ' HD23 ' A' ' 81' ' ' LEU . 69.4 m -86.34 152.59 55.44 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.44 -177.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.7 Cg_endo -59.95 159.07 26.76 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 121.96 1.774 . . . . 0.0 111.519 -179.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 92.18 -36.57 3.63 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 41.5 mmtt -80.06 -174.36 4.43 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.889 -0.325 . . . . 0.0 110.541 178.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 71.1 p -113.43 164.29 13.79 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.141 -0.481 . . . . 0.0 110.398 175.896 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 41.2 t -123.09 132.35 71.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 121.499 0.666 . . . . 0.0 110.034 179.011 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 17.9 m -118.19 118.8 32.84 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.457 -0.792 . . . . 0.0 109.023 176.804 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 51.1 mm -101.04 114.49 40.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 N-CA-C 109.732 -0.47 . . . . 0.0 109.732 177.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.416 ' O ' ' OG ' ' A' ' 21' ' ' SER . 0.5 OUTLIER -101.59 112.33 24.86 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.295 -0.632 . . . . 0.0 109.295 -179.618 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -113.68 116.38 29.35 Favored 'General case' 0 CA--C 1.531 0.24 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 179.709 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.5 m -96.57 134.02 40.31 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 109.851 -0.425 . . . . 0.0 109.851 178.805 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.651 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.56 150.34 17.19 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 111.446 -0.661 . . . . 0.0 111.446 -179.914 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.515 ' C ' ' H ' ' A' ' 27' ' ' GLY . 28.1 t -119.9 142.98 48.2 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.031 -0.359 . . . . 0.0 110.031 -179.389 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 35.0 t 58.55 -0.83 0.11 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.815 -179.031 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.515 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.05 143.27 12.68 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.444 -1.062 . . . . 0.0 110.444 -178.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.527 ' C ' ' H ' ' A' ' 30' ' ' ALA . 47.7 t -103.21 125.95 50.14 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.939 0.399 . . . . 0.0 110.389 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.652 ' N ' HD13 ' A' ' 29' ' ' ILE . 0.1 OUTLIER -64.46 7.55 0.12 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 115.934 -0.575 . . . . 0.0 111.146 178.587 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.527 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -112.1 -27.09 8.52 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.385 177.5 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 80.9 p -77.11 -12.38 59.93 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.699 -179.247 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -144.85 162.69 36.19 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 -177.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -83.54 145.94 28.61 Favored 'General case' 0 C--N 1.329 -0.307 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 -179.51 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 22.3 t -113.87 145.17 20.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 N-CA-C 109.753 -0.462 . . . . 0.0 109.753 179.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 28.9 mt-30 -126.29 142.74 51.41 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.733 -0.84 . . . . 0.0 108.733 178.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 62.9 m95 -109.67 147.74 32.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 121.192 0.52 . . . . 0.0 110.609 -178.038 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -140.01 154.33 47.09 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.331 -178.195 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.506 ' NE2' ' O ' ' A' ' 88' ' ' ASP . 2.3 mm-40 -127.04 143.18 51.36 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 179.313 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.572 ' NE2' ' CE1' ' A' ' 90' ' ' TYR . 1.0 OUTLIER -121.29 112.08 18.16 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.684 -0.234 . . . . 0.0 110.437 -176.485 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 17.1 mtm180 -98.85 139.39 21.02 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 115.388 -0.823 . . . . 0.0 111.781 177.75 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . 0.547 ' C ' ' H ' ' A' ' 43' ' ' SER . 3.1 Cg_exo -58.65 137.16 78.59 Favored 'Trans proline' 0 C--N 1.309 -1.51 0 C-N-CA 121.257 1.305 . . . . 0.0 111.21 -178.222 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 69.11 -29.1 0.31 Allowed Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.258 -0.737 . . . . 0.0 111.258 179.055 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.547 ' H ' ' C ' ' A' ' 41' ' ' PRO . 0.4 OUTLIER -87.39 168.62 12.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.833 0.349 . . . . 0.0 110.415 -178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.433 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.5 OUTLIER -85.72 -179.92 1.61 Allowed Pre-proline 0 C--N 1.33 -0.242 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.319 -179.562 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.433 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.7 Cg_exo -73.08 154.85 52.59 Favored 'Trans proline' 0 C--N 1.306 -1.697 0 C-N-CA 122.506 2.138 . . . . 0.0 111.862 178.425 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 46.5 m -136.71 129.63 30.87 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.484 178.533 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -73.6 131.17 41.41 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.788 -0.365 . . . . 0.0 110.364 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.57 HG13 ' CG ' ' A' ' 63' ' ' PHE . 59.5 t -101.26 -39.07 6.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 C-N-CA 120.744 -0.382 . . . . 0.0 111.393 -179.8 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.567 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.4 mt -143.41 171.53 8.53 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 N-CA-C 109.477 -0.564 . . . . 0.0 109.477 177.143 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.567 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -138.59 132.68 31.43 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.115 -0.948 . . . . 0.0 109.74 175.233 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.403 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 2.7 mt-10 56.63 27.45 12.54 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 114.975 -1.011 . . . . 0.0 110.813 174.356 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.468 ' OD2' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 47.02 21.42 0.16 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.429 -0.35 . . . . 0.0 110.344 177.975 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.403 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 11.9 m120 -110.96 -41.87 4.13 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.669 0.271 . . . . 0.0 110.593 -178.921 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -171.67 -164.01 0.3 Allowed 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.942 -0.392 . . . . 0.0 109.942 -177.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.525 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 2.1 ptp85 -139.79 154.12 70.59 Favored Pre-proline 0 C--N 1.33 -0.256 0 N-CA-C 110.241 -0.281 . . . . 0.0 110.241 -178.172 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.548 ' O ' HG22 ' A' ' 59' ' ' VAL . 4.9 Cg_endo -55.93 159.09 12.63 Favored 'Trans proline' 0 C--N 1.307 -1.616 0 C-N-CA 121.882 1.722 . . . . 0.0 111.438 -178.839 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.1 m -71.41 143.72 50.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.722 -0.672 . . . . 0.0 110.483 178.158 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.74 -36.07 4.6 Favored Glycine 0 CA--C 1.524 0.598 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 175.976 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.548 HG22 ' O ' ' A' ' 56' ' ' PRO . 21.7 m -75.32 152.32 85.83 Favored Pre-proline 0 C--N 1.329 -0.318 0 C-N-CA 120.348 -0.541 . . . . 0.0 109.998 179.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.61 160.62 20.12 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.185 1.256 . . . . 0.0 111.12 -176.697 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -113.94 40.46 2.46 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.973 0.416 . . . . 0.0 110.674 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.534 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 13.3 mtp-105 -92.1 1.87 56.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.14 -177.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.57 ' CG ' HG13 ' A' ' 48' ' ' VAL . 0.4 OUTLIER -123.99 147.93 47.37 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-O 120.788 0.328 . . . . 0.0 110.702 -175.607 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.429 ' O ' ' CB ' ' A' ' 76' ' ' LEU . 5.2 t -138.17 152.61 48.85 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.897 -0.592 . . . . 0.0 109.929 176.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -125.51 140.24 12.11 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.682 -0.967 . . . . 0.0 110.682 -178.307 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 58.1 m -145.78 150.27 35.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.797 0.332 . . . . 0.0 110.321 177.328 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.468 HG23 ' OD2' ' A' ' 52' ' ' ASP . 20.1 pt -124.75 141.91 43.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.058 0.456 . . . . 0.0 110.762 -178.174 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 68.7 m-20 -123.55 96.47 4.99 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.697 -0.683 . . . . 0.0 110.494 -177.884 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 84.4 p -62.19 -25.14 67.62 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.466 177.638 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 18.0 m -79.22 -51.03 10.02 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.148 -177.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.5 t -82.96 -7.33 59.68 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.914 -179.028 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' C ' HD12 ' A' ' 29' ' ' ILE . 3.7 t30 56.56 31.37 18.94 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.92 -0.582 . . . . 0.0 110.626 179.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 1.9 p -139.64 148.31 42.27 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-O 120.779 0.323 . . . . 0.0 110.71 -178.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.36 142.17 35.59 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.223 -0.658 . . . . 0.0 109.223 -175.861 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.6 m -136.68 123.51 21.28 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.149 -173.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.923 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.81 134.49 47.03 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.093 177.21 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -104.06 120.46 41.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.104 175.306 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.464 ' CD1' HD21 ' A' ' 76' ' ' LEU . 4.0 mt -105.77 125.05 61.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 N-CA-C 109.484 -0.561 . . . . 0.0 109.484 -179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 10.3 m -109.13 125.39 52.12 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.516 -0.765 . . . . 0.0 110.578 178.116 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 87.93 65.69 1.33 Allowed Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.709 -0.956 . . . . 0.0 110.709 179.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.6 HD23 ' O ' ' A' ' 13' ' ' SER . 54.8 tp -66.56 135.46 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.637 0.256 . . . . 0.0 110.513 178.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 9.2 mmtt -152.77 166.53 31.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.48 175.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.429 ' O ' ' N ' ' A' ' 86' ' ' GLU . 10.8 p -50.96 -25.87 5.22 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.839 -0.619 . . . . 0.0 110.664 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -54.97 -13.51 1.13 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 114.977 -1.011 . . . . 0.0 109.365 177.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.565 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -101.36 -21.22 14.9 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.916 -0.584 . . . . 0.0 109.899 179.477 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.429 ' N ' ' O ' ' A' ' 83' ' ' THR . 83.7 tt0 -47.77 84.72 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.958 177.943 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.565 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -173.63 -169.39 0.5 Allowed 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.683 -0.407 . . . . 0.0 110.22 179.448 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.506 ' O ' ' NE2' ' A' ' 38' ' ' GLN . 1.3 m-20 -91.91 166.31 12.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.735 178.236 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -128.44 158.36 38.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.567 -179.308 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.572 ' CE1' ' NE2' ' A' ' 39' ' ' GLN . 0.3 OUTLIER -140.11 143.83 36.44 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.704 178.167 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 65.8 m -117.76 141.76 48.04 Favored 'General case' 0 C--N 1.331 -0.197 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 177.355 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 1.7 mt-30 -134.67 144.66 47.94 Favored 'General case' 0 C--N 1.331 -0.216 0 O-C-N 121.832 -0.542 . . . . 0.0 109.953 177.072 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 35.8 p -144.84 166.8 24.22 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.746 0.308 . . . . 0.0 110.259 -178.817 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 41.7 m-85 -117.47 141.14 48.7 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-O 121.025 0.44 . . . . 0.0 109.911 -178.735 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.448 ' O ' ' N ' ' A' ' 98' ' ' ASN . 29.3 t0 -98.01 151.56 20.19 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.287 178.654 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 9.0 t -46.45 -29.09 1.58 Allowed 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.95 -0.568 . . . . 0.0 110.585 -179.774 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 7.3 p -80.07 18.32 0.86 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.101 -0.499 . . . . 0.0 110.698 -179.518 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.448 ' N ' ' O ' ' A' ' 95' ' ' ASP . 85.6 m-20 55.67 44.14 26.93 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.248 -0.433 . . . . 0.0 110.828 178.139 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 46.5 t60 -113.25 152.15 30.17 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.72 0.295 . . . . 0.0 110.86 -178.582 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.465 HG13 ' O ' ' A' ' 100' ' ' VAL . 11.8 p -82.9 127.26 39.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.866 -0.607 . . . . 0.0 111.154 178.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 37.8 t -119.42 139.89 45.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 N-CA-C 109.14 -0.689 . . . . 0.0 109.14 -179.632 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.46 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 12.8 p90 -129.6 147.71 51.42 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.598 179.868 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -100.56 162.35 18.74 Favored Glycine 0 CA--C 1.524 0.643 0 N-CA-C 111.028 -0.829 . . . . 0.0 111.028 179.752 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.12 -22.77 50.53 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 179.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 88.72 -178.95 45.73 Favored Glycine 0 CA--C 1.525 0.684 0 N-CA-C 110.822 -0.911 . . . . 0.0 110.822 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 7.4 m -143.02 134.78 26.68 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 110.368 -0.234 . . . . 0.0 110.368 -177.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 83.9 tttt -89.38 100.15 13.0 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.788 179.076 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 23.6 tp -90.71 129.4 36.81 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.147 176.617 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 34.5 m -123.03 136.45 54.85 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.149 0.5 . . . . 0.0 110.448 178.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 40.7 t -116.91 129.96 72.59 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.381 179.771 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.563 HD12 ' OXT' ' A' ' 111' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.33 -0.277 0 CA-C-O 117.122 -1.418 . . . . 0.0 110.184 -178.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 . . . . . 0 N--CA 1.489 1.514 0 N-CA-C 108.798 -0.816 . . . . 0.0 108.798 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.477 ' CD2' ' CB ' ' A' ' 26' ' ' SER . 2.3 t80 -131.76 119.22 20.99 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.205 -0.665 . . . . 0.0 109.205 177.258 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 1.9 mmt -144.59 167.88 21.47 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 179.451 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.555 HD23 ' HA2' ' A' ' 24' ' ' GLY . 29.7 mt -119.89 134.64 55.17 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.228 0.537 . . . . 0.0 110.447 178.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 7.6 m -112.52 118.85 36.25 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.37 -0.832 . . . . 0.0 109.952 -179.894 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.52 ' OE1' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -127.51 -179.24 0.91 Allowed Pre-proline 0 C--N 1.331 -0.223 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 -179.105 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.437 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.9 Cg_exo -69.52 152.29 70.52 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.271 1.981 . . . . 0.0 111.891 178.012 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 30.2 t-80 -68.12 -41.33 81.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.012 -0.54 . . . . 0.0 111.248 177.219 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 11.5 t -171.77 169.2 5.95 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 110.172 -0.307 . . . . 0.0 110.172 -179.418 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.477 HG22 ' N ' ' A' ' 11' ' ' SER . 5.2 p -166.01 158.15 1.19 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 120.596 -0.441 . . . . 0.0 110.78 -177.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.477 ' N ' HG22 ' A' ' 10' ' ' VAL . 49.9 m -137.56 153.48 49.95 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.049 -0.523 . . . . 0.0 110.092 179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 43.4 tp10 -156.0 149.76 25.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.523 -0.308 . . . . 0.0 110.599 179.988 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 34.7 m -91.07 151.21 42.94 Favored Pre-proline 0 C--N 1.33 -0.241 0 CA-C-N 116.571 -0.286 . . . . 0.0 110.627 -177.504 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.9 Cg_endo -60.78 158.4 33.31 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 121.501 1.467 . . . . 0.0 110.981 -179.129 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 84.8 -26.21 5.46 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 178.214 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 46.2 mmtt -90.84 -161.04 0.77 Allowed 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 110.151 -0.314 . . . . 0.0 110.151 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.511 HG22 ' HA ' ' A' ' 79' ' ' SER . 71.8 p -133.8 167.06 21.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.421 0.629 . . . . 0.0 111.529 -178.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 12.2 p -146.35 143.29 21.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 114.866 -1.061 . . . . 0.0 111.412 177.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.466 HG23 ' O ' ' A' ' 76' ' ' LEU . 58.9 m -125.55 126.69 45.22 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.157 -0.683 . . . . 0.0 109.157 -179.008 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 82.0 mt -105.63 125.46 60.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.939 178.263 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 5.6 p -104.95 129.93 53.24 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.281 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.52 ' SG ' ' OE1' ' A' ' 6' ' ' GLN . 1.8 m -113.85 116.17 28.89 Favored 'General case' 0 CA--C 1.534 0.336 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 177.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 96.1 m -97.28 130.79 44.43 Favored 'General case' 0 N--CA 1.463 0.189 0 C-N-CA 123.067 0.547 . . . . 0.0 109.894 -179.096 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.555 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.67 125.45 7.96 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 111.182 -0.767 . . . . 0.0 111.182 -179.247 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.473 ' O ' ' CB ' ' A' ' 26' ' ' SER . 34.6 t -97.1 97.05 8.89 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.648 0.261 . . . . 0.0 110.868 179.044 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.477 ' CB ' ' CD2' ' A' ' 2' ' ' PHE . 0.7 OUTLIER 163.42 -52.34 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.071 0.462 . . . . 0.0 110.035 177.924 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -161.84 -175.16 32.57 Favored Glycine 0 CA--C 1.524 0.625 0 N-CA-C 110.753 -0.939 . . . . 0.0 110.753 -177.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.5 m -63.31 144.11 57.23 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 120.852 0.358 . . . . 0.0 110.326 178.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.548 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.5 OUTLIER -77.74 -7.09 9.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.067 -179.12 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -90.72 -4.31 56.81 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.078 -0.51 . . . . 0.0 109.71 179.291 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.434 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 87.3 p -69.94 -14.63 62.8 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.242 -0.89 . . . . 0.0 110.516 178.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.434 ' ND2' ' O ' ' A' ' 31' ' ' SER . 0.6 OUTLIER -152.56 167.13 29.85 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.627 -0.508 . . . . 0.0 109.627 -177.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -84.72 143.76 28.96 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.191 -0.3 . . . . 0.0 110.191 178.599 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 10.5 t -125.13 141.84 43.87 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.187 0 N-CA-C 109.457 -0.572 . . . . 0.0 109.457 -179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 58.4 mt-30 -121.08 153.03 37.96 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.203 -0.908 . . . . 0.0 109.473 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 76.1 m95 -110.02 150.59 28.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.32 -0.4 . . . . 0.0 110.395 -179.556 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 30.8 m-85 -141.69 154.3 45.23 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.72 -177.09 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.792 HE22 ' HB3' ' A' ' 87' ' ' ALA . 0.8 OUTLIER -134.11 139.83 46.18 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 179.609 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.618 HE21 ' CA ' ' A' ' 39' ' ' GLN . 0.0 OUTLIER -110.86 98.1 7.32 Favored 'General case' 0 C--N 1.331 -0.225 0 N-CA-C 109.179 -0.675 . . . . 0.0 109.179 -178.693 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt180 -89.81 119.53 69.43 Favored Pre-proline 0 C--N 1.331 -0.198 0 CA-C-N 115.812 -0.631 . . . . 0.0 110.26 179.187 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -58.19 120.07 7.73 Favored 'Trans proline' 0 C--N 1.309 -1.502 0 CA-C-N 120.463 1.201 . . . . 0.0 110.622 179.345 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 106.22 -21.67 32.82 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 179.82 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -124.21 151.45 44.07 Favored 'General case' 0 C--N 1.331 -0.201 0 N-CA-C 110.015 -0.365 . . . . 0.0 110.015 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.431 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.9 OUTLIER -67.16 179.72 0.52 Allowed Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.07 179.871 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.431 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 3.2 Cg_exo -67.13 144.77 70.54 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 122.2 1.934 . . . . 0.0 111.279 177.76 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 21.6 p -129.66 116.89 19.49 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.52 176.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 2.8 m -57.01 120.91 8.78 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.583 -0.525 . . . . 0.0 109.583 178.802 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.489 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 14.3 t -88.36 -34.99 7.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 C-N-CA 120.605 -0.438 . . . . 0.0 110.361 -176.551 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.541 HG22 ' N ' ' A' ' 50' ' ' TYR . 13.8 mt -145.02 167.25 10.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-N 116.11 -0.496 . . . . 0.0 110.221 177.515 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.541 ' N ' HG22 ' A' ' 49' ' ' ILE . 10.8 t80 -128.93 148.98 50.97 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.694 -0.684 . . . . 0.0 110.537 -179.226 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.449 ' O ' ' N ' ' A' ' 53' ' ' ASN . 82.3 mt-10 45.7 22.39 0.11 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.579 -0.737 . . . . 0.0 111.156 -179.6 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.471 ' OD1' HD12 ' A' ' 67' ' ' ILE . 3.4 p30 46.76 19.94 0.1 Allowed 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 121.243 0.544 . . . . 0.0 110.944 178.374 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.459 ' ND2' ' OD1' ' A' ' 52' ' ' ASP . 9.0 m120 -110.58 -45.98 3.45 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.585 -0.734 . . . . 0.0 110.105 -179.188 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.405 HE21 ' HB2' ' A' ' 54' ' ' GLN . 0.0 OUTLIER -167.69 -170.04 1.31 Allowed 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 -179.226 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.53 ' NH2' ' O ' ' A' ' 63' ' ' PHE . 0.6 OUTLIER -128.56 155.52 78.73 Favored Pre-proline 0 C--N 1.329 -0.285 0 N-CA-C 109.51 -0.552 . . . . 0.0 109.51 -176.952 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.2 Cg_endo -54.84 164.32 3.38 Favored 'Trans proline' 0 C--N 1.307 -1.632 0 C-N-CA 121.565 1.51 . . . . 0.0 111.19 -178.952 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -74.37 134.62 42.47 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.367 -0.533 . . . . 0.0 110.063 179.043 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 114.71 -35.79 4.25 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 111.14 -0.784 . . . . 0.0 111.14 173.678 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.45 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.0 OUTLIER -73.42 157.57 87.75 Favored Pre-proline 0 C--N 1.33 -0.262 0 N-CA-C 109.778 -0.452 . . . . 0.0 109.778 179.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -60.68 147.23 95.51 Favored 'Trans proline' 0 C--N 1.308 -1.58 0 C-N-CA 121.758 1.638 . . . . 0.0 111.28 -179.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.403 ' OD2' ' NH1' ' A' ' 55' ' ' ARG . 9.2 m-20 -98.89 19.56 14.76 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.47 -0.332 . . . . 0.0 111.258 178.511 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.572 HH12 ' H ' ' A' ' 82' ' ' LYS . 36.8 mtm180 -64.95 -10.07 26.3 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.756 179.585 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.576 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.4 OUTLIER -119.78 147.34 44.75 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 110.291 -0.262 . . . . 0.0 110.291 179.685 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.459 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.4 OUTLIER -141.81 134.0 27.76 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 119.085 -0.483 . . . . 0.0 110.491 175.634 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.417 ' N ' HD13 ' A' ' 49' ' ' ILE . . . -98.82 150.02 19.23 Favored Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 178.986 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.02 155.28 39.62 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-O 120.808 0.337 . . . . 0.0 110.485 179.134 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.471 HD12 ' OD1' ' A' ' 52' ' ' ASP . 0.0 OUTLIER -132.27 143.85 38.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.593 -179.438 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 35.3 m-20 -124.12 82.97 2.09 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.486 179.153 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.1 p -54.19 -26.5 28.51 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.04 0.447 . . . . 0.0 110.268 179.354 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.9 m -80.92 -50.98 9.07 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.593 -178.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 3.7 t -77.31 -5.36 49.23 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.236 -0.438 . . . . 0.0 109.924 -179.55 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.519 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.5 t30 57.76 33.58 23.39 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.909 -0.587 . . . . 0.0 111.112 177.436 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 68.4 p -148.24 152.11 36.61 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.705 0.288 . . . . 0.0 110.607 -179.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -105.95 149.39 26.65 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 108.86 -0.793 . . . . 0.0 108.86 -176.118 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.1 m -147.28 131.13 17.06 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.456 -177.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.863 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -107.07 136.99 45.98 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.852 176.688 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.459 ' N ' ' O ' ' A' ' 64' ' ' SER . 17.7 m -107.53 123.2 48.08 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.508 0.194 . . . . 0.0 110.707 175.468 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.555 HD12 HD21 ' A' ' 76' ' ' LEU . 7.0 mt -109.14 133.25 54.9 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.511 ' HA ' HG22 ' A' ' 17' ' ' THR . 44.9 p -112.52 130.72 55.91 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.927 179.337 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 57.5 65.32 3.64 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 111.38 -0.688 . . . . 0.0 111.38 175.872 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.646 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.3 pt? -71.71 157.17 38.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.5 0.19 . . . . 0.0 111.128 178.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.572 ' H ' HH12 ' A' ' 62' ' ' ARG . 51.3 mtpt -138.73 159.67 41.53 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 120.562 0.22 . . . . 0.0 110.731 178.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.45 ' O ' ' N ' ' A' ' 86' ' ' GLU . 4.2 m -53.57 -32.55 51.31 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.973 0.416 . . . . 0.0 110.971 -179.903 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 5.4 mm-40 -54.84 -8.64 0.27 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.805 -0.634 . . . . 0.0 109.823 178.942 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.52 ' OD2' ' NH2' ' A' ' 62' ' ' ARG . 93.2 m-20 -107.67 -15.9 14.47 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.092 -0.336 . . . . 0.0 110.092 178.297 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.579 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 81.6 tt0 -44.51 107.16 0.08 Allowed 'General case' 0 C--N 1.331 -0.224 0 C-N-CA 120.672 -0.411 . . . . 0.0 111.03 178.072 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.792 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 175.56 -168.68 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 119.927 -0.709 . . . . 0.0 111.022 179.787 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.44 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 12.9 m-20 -90.97 142.66 27.54 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.278 -0.873 . . . . 0.0 110.791 179.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.615 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 22.7 m-85 -112.09 149.56 31.95 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.338 -0.846 . . . . 0.0 109.903 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 51.5 m-85 -136.82 158.19 45.02 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 116.43 -0.35 . . . . 0.0 110.893 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 13.3 m -124.53 147.71 48.24 Favored 'General case' 0 N--CA 1.465 0.284 0 N-CA-C 107.448 -1.316 . . . . 0.0 107.448 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 67.0 mt-30 -133.66 132.46 40.74 Favored 'General case' 0 N--CA 1.463 0.223 0 O-C-N 121.806 -0.559 . . . . 0.0 110.616 174.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 74.2 p -129.8 159.65 35.88 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.749 0.309 . . . . 0.0 110.561 -179.718 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.514 ' CE1' HG23 ' A' ' 100' ' ' VAL . 33.7 m-85 -122.66 148.15 45.61 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.487 -0.324 . . . . 0.0 110.327 179.627 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 20.8 t0 -107.79 -178.22 3.56 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.229 -0.441 . . . . 0.0 110.388 178.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 41.3 p -67.57 -22.09 65.4 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.925 179.447 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.2 m -83.85 11.19 7.97 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.538 -179.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 97.6 m-20 55.82 38.92 30.63 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.625 -179.109 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 8.2 m170 -113.02 122.25 47.06 Favored 'General case' 0 C--N 1.331 -0.231 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 177.158 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.514 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.8 p -73.83 133.38 31.76 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 115.399 -0.819 . . . . 0.0 110.516 -179.812 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 67.2 t -125.21 141.68 44.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.051 178.771 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.592 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 0.0 OUTLIER -114.39 148.37 37.78 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.848 -0.614 . . . . 0.0 109.479 -179.187 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -93.16 173.01 34.05 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.553 -1.019 . . . . 0.0 110.553 -179.112 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -61.89 -21.04 60.64 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 -179.85 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 82.92 -176.42 53.27 Favored Glycine 0 CA--C 1.525 0.668 0 N-CA-C 110.846 -0.902 . . . . 0.0 110.846 178.6 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 57.3 m -148.7 147.16 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.586 0.231 . . . . 0.0 110.784 -179.292 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 78.8 tttt -100.52 122.56 43.43 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.371 -0.377 . . . . 0.0 110.541 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.6 tp -110.31 124.92 52.55 Favored 'General case' 0 C--N 1.331 -0.21 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.819 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 31.1 m -111.69 129.6 56.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.882 0.372 . . . . 0.0 110.454 176.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 28.0 t -109.63 127.6 66.31 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 N-CA-C 109.526 -0.546 . . . . 0.0 109.526 -177.299 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 13.1 mt . . . . . 0 C--O 1.221 -0.426 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.29 -178.416 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 13.8 m120 . . . . . 0 N--CA 1.491 1.594 0 N-CA-C 109.501 -0.555 . . . . 0.0 109.501 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 22.3 t80 -108.1 121.49 44.94 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.067 -179.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 75.5 mtm -148.63 172.3 14.77 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.667 -0.494 . . . . 0.0 109.667 178.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.649 HD23 ' HA2' ' A' ' 24' ' ' GLY . 51.9 mt -127.68 151.95 48.31 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.246 0.546 . . . . 0.0 110.597 179.583 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 55.2 m -125.48 129.87 50.66 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.541 179.362 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.494 ' CD ' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.47 -175.91 0.51 Allowed Pre-proline 0 C--N 1.331 -0.208 0 CA-C-N 116.288 -0.415 . . . . 0.0 110.325 -178.334 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.465 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.8 Cg_exo -75.01 135.81 19.54 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 122.121 1.881 . . . . 0.0 111.637 176.659 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 34.5 m170 -69.36 -47.86 63.03 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.025 0.44 . . . . 0.0 110.82 176.566 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.8 m -152.44 147.09 25.84 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.408 -178.328 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -164.5 148.68 2.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 115.396 -0.82 . . . . 0.0 109.968 -176.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 51.5 m -137.7 158.23 44.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 121.0 0.429 . . . . 0.0 110.426 -177.518 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.45 ' OE1' ' O ' ' A' ' 17' ' ' THR . 49.7 tt0 -156.14 155.24 32.18 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.967 179.446 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -91.29 153.21 44.45 Favored Pre-proline 0 C--N 1.33 -0.273 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 -178.919 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.3 Cg_endo -60.39 158.99 28.9 Favored 'Trans proline' 0 C--N 1.307 -1.621 0 C-N-CA 121.912 1.741 . . . . 0.0 111.632 -178.227 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.12 -35.06 4.79 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.167 -0.773 . . . . 0.0 111.167 176.174 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.415 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 64.3 mmtt -83.71 -161.4 0.52 Allowed 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.817 -0.225 . . . . 0.0 110.883 178.47 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.45 ' O ' ' OE1' ' A' ' 12' ' ' GLU . 75.3 p -122.03 163.63 19.05 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.155 -179.907 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.689 HG23 HD13 ' A' ' 81' ' ' LEU . 18.6 t -120.35 135.33 60.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.891 0.853 . . . . 0.0 110.318 175.998 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 18.0 m -122.21 120.03 32.97 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 114.898 -1.047 . . . . 0.0 109.328 174.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 71.5 mt -104.85 121.25 56.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.138 174.732 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.7 t -104.27 126.44 51.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.682 -0.69 . . . . 0.0 110.384 -178.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.494 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 1.3 m -123.71 117.87 25.93 Favored 'General case' 0 CA--C 1.533 0.309 0 N-CA-C 107.511 -1.292 . . . . 0.0 107.511 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 18.6 m -110.08 138.8 45.96 Favored 'General case' 0 N--CA 1.465 0.294 0 O-C-N 121.434 -0.791 . . . . 0.0 110.28 -178.54 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.649 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -102.65 142.33 15.52 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 111.105 -0.798 . . . . 0.0 111.105 -177.308 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 15.3 t -104.63 65.15 0.75 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.963 0.411 . . . . 0.0 110.219 -178.087 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.1 t -170.12 -72.09 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.739 178.726 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -141.22 -176.61 15.7 Favored Glycine 0 CA--C 1.523 0.573 0 N-CA-C 110.488 -1.045 . . . . 0.0 110.488 -178.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.407 ' C ' ' H ' ' A' ' 30' ' ' ALA . 69.1 m -70.54 143.88 51.48 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 121.038 0.447 . . . . 0.0 110.338 -178.326 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.612 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -64.66 -1.89 0.96 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.931 -0.577 . . . . 0.0 110.012 -179.846 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.407 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -91.01 -9.02 47.47 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.54 0.686 . . . . 0.0 109.163 -177.794 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.416 ' OG ' ' OD1' ' A' ' 32' ' ' ASN . 14.0 p -83.57 -14.69 51.56 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.103 -0.953 . . . . 0.0 110.497 178.609 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.416 ' OD1' ' OG ' ' A' ' 31' ' ' SER . 0.4 OUTLIER -147.38 152.55 38.36 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.143 -0.48 . . . . 0.0 109.934 -179.338 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 68.0 m-85 -85.04 143.42 28.91 Favored 'General case' 0 C--N 1.331 -0.238 0 N-CA-C 109.877 -0.416 . . . . 0.0 109.877 177.684 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 2.7 t -119.71 148.17 22.91 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -178.485 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.611 ' NE2' ' CE2' ' A' ' 50' ' ' TYR . 7.5 mt-30 -121.9 146.71 46.85 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 178.353 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.465 ' HE1' ' CG ' ' A' ' 52' ' ' ASP . 76.9 m95 -109.87 137.38 47.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.387 0.613 . . . . 0.0 110.567 -179.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -129.82 154.43 47.26 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.274 -0.875 . . . . 0.0 109.149 179.553 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.593 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -124.14 143.09 50.69 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 108.294 -1.002 . . . . 0.0 108.294 176.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.49 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 1.2 tp60 -115.93 97.97 6.39 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.197 -0.668 . . . . 0.0 109.197 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 28.6 ttt-85 -94.48 124.04 56.52 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-N 115.669 -0.696 . . . . 0.0 110.46 -179.197 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.13 131.9 48.67 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 121.133 1.222 . . . . 0.0 110.66 -178.765 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 101.9 -25.61 27.3 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.319 -0.712 . . . . 0.0 111.319 177.158 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 70.4 m -126.22 162.2 25.97 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 121.252 0.549 . . . . 0.0 110.988 -179.56 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.455 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -69.63 -177.23 0.38 Allowed Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 115.596 -0.729 . . . . 0.0 110.092 -178.248 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.455 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 2.7 Cg_exo -70.24 154.45 65.82 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.57 2.18 . . . . 0.0 111.363 178.147 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.5 p -139.39 127.94 23.04 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.799 0.333 . . . . 0.0 110.924 177.773 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 5.9 m -63.34 129.95 42.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.833 -0.622 . . . . 0.0 110.168 178.49 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.585 HG12 HG13 ' A' ' 49' ' ' ILE . 60.0 t -97.31 -43.21 12.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.519 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.712 HG22 ' N ' ' A' ' 50' ' ' TYR . 40.4 mt -144.68 170.13 7.79 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.183 0 C-N-CA 120.866 -0.334 . . . . 0.0 110.991 -179.509 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.712 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.5 152.58 50.6 Favored 'General case' 0 N--CA 1.462 0.157 0 CA-C-O 121.195 0.521 . . . . 0.0 110.959 179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.494 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 96.6 mt-10 43.83 21.49 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 114.735 -1.12 . . . . 0.0 109.849 -176.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.502 ' N ' ' O ' ' A' ' 50' ' ' TYR . 50.0 t0 46.23 19.37 0.07 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.205 -0.907 . . . . 0.0 110.872 178.144 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.494 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 79.1 m-20 -112.53 -33.14 6.24 Favored 'General case' 0 C--O 1.233 0.19 0 N-CA-C 111.594 0.22 . . . . 0.0 111.594 -179.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -177.01 158.3 1.53 Allowed 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.963 -0.384 . . . . 0.0 109.963 -173.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.445 HH11 HG12 ' A' ' 49' ' ' ILE . 0.0 OUTLIER -108.13 154.62 41.13 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 115.637 -0.711 . . . . 0.0 110.518 -174.858 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.609 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.2 Cg_endo -55.59 159.95 10.19 Favored 'Trans proline' 0 C--N 1.307 -1.615 0 C-N-CA 122.148 1.899 . . . . 0.0 111.137 -179.676 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 17.9 m -70.46 144.17 51.52 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.161 -0.616 . . . . 0.0 110.829 174.687 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.6 -36.7 3.98 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.303 -0.719 . . . . 0.0 111.303 175.695 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.609 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.0 m -71.03 150.67 94.92 Favored Pre-proline 0 C--N 1.33 -0.267 0 N-CA-C 109.552 -0.536 . . . . 0.0 109.552 178.732 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -57.83 150.91 59.92 Favored 'Trans proline' 0 C--N 1.306 -1.659 0 C-N-CA 121.472 1.448 . . . . 0.0 110.698 -175.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 4.9 t70 -108.98 22.74 15.52 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-O 120.323 0.106 . . . . 0.0 111.18 -178.543 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.536 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 56.3 mtp180 -69.19 -14.3 62.9 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.339 -0.544 . . . . 0.0 110.224 -178.039 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.464 ' CD1' HG13 ' A' ' 48' ' ' VAL . 0.0 OUTLIER -117.54 156.58 27.81 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.009 -0.541 . . . . 0.0 110.39 -179.633 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.445 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.14 138.66 24.1 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.363 176.312 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.401 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -102.65 142.36 15.53 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.711 -0.956 . . . . 0.0 110.711 179.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.5 t -142.5 146.31 34.58 Favored 'General case' 0 C--N 1.331 -0.213 0 O-C-N 122.664 -0.315 . . . . 0.0 110.712 177.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 47.0 pt -124.87 140.76 47.08 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.167 0 CA-C-N 116.436 -0.347 . . . . 0.0 111.021 -178.193 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.407 ' C ' HD11 ' A' ' 29' ' ' ILE . 92.4 m-20 -124.14 94.27 4.17 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 112.015 0.376 . . . . 0.0 112.015 -177.731 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 61.9 p -58.57 -34.52 71.15 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.097 0.475 . . . . 0.0 110.225 -178.539 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 6.3 m -69.3 -51.01 41.35 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.663 -0.699 . . . . 0.0 110.894 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.9 t -76.98 -3.83 40.91 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.773 -178.403 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.568 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 54.86 28.04 9.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.946 -0.57 . . . . 0.0 110.321 179.67 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.5 p -142.95 163.18 33.48 Favored 'General case' 0 C--N 1.33 -0.263 0 O-C-N 121.894 -0.504 . . . . 0.0 110.145 -178.638 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -119.25 143.6 47.22 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 121.099 0.476 . . . . 0.0 110.248 179.607 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -136.28 143.12 44.06 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 115.656 -0.702 . . . . 0.0 110.404 -177.865 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.737 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -105.64 138.2 42.23 Favored 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.922 0.392 . . . . 0.0 111.247 175.767 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 0.2 OUTLIER -106.2 124.59 49.82 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.385 175.709 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 3.4 mt -113.42 139.9 36.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 110.044 -0.354 . . . . 0.0 110.044 176.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 15.3 m -115.4 121.59 43.25 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 115.494 -0.775 . . . . 0.0 110.618 179.842 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 63.04 75.65 0.32 Allowed Glycine 0 CA--C 1.525 0.708 0 N-CA-C 111.308 -0.717 . . . . 0.0 111.308 176.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.987 ' H ' HD23 ' A' ' 81' ' ' LEU . 1.9 pt? -75.54 147.51 39.66 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.645 0.259 . . . . 0.0 111.099 -179.434 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.434 ' H ' ' NH2' ' A' ' 62' ' ' ARG . 14.2 mtpt -145.56 176.17 9.81 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 -178.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.431 ' C ' ' N ' ' A' ' 85' ' ' ASP . 55.2 p -59.56 -30.57 68.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.318 0.58 . . . . 0.0 110.52 -179.504 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 29.6 tt0 -55.67 -8.05 0.35 Allowed 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.166 177.564 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.536 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 64.5 m-20 -109.06 -25.85 10.47 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.264 176.966 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 61.3 tt0 -40.42 90.92 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.914 -0.315 . . . . 0.0 111.581 -179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.593 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -173.84 179.54 1.97 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.887 0.375 . . . . 0.0 110.852 -176.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -89.28 150.1 22.77 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.432 -0.804 . . . . 0.0 110.57 -179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.411 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 26.8 m-85 -114.78 150.19 35.78 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.717 179.695 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -133.53 151.85 51.81 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.027 -0.533 . . . . 0.0 109.576 177.761 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.431 ' HB2' ' OE1' ' A' ' 6' ' ' GLN . 63.0 m -118.07 141.79 48.09 Favored 'General case' 0 N--CA 1.464 0.257 0 N-CA-C 107.598 -1.26 . . . . 0.0 107.598 177.302 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -124.99 146.34 49.45 Favored 'General case' 0 N--CA 1.463 0.184 0 O-C-N 122.071 -0.393 . . . . 0.0 110.487 175.027 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.433 ' HB3' HD11 ' A' ' 4' ' ' LEU . 11.1 p -145.61 166.92 24.37 Favored 'General case' 0 C--N 1.33 -0.277 0 O-C-N 122.236 -0.29 . . . . 0.0 110.537 -178.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 12.0 m-85 -124.99 140.69 52.69 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.174 0.512 . . . . 0.0 110.777 178.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 42.6 m-20 -92.76 -172.39 3.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.284 -0.871 . . . . 0.0 110.653 179.465 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -75.36 -16.51 60.38 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.069 -178.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 2.8 p -85.91 5.05 34.73 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.695 -179.308 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 66.09 35.51 6.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.818 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 4.8 m80 -113.33 146.8 38.84 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 110.256 -0.276 . . . . 0.0 110.256 179.228 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 7.4 p -76.64 148.13 7.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 115.707 -0.678 . . . . 0.0 110.978 179.271 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 31.9 t -132.43 153.09 37.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 N-CA-C 109.969 -0.382 . . . . 0.0 109.969 178.316 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 2.7 p90 -110.77 147.34 34.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.541 -0.754 . . . . 0.0 109.383 -176.629 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -97.88 172.31 26.92 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 111.26 -0.736 . . . . 0.0 111.26 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.48 -34.43 85.52 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 -177.594 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.93 169.45 39.72 Favored Glycine 0 CA--C 1.524 0.641 0 N-CA-C 111.317 -0.713 . . . . 0.0 111.317 -177.3 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 87.1 m -154.82 135.89 13.87 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.585 0.231 . . . . 0.0 110.505 -179.459 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 42.2 tttp -95.91 97.71 9.84 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.419 -0.355 . . . . 0.0 110.314 178.572 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 16.9 tp -88.73 130.28 35.37 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.668 174.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 88.8 m -124.26 144.16 50.13 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.575 -0.738 . . . . 0.0 110.888 176.164 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 55.9 t -115.1 131.61 66.84 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.24 0 CA-C-N 116.093 -0.503 . . . . 0.0 109.806 179.366 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 20.6 mt . . . . . 0 C--O 1.215 -0.731 0 CA-C-O 118.275 -0.869 . . . . 0.0 110.527 179.956 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.9 m120 . . . . . 0 N--CA 1.49 1.543 0 N-CA-C 109.034 -0.728 . . . . 0.0 109.034 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.441 ' CD1' ' CG ' ' A' ' 95' ' ' ASP . 2.1 m-85 -96.64 112.3 24.1 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 115.888 -0.596 . . . . 0.0 109.661 -178.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 27.5 mtt -154.58 169.74 23.13 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.046 -0.524 . . . . 0.0 109.817 176.594 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.612 HD23 ' HA2' ' A' ' 24' ' ' GLY . 46.6 mt -129.89 150.19 51.29 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.008 0.432 . . . . 0.0 110.167 179.115 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.9 m -126.73 131.96 51.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.633 -0.712 . . . . 0.0 110.119 179.144 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.528 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.3 OUTLIER -146.12 -177.42 0.65 Allowed Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 -179.263 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.411 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 4.5 Cg_exo -74.62 147.09 35.2 Favored 'Trans proline' 0 C--N 1.308 -1.584 0 C-N-CA 122.243 1.962 . . . . 0.0 111.824 177.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 46.4 t-80 -73.89 -40.25 63.32 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.134 177.566 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 14.3 m -171.91 146.27 2.0 Favored 'General case' 0 C--N 1.33 -0.245 0 N-CA-C 110.003 -0.369 . . . . 0.0 110.003 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.478 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.6 p -158.0 161.16 1.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.009 -177.639 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.478 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 53.3 m -136.32 165.99 24.48 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.83 -0.623 . . . . 0.0 110.204 179.368 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -156.3 146.8 21.66 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.453 179.187 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -86.16 152.16 55.3 Favored Pre-proline 0 C--N 1.33 -0.273 0 CA-C-O 119.384 -0.341 . . . . 0.0 110.104 -178.177 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -59.47 157.55 31.01 Favored 'Trans proline' 0 C--N 1.309 -1.526 0 C-N-CA 121.918 1.745 . . . . 0.0 111.633 -179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 85.11 -15.66 42.75 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 176.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.409 ' O ' HD23 ' A' ' 81' ' ' LEU . 37.3 mmtm -101.03 -175.28 2.83 Favored 'General case' 0 C--N 1.33 -0.277 0 N-CA-C 110.113 -0.329 . . . . 0.0 110.113 178.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.557 HG22 ' HA ' ' A' ' 79' ' ' SER . 31.6 p -114.01 163.5 15.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.283 0.563 . . . . 0.0 111.199 179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 44.8 t -121.45 130.72 74.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 115.073 -0.967 . . . . 0.0 109.797 179.407 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 52.9 m -121.31 123.12 41.4 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.134 178.91 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 38.1 mt -114.08 119.9 62.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.114 -0.494 . . . . 0.0 109.895 178.782 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -102.77 130.51 49.77 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 110.046 -0.353 . . . . 0.0 110.046 179.7 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.528 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -127.64 119.64 26.33 Favored 'General case' 0 CA--C 1.533 0.3 0 N-CA-C 107.25 -1.389 . . . . 0.0 107.25 -178.208 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 98.4 m -109.56 136.02 49.61 Favored 'General case' 0 N--CA 1.465 0.289 0 O-C-N 121.555 -0.716 . . . . 0.0 110.498 179.509 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.612 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -107.81 157.57 15.34 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.11 -0.796 . . . . 0.0 111.11 -179.265 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 27' ' ' GLY . 1.5 t -112.54 159.17 19.08 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.851 0.357 . . . . 0.0 110.441 179.627 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 15.1 t 56.18 -82.24 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.887 -0.597 . . . . 0.0 110.548 -178.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.524 ' N ' ' O ' ' A' ' 25' ' ' SER . . . -63.78 154.91 45.64 Favored Glycine 0 CA--C 1.524 0.621 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 -178.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.451 ' C ' ' H ' ' A' ' 30' ' ' ALA . 0.2 OUTLIER -99.45 131.39 45.49 Favored 'General case' 0 C--N 1.329 -0.32 0 N-CA-C 109.724 -0.473 . . . . 0.0 109.724 179.577 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.542 ' C ' HD12 ' A' ' 29' ' ' ILE . 2.3 pp -63.34 1.55 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.544 -179.942 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.518 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -106.61 -27.54 10.79 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.912 -0.403 . . . . 0.0 109.912 178.19 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.508 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 35.1 p -76.46 -8.67 57.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.677 179.68 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.508 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.1 m120 -142.28 157.38 44.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.945 -0.57 . . . . 0.0 110.219 179.676 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.544 ' N ' ' CD1' ' A' ' 33' ' ' TYR . 0.2 OUTLIER -83.8 146.36 28.17 Favored 'General case' 0 C--N 1.329 -0.288 0 N-CA-C 109.668 -0.493 . . . . 0.0 109.668 179.75 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 31.7 t -120.82 140.37 45.18 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.233 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -178.122 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 12.6 mt-30 -127.23 145.39 50.79 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 109.081 -0.711 . . . . 0.0 109.081 -179.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 54.3 m95 -105.55 143.0 34.32 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 121.077 0.465 . . . . 0.0 110.303 -178.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 17.7 m-85 -130.99 154.42 48.19 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.332 -0.618 . . . . 0.0 109.332 -177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.8 OUTLIER -126.96 146.59 50.27 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 179.66 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 2.0 tt0 -116.86 97.83 6.17 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 121.053 0.454 . . . . 0.0 109.866 -179.373 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -92.98 109.45 39.47 Favored Pre-proline 0 C--N 1.329 -0.298 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.231 179.529 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 6.0 Cg_exo -55.65 140.66 84.22 Favored 'Trans proline' 0 C--N 1.309 -1.541 0 CA-C-N 119.992 1.033 . . . . 0.0 110.939 178.397 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.11 -19.71 41.0 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 178.959 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 37.7 p -138.87 159.97 40.84 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.759 0.314 . . . . 0.0 110.282 -178.127 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -64.86 173.0 1.84 Allowed Pre-proline 0 C--N 1.329 -0.326 0 C-N-CA 120.416 -0.514 . . . . 0.0 109.946 -177.154 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 5.0 Cg_exo -72.87 156.32 52.71 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.89 1.727 . . . . 0.0 111.697 175.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 26.9 m -129.3 122.61 29.94 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.782 175.449 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 36.5 m -61.01 128.14 34.98 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.427 177.456 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.515 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 21.4 t -94.89 -34.99 5.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 C-N-CA 120.465 -0.494 . . . . 0.0 110.505 -176.409 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.568 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.83 170.83 10.64 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 N-CA-C 109.286 -0.635 . . . . 0.0 109.286 177.228 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.568 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.4 OUTLIER -135.96 132.69 36.71 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 114.9 -1.045 . . . . 0.0 109.979 174.49 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.425 ' C ' ' N ' ' A' ' 53' ' ' ASN . 64.3 mt-10 59.64 21.62 10.28 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 114.794 -1.093 . . . . 0.0 111.42 173.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.429 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.4 OUTLIER 47.24 18.72 0.1 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.044 178.902 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.429 HD22 ' C ' ' A' ' 52' ' ' ASP . 2.4 m120 -112.22 -35.28 5.67 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.797 0.332 . . . . 0.0 110.705 -179.308 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.1 pt20 -169.49 -170.03 1.01 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.526 -178.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.554 ' HE ' ' C ' ' A' ' 60' ' ' PRO . 0.1 OUTLIER -137.01 157.25 74.99 Favored Pre-proline 0 C--N 1.329 -0.305 0 N-CA-C 109.616 -0.513 . . . . 0.0 109.616 179.751 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.5 Cg_endo -56.29 155.91 23.1 Favored 'Trans proline' 0 C--N 1.308 -1.572 0 C-N-CA 121.243 1.295 . . . . 0.0 111.143 -178.584 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -70.87 133.54 46.55 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.056 178.181 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -32.16 6.41 Favored Glycine 0 CA--C 1.527 0.793 0 N-CA-C 111.227 -0.749 . . . . 0.0 111.227 174.467 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.419 HG22 ' H ' ' A' ' 59' ' ' VAL . 5.0 m -76.92 149.92 80.71 Favored Pre-proline 0 C--N 1.33 -0.243 0 C-N-CA 120.272 -0.571 . . . . 0.0 110.32 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.554 ' C ' ' HE ' ' A' ' 55' ' ' ARG . 2.5 Cg_endo -61.79 156.27 49.4 Favored 'Trans proline' 0 C--N 1.309 -1.53 0 C-N-CA 121.263 1.308 . . . . 0.0 111.162 -177.88 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.445 ' C ' ' H ' ' A' ' 63' ' ' PHE . 0.5 OUTLIER -100.65 17.54 21.59 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.735 0.302 . . . . 0.0 110.675 -179.51 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.608 HH22 ' CG ' ' A' ' 85' ' ' ASP . 37.2 mtp180 -58.52 -6.44 0.7 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.558 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.515 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -119.42 150.84 39.53 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.055 -178.625 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.439 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.2 OUTLIER -147.05 125.96 12.75 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.981 177.451 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.502 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.22 143.04 16.34 Favored Glycine 0 CA--C 1.523 0.579 0 N-CA-C 110.196 -1.162 . . . . 0.0 110.196 -178.395 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 5.6 p -141.1 162.49 35.35 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.43 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.815 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.1 OUTLIER -138.79 144.69 29.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 121.014 0.435 . . . . 0.0 110.441 -177.249 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.549 ' O ' ' N ' ' A' ' 72' ' ' ASN . 34.9 m-20 -123.69 80.73 1.83 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.181 -179.506 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 25.6 p -55.09 -40.63 70.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.033 0.444 . . . . 0.0 110.393 -178.499 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 20.2 m -58.8 -51.0 71.85 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.777 178.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.2 t -85.1 -9.52 57.83 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.832 -0.622 . . . . 0.0 110.166 -177.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.549 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.2 OUTLIER 60.77 41.22 15.11 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.103 -0.499 . . . . 0.0 111.132 179.461 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 12.4 p -143.06 157.52 44.45 Favored 'General case' 0 C--N 1.33 -0.275 0 O-C-N 122.079 -0.388 . . . . 0.0 110.643 -178.886 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.07 145.66 40.5 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 109.56 -0.534 . . . . 0.0 109.56 -178.063 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -147.12 130.18 16.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.358 -179.427 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.767 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -108.11 138.66 43.99 Favored 'General case' 0 C--N 1.331 -0.199 0 N-CA-C 109.886 -0.413 . . . . 0.0 109.886 177.524 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.439 ' N ' ' O ' ' A' ' 64' ' ' SER . 79.7 m -111.97 123.97 51.39 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.53 174.895 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.0 mt -109.18 142.88 20.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 N-CA-C 109.024 -0.732 . . . . 0.0 109.024 179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.557 ' HA ' HG22 ' A' ' 17' ' ' THR . 72.4 m -126.51 136.38 52.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.202 -0.454 . . . . 0.0 110.803 178.606 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 70.1 59.51 5.41 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.291 -0.724 . . . . 0.0 111.291 -179.333 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.409 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.3 pp -71.11 143.54 50.58 Favored 'General case' 0 C--N 1.329 -0.293 0 C-N-CA 121.124 -0.23 . . . . 0.0 110.446 178.578 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 6.6 mmtt -139.93 162.84 34.21 Favored 'General case' 0 C--N 1.33 -0.27 0 N-CA-C 109.932 -0.395 . . . . 0.0 109.932 179.617 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -46.55 -35.81 6.16 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.105 0.479 . . . . 0.0 110.62 178.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 -55.03 -10.51 0.51 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.164 -0.925 . . . . 0.0 110.225 -177.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.608 ' CG ' HH22 ' A' ' 62' ' ' ARG . 0.8 OUTLIER -96.0 -8.39 33.81 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.74 -0.209 . . . . 0.0 110.521 179.201 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -53.05 87.49 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.223 -0.591 . . . . 0.0 110.472 177.11 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.592 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -165.37 -170.5 1.88 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.551 -0.295 . . . . 0.0 110.446 -179.772 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.456 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.0 OUTLIER -107.01 129.88 54.73 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 121.039 0.447 . . . . 0.0 110.63 -179.954 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.7 m-85 -94.12 142.36 27.49 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.479 -0.782 . . . . 0.0 110.547 178.054 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -122.59 154.06 38.45 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.978 -0.556 . . . . 0.0 109.75 178.878 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 7.7 m -117.72 141.97 47.8 Favored 'General case' 0 CA--C 1.533 0.318 0 N-CA-C 107.007 -1.479 . . . . 0.0 107.007 179.153 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 56.7 mt-30 -134.47 124.16 25.16 Favored 'General case' 0 N--CA 1.463 0.176 0 O-C-N 121.898 -0.501 . . . . 0.0 110.737 177.367 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.51 ' OG ' HD11 ' A' ' 4' ' ' LEU . 88.4 p -126.33 161.62 27.4 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.297 -0.41 . . . . 0.0 110.799 -179.408 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.507 ' CE1' HG23 ' A' ' 100' ' ' VAL . 5.9 m-85 -118.43 153.25 34.41 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.949 -0.389 . . . . 0.0 109.949 179.064 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.441 ' CG ' ' CD1' ' A' ' 2' ' ' PHE . 3.6 m-20 -107.42 170.78 7.76 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.296 179.217 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 87.0 p -61.97 -33.22 73.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.656 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.7 m -75.95 11.05 1.55 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 115.989 -0.551 . . . . 0.0 110.305 -179.167 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.1 t30 60.01 42.56 15.75 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.643 -178.831 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 28.1 m80 -111.64 120.37 41.84 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 178.308 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.507 HG23 ' CE1' ' A' ' 94' ' ' TYR . 9.2 p -70.77 132.72 32.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.65 -0.705 . . . . 0.0 110.575 179.209 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 98.3 t -129.3 140.03 50.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.41 -0.359 . . . . 0.0 110.172 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 4.4 p90 -115.58 146.66 41.55 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.01 179.501 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -91.03 175.03 39.51 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 110.844 -0.903 . . . . 0.0 110.844 -179.214 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.17 -32.93 85.84 Favored Glycine 0 CA--C 1.526 0.72 0 N-CA-C 110.953 -0.859 . . . . 0.0 110.953 -178.348 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 98.14 -179.89 32.56 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.174 -0.77 . . . . 0.0 111.174 179.767 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.8 m -151.15 136.31 17.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.855 0.36 . . . . 0.0 110.656 -178.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . 0.422 ' NZ ' ' OG1' ' A' ' 109' ' ' THR . 63.1 tttm -91.17 111.21 22.59 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.361 178.502 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.416 HD12 HG13 ' A' ' 10' ' ' VAL . 9.6 tp -101.41 126.81 48.24 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.402 177.474 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.422 ' OG1' ' NZ ' ' A' ' 107' ' ' LYS . 53.5 m -119.3 148.54 43.05 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 115.917 -0.583 . . . . 0.0 110.309 178.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 41.1 t -113.42 127.48 70.71 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.237 0 CA-C-N 115.972 -0.558 . . . . 0.0 109.512 -177.623 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 10.6 mt . . . . . 0 C--N 1.329 -0.302 0 CA-C-O 116.824 -1.56 . . . . 0.0 110.475 -179.366 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 17.9 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.165 -0.68 . . . . 0.0 109.165 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.529 ' CD1' ' O ' ' A' ' 2' ' ' PHE . 18.0 p90 -144.41 129.44 18.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.245 -179.849 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 49.0 mtt -152.96 169.03 23.88 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.966 -0.294 . . . . 0.0 110.537 178.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.486 HD23 ' HA2' ' A' ' 24' ' ' GLY . 17.5 mt -116.67 127.69 54.66 Favored 'General case' 0 C--N 1.333 -0.144 0 CA-C-O 120.801 0.334 . . . . 0.0 110.118 175.161 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 85.0 m -101.57 117.41 34.86 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.27 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.59 ' NE2' ' SG ' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -144.64 162.28 39.67 Favored Pre-proline 0 C--N 1.329 -0.287 0 N-CA-C 109.362 -0.607 . . . . 0.0 109.362 -179.808 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.413 ' O ' ' OG1' ' A' ' 106' ' ' THR . 5.6 Cg_exo -56.26 143.53 85.13 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.182 1.922 . . . . 0.0 111.077 179.957 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 4.3 m-70 -77.66 -35.38 52.47 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.791 -0.364 . . . . 0.0 110.278 178.512 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 64.6 m -167.87 148.47 5.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.341 -0.391 . . . . 0.0 109.982 -177.511 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.6 p -158.52 150.18 7.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.396 -177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 20.3 m -140.87 154.56 46.22 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.662 -0.699 . . . . 0.0 109.817 -177.62 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.491 ' CD ' ' H ' ' A' ' 13' ' ' SER . 1.2 tm-20 -156.17 159.84 39.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.442 -0.345 . . . . 0.0 110.171 177.365 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.491 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.3 OUTLIER -82.25 150.13 63.55 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.071 -179.955 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.76 155.76 36.05 Favored 'Trans proline' 0 C--N 1.307 -1.631 0 C-N-CA 121.682 1.588 . . . . 0.0 110.96 178.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.99 -33.86 5.3 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 111.145 -0.782 . . . . 0.0 111.145 179.849 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.418 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 49.3 mmtt -81.32 -157.63 0.18 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.829 0.347 . . . . 0.0 110.598 179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.435 HG22 ' HA ' ' A' ' 79' ' ' SER . 41.5 p -133.71 165.7 24.33 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.854 179.615 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.568 HG23 HD13 ' A' ' 81' ' ' LEU . 17.0 t -127.88 138.72 53.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.26 178.312 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -127.53 118.63 24.34 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.252 174.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 64.4 mt -108.18 120.2 59.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.748 177.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 10.5 p -99.67 134.44 42.56 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.163 179.225 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 58.3 m -127.4 116.59 20.69 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 174.53 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 23.1 m -102.13 127.54 49.0 Favored 'General case' 0 N--CA 1.463 0.192 0 O-C-N 121.924 -0.485 . . . . 0.0 110.668 176.752 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.486 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -104.49 133.05 11.35 Favored Glycine 0 CA--C 1.523 0.589 0 N-CA-C 111.007 -0.837 . . . . 0.0 111.007 -179.665 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 1.5 t -101.01 7.51 43.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.683 0.277 . . . . 0.0 110.364 178.213 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 9.7 p -78.12 -51.47 10.21 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.33 178.372 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -165.66 -175.67 36.39 Favored Glycine 0 CA--C 1.523 0.575 0 N-CA-C 110.274 -1.13 . . . . 0.0 110.274 178.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.511 ' C ' ' H ' ' A' ' 30' ' ' ALA . 21.5 t -62.9 113.4 3.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.453 -0.499 . . . . 0.0 110.044 -179.76 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.58 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.0 pp -62.89 0.7 0.43 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 115.939 -0.573 . . . . 0.0 109.793 -176.663 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.58 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.52 -19.59 14.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.058 179.57 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 m -79.86 -10.98 59.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.008 177.194 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -135.61 165.32 25.83 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.901 -0.407 . . . . 0.0 109.901 -177.685 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.418 ' CD1' ' N ' ' A' ' 33' ' ' TYR . 1.6 m-85 -93.07 146.89 23.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.295 -178.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.593 HG13 ' O ' ' A' ' 92' ' ' GLN . 22.8 t -125.8 138.8 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 N-CA-C 109.631 -0.507 . . . . 0.0 109.631 -179.856 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.594 ' NE2' ' CE1' ' A' ' 50' ' ' TYR . 76.4 mt-30 -125.31 148.48 48.7 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.358 -0.608 . . . . 0.0 109.358 179.369 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.497 ' O ' ' N ' ' A' ' 48' ' ' VAL . 33.3 m95 -117.32 149.17 40.93 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.649 0.261 . . . . 0.0 110.993 -178.416 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.516 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.2 OUTLIER -148.15 154.54 40.28 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 115.944 -0.571 . . . . 0.0 109.597 -179.253 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.498 ' NE2' ' CD2' ' A' ' 89' ' ' TYR . 1.1 mm-40 -119.98 148.32 43.69 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 108.656 -0.868 . . . . 0.0 108.656 -176.082 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -108.21 97.9 7.52 Favored 'General case' 0 C--N 1.332 -0.16 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 179.265 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 54.2 ttp180 -94.53 117.2 67.01 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-N 115.817 -0.629 . . . . 0.0 110.865 176.462 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.6 Cg_exo -59.48 145.44 97.96 Favored 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 121.197 1.264 . . . . 0.0 111.273 176.489 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 90.59 -6.53 82.14 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 110.935 -0.866 . . . . 0.0 110.935 178.091 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.3 p -152.15 164.13 37.94 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.728 0.299 . . . . 0.0 110.625 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -73.47 158.43 86.51 Favored Pre-proline 0 C--N 1.33 -0.264 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -178.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.4 Cg_exo -58.26 148.17 80.46 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 121.761 1.641 . . . . 0.0 110.863 179.014 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 56.4 m -127.46 125.95 41.46 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.539 -0.3 . . . . 0.0 110.595 178.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 12.8 m -57.26 124.69 19.72 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.004 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.516 HG23 ' HA ' ' A' ' 37' ' ' TYR . 58.3 t -84.03 -42.0 16.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.711 -0.478 . . . . 0.0 109.711 -177.861 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.503 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.2 mt -140.81 168.48 16.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 109.653 -0.499 . . . . 0.0 109.653 178.223 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.594 ' CE1' ' NE2' ' A' ' 35' ' ' GLN . 0.5 OUTLIER -135.02 142.72 46.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 114.609 -1.178 . . . . 0.0 110.017 -178.751 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 11.6 tt0 45.6 21.96 0.09 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.313 -0.858 . . . . 0.0 110.859 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 3.1 t0 48.38 19.98 0.26 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.481 -0.327 . . . . 0.0 110.46 179.785 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 14.9 m120 -112.26 -35.85 5.49 Favored 'General case' 0 C--N 1.332 -0.178 0 CA-C-O 120.833 0.349 . . . . 0.0 110.683 -179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -164.41 -168.94 1.64 Allowed 'General case' 0 C--N 1.329 -0.31 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.15 -177.426 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 13.1 ptt-85 -133.47 155.17 80.94 Favored Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.505 -0.554 . . . . 0.0 109.505 -179.103 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.636 ' O ' HG22 ' A' ' 59' ' ' VAL . 2.1 Cg_endo -54.51 153.79 22.02 Favored 'Trans proline' 0 C--N 1.306 -1.669 0 C-N-CA 121.764 1.643 . . . . 0.0 110.823 -178.166 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.7 m -68.73 140.63 55.37 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 119.892 -0.723 . . . . 0.0 110.364 178.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 102.57 -33.75 6.29 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 176.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.636 HG22 ' O ' ' A' ' 56' ' ' PRO . 10.8 m -74.25 152.48 88.12 Favored Pre-proline 0 C--N 1.33 -0.27 0 C-N-CA 120.058 -0.657 . . . . 0.0 110.144 -178.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.67 155.27 54.73 Favored 'Trans proline' 0 C--N 1.307 -1.625 0 C-N-CA 121.193 1.262 . . . . 0.0 111.571 -179.279 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 56.3 p30 -104.09 32.27 4.07 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.074 179.842 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.426 HH12 ' CG ' ' A' ' 85' ' ' ASP . 19.6 mtp-105 -73.63 -12.42 60.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.79 -0.641 . . . . 0.0 111.016 -178.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.502 ' CG ' ' CG1' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -121.08 145.98 47.22 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.671 0.272 . . . . 0.0 110.304 -178.755 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.454 ' N ' ' O ' ' A' ' 77' ' ' THR . 6.3 t -139.0 140.04 38.05 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.833 -0.621 . . . . 0.0 110.293 177.1 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.498 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -101.36 142.83 15.88 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 1.1 p -146.78 145.21 29.84 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 110.126 -0.324 . . . . 0.0 110.126 178.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 1.8 pp -119.92 145.18 26.56 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.223 0 CA-C-O 120.853 0.359 . . . . 0.0 110.868 -179.395 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.468 ' O ' ' N ' ' A' ' 72' ' ' ASN . 60.3 m-20 -121.95 82.66 1.98 Allowed 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.634 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.2 p -56.78 -34.14 67.34 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 0.0 110.611 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 50.2 m -66.88 -50.52 62.2 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.759 179.318 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 9.1 t -81.3 -7.22 59.53 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.81 -0.632 . . . . 0.0 109.985 179.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.468 ' N ' ' O ' ' A' ' 68' ' ' ASP . 0.6 OUTLIER 58.23 33.84 23.53 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.11 -179.158 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 10.7 p -138.33 164.08 30.2 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.004 0.431 . . . . 0.0 110.756 -178.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -116.51 146.79 42.34 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.086 -0.507 . . . . 0.0 109.949 -178.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.4 m -147.01 118.68 8.02 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.052 -0.522 . . . . 0.0 110.89 -176.235 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.905 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -96.59 137.85 35.05 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.719 176.447 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.454 ' O ' ' N ' ' A' ' 64' ' ' SER . 36.8 m -107.54 131.41 54.37 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.256 176.373 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.7 mt -115.68 139.92 39.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 179.609 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.435 ' HA ' HG22 ' A' ' 17' ' ' THR . 16.7 m -122.24 120.73 34.98 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.926 0.393 . . . . 0.0 110.969 -179.668 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 74.06 71.43 1.12 Allowed Glycine 0 CA--C 1.527 0.781 0 N-CA-C 111.633 -0.587 . . . . 0.0 111.633 178.154 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.975 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.0 pt? -78.65 148.33 33.22 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.349 0.118 . . . . 0.0 111.31 176.821 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 19.7 mmtt -151.93 172.25 16.52 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-O 120.892 0.377 . . . . 0.0 110.255 177.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.469 ' C ' ' H ' ' A' ' 85' ' ' ASP . 82.7 p -50.99 -33.14 23.53 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 121.31 0.576 . . . . 0.0 110.676 178.826 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 2.1 mm-40 -55.39 -8.07 0.3 Allowed 'General case' 0 C--N 1.326 -0.421 0 CA-C-N 115.084 -0.962 . . . . 0.0 109.467 178.83 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.488 ' O ' ' N ' ' A' ' 87' ' ' ALA . 0.6 OUTLIER -113.07 -22.4 10.57 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.652 -0.249 . . . . 0.0 110.477 179.507 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 84.6 tt0 -40.81 93.71 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.203 0 C-N-CA 120.575 -0.45 . . . . 0.0 111.363 178.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.488 ' N ' ' O ' ' A' ' 85' ' ' ASP . . . -172.52 -173.08 0.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.101 -0.499 . . . . 0.0 109.942 -176.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.52 ' OD1' ' N ' ' A' ' 88' ' ' ASP . 0.1 OUTLIER -87.37 153.15 21.68 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.855 0.36 . . . . 0.0 110.314 179.504 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.498 ' CD2' ' NE2' ' A' ' 38' ' ' GLN . 0.2 OUTLIER -126.52 133.01 51.25 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.336 -0.847 . . . . 0.0 109.456 179.181 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.455 ' CE2' ' O ' ' A' ' 104' ' ' GLY . 13.9 m-85 -130.7 154.83 47.53 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.483 -179.836 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.59 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 0.0 OUTLIER -119.31 149.39 41.89 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 108.507 -0.923 . . . . 0.0 108.507 175.832 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.593 ' O ' HG13 ' A' ' 34' ' ' VAL . 77.0 mt-30 -123.23 128.43 49.99 Favored 'General case' 0 N--CA 1.463 0.197 0 N-CA-C 109.862 -0.421 . . . . 0.0 109.862 176.215 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.43 ' O ' ' N ' ' A' ' 101' ' ' VAL . 27.8 p -121.22 158.63 27.65 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-O 120.777 0.322 . . . . 0.0 110.969 -178.353 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 20.5 m-85 -121.31 150.87 40.77 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.095 -0.502 . . . . 0.0 109.928 -179.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.408 ' CG ' ' H ' ' A' ' 96' ' ' SER . 16.4 t70 -111.34 -172.96 2.14 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.918 0.39 . . . . 0.0 110.442 -179.065 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.482 ' C ' ' H ' ' A' ' 98' ' ' ASN . 97.0 p -60.75 -39.65 89.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.952 -0.567 . . . . 0.0 110.75 -179.2 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 25.1 p -69.89 9.68 0.5 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.599 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.482 ' H ' ' C ' ' A' ' 96' ' ' SER . 14.0 t30 51.72 46.71 26.1 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.339 -178.364 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 62.9 t-80 -112.92 128.96 56.62 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.305 -0.407 . . . . 0.0 110.262 179.494 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -67.77 133.97 30.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.356 -178.478 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.541 HG12 ' N ' ' A' ' 102' ' ' PHE . 59.2 t -127.71 161.87 34.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.048 179.863 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.541 ' N ' HG12 ' A' ' 101' ' ' VAL . 50.4 p90 -131.13 149.86 52.4 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.273 -0.421 . . . . 0.0 110.973 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -98.37 174.97 28.96 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.286 -0.725 . . . . 0.0 111.286 179.582 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . 0.455 ' O ' ' CE2' ' A' ' 90' ' ' TYR . . . -56.34 -41.83 88.0 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.124 -0.79 . . . . 0.0 111.124 178.254 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 105.96 -176.62 22.12 Favored Glycine 0 CA--C 1.525 0.676 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . 0.413 ' OG1' ' O ' ' A' ' 7' ' ' PRO . 2.2 m -151.77 125.18 8.83 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.713 -0.477 . . . . 0.0 109.713 -177.559 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 25.2 tttm -81.28 113.4 19.38 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.005 177.424 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 19.1 tp -100.18 128.19 46.3 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.808 176.711 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 74.9 m -125.57 141.97 51.75 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.783 -0.644 . . . . 0.0 111.039 179.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 69.6 t -113.11 136.22 50.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.162 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.22 -179.222 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 12.0 mt . . . . . 0 C--O 1.22 -0.452 0 CA-C-O 118.023 -0.989 . . . . 0.0 110.584 178.357 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 11.6 t-20 . . . . . 0 N--CA 1.491 1.604 0 N-CA-C 109.065 -0.717 . . . . 0.0 109.065 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -91.13 102.66 15.4 Favored 'General case' 0 C--N 1.329 -0.303 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 179.518 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 53.5 mtp -150.86 172.06 16.25 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.601 -0.518 . . . . 0.0 109.601 178.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 9.7 mt -113.08 146.18 39.6 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-O 121.13 0.491 . . . . 0.0 109.77 178.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.3 m -115.66 133.97 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 177.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.589 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -146.02 -178.15 0.75 Allowed Pre-proline 0 C--N 1.331 -0.215 0 CA-C-N 116.237 -0.438 . . . . 0.0 109.906 -178.831 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.421 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -74.07 157.04 47.04 Favored 'Trans proline' 0 C--N 1.308 -1.57 0 C-N-CA 122.337 2.025 . . . . 0.0 111.924 177.466 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 71.9 m80 -76.0 -38.39 57.42 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.12 -0.491 . . . . 0.0 111.206 176.935 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 30.9 t -171.01 157.82 5.39 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.359 -0.382 . . . . 0.0 110.389 -178.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -160.38 152.61 4.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.395 -179.597 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.7 t -139.38 153.55 47.67 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.833 0.349 . . . . 0.0 110.947 -178.391 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 5.9 tp10 -156.13 149.8 24.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.327 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -92.66 156.89 40.66 Favored Pre-proline 0 C--N 1.33 -0.25 0 N-CA-C 110.021 -0.363 . . . . 0.0 110.021 -179.03 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -59.65 150.07 78.8 Favored 'Trans proline' 0 C--N 1.307 -1.624 0 C-N-CA 121.805 1.67 . . . . 0.0 110.754 -179.476 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 102.34 -25.98 25.8 Favored Glycine 0 CA--C 1.525 0.673 0 N-CA-C 110.908 -0.877 . . . . 0.0 110.908 176.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 60.4 mmtt -98.4 -161.54 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 N-CA-C 109.883 -0.414 . . . . 0.0 109.883 179.427 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.531 HG22 ' HA ' ' A' ' 79' ' ' SER . 44.1 p -130.78 157.77 41.94 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 121.123 0.487 . . . . 0.0 111.374 177.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.557 HG23 HD22 ' A' ' 81' ' ' LEU . 23.2 t -119.62 131.54 71.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 115.471 -0.786 . . . . 0.0 109.88 178.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 28.5 m -122.67 118.37 27.96 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 115.194 -0.912 . . . . 0.0 109.884 178.456 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 78.8 mt -107.32 126.84 63.5 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 115.965 -0.562 . . . . 0.0 110.15 178.343 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 19.6 m -102.5 134.4 45.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.171 178.601 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.589 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 3.2 m -124.65 116.85 23.05 Favored 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 179.519 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 1.8 m -93.75 132.88 37.7 Favored 'General case' 0 N--CA 1.463 0.181 0 O-C-N 122.033 -0.417 . . . . 0.0 110.256 179.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -102.61 143.04 15.75 Favored Glycine 0 CA--C 1.524 0.612 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 177.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.535 ' C ' ' H ' ' A' ' 27' ' ' GLY . 2.6 t -116.47 141.57 48.0 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 178.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 64.6 -9.37 0.18 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.338 -0.392 . . . . 0.0 110.847 -178.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.535 ' H ' ' C ' ' A' ' 25' ' ' SER . . . -142.58 139.4 9.08 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.803 -0.919 . . . . 0.0 110.803 179.89 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 41.4 m -94.97 141.54 28.53 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.267 0.556 . . . . 0.0 110.948 179.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.764 HD13 ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -70.44 3.26 0.74 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 115.549 -0.75 . . . . 0.0 110.927 -179.966 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -109.5 -37.77 5.62 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.237 179.357 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 99.8 p -67.68 -15.29 63.57 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.404 -178.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.451 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.7 OUTLIER -144.8 167.01 23.62 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.246 -179.354 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -82.31 149.06 27.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.006 -0.543 . . . . 0.0 109.803 -178.281 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 89.5 t -125.18 138.59 53.81 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.522 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 11.9 mt-30 -124.19 149.25 46.56 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 -177.783 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 66.9 m95 -108.55 139.59 43.1 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.463 179.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.577 ' CD1' ' NE2' ' A' ' 92' ' ' GLN . 4.4 m-85 -125.22 154.25 41.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.894 -0.593 . . . . 0.0 109.468 178.785 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.622 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm100 -129.35 148.0 51.23 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 108.814 -0.81 . . . . 0.0 108.814 177.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.431 ' N ' ' O ' ' A' ' 88' ' ' ASP . 1.0 OUTLIER -119.0 97.83 5.88 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.446 -0.576 . . . . 0.0 109.446 -178.644 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 27.3 mtt180 -91.1 122.59 66.29 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-N 115.552 -0.749 . . . . 0.0 109.99 179.327 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 4.9 Cg_exo -59.0 144.59 99.27 Favored 'Trans proline' 0 C--N 1.307 -1.608 0 CA-C-N 120.304 1.144 . . . . 0.0 110.83 -179.05 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 85.57 -14.7 50.22 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 110.797 -0.921 . . . . 0.0 110.797 178.61 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.8 m -133.15 171.45 13.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.679 0.276 . . . . 0.0 110.383 178.239 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -89.8 169.02 13.38 Favored Pre-proline 0 C--N 1.33 -0.261 0 CA-C-N 116.304 -0.407 . . . . 0.0 110.196 -178.194 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.6 Cg_exo -63.25 151.22 85.91 Favored 'Trans proline' 0 C--N 1.306 -1.672 0 C-N-CA 121.679 1.586 . . . . 0.0 111.599 -179.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 8.1 t -137.88 143.85 41.07 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.754 0.311 . . . . 0.0 111.146 177.54 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.414 HG22 ' CZ ' ' A' ' 37' ' ' TYR . 23.7 p -64.47 129.06 38.42 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.771 178.573 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.5 t -100.89 -37.84 5.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.207 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.653 -178.559 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.527 HG12 ' HE ' ' A' ' 55' ' ' ARG . 9.1 mt -145.0 163.92 12.87 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 N-CA-C 109.742 -0.466 . . . . 0.0 109.742 174.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.469 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -131.48 145.54 51.82 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.362 178.847 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.475 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 16.8 tt0 50.13 21.93 0.85 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.685 -0.689 . . . . 0.0 110.675 -179.737 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.489 ' HB3' HG23 ' A' ' 67' ' ' ILE . 0.1 OUTLIER 46.96 19.62 0.1 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.568 -0.742 . . . . 0.0 110.043 178.445 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.475 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 4.6 m120 -112.21 -42.45 3.72 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.768 0.318 . . . . 0.0 110.67 -178.276 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -165.8 -172.61 2.42 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.177 -0.465 . . . . 0.0 109.805 -177.536 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.533 ' NH1' ' O ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -134.16 157.11 78.35 Favored Pre-proline 0 C--N 1.331 -0.228 0 CA-C-N 116.351 -0.386 . . . . 0.0 109.97 -178.928 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.444 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.8 Cg_endo -56.61 145.31 82.0 Favored 'Trans proline' 0 C--N 1.307 -1.648 0 C-N-CA 121.447 1.431 . . . . 0.0 110.64 -179.444 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.5 m -61.05 139.28 58.11 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.909 177.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 113.21 -38.37 3.25 Favored Glycine 0 CA--C 1.527 0.805 0 CA-C-N 115.604 -0.726 . . . . 0.0 111.316 174.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.444 HG22 ' O ' ' A' ' 56' ' ' PRO . 2.8 m -78.44 155.41 78.97 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 117.301 0.55 . . . . 0.0 110.358 177.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.3 Cg_exo -54.84 166.11 2.23 Favored 'Trans proline' 0 C--N 1.308 -1.574 0 C-N-CA 122.058 1.839 . . . . 0.0 111.538 -175.406 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.536 ' O ' ' N ' ' A' ' 63' ' ' PHE . 61.8 t0 -105.69 -116.82 0.24 Allowed 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.517 178.028 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.626 HH22 ' CG ' ' A' ' 85' ' ' ASP . 66.6 mtp180 62.18 -68.91 0.06 Allowed 'General case' 0 C--N 1.329 -0.302 0 O-C-N 123.281 0.363 . . . . 0.0 110.723 178.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.536 ' N ' ' O ' ' A' ' 61' ' ' ASP . 0.0 OUTLIER -58.63 143.54 46.08 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.343 0.592 . . . . 0.0 109.74 -178.805 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.455 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.5 OUTLIER -142.38 125.13 15.95 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.233 -0.894 . . . . 0.0 110.262 178.323 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.457 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -95.02 144.16 17.03 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 110.942 -0.863 . . . . 0.0 110.942 179.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -143.05 149.71 38.58 Favored 'General case' 0 C--N 1.33 -0.249 0 O-C-N 122.646 -0.326 . . . . 0.0 110.324 177.805 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 1.0 HD13 ' H ' ' A' ' 67' ' ' ILE . 0.2 OUTLIER -124.15 144.45 33.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.546 -179.909 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.474 ' N ' ' OD1' ' A' ' 68' ' ' ASP . 1.4 m-20 -121.59 92.43 3.74 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.232 -0.44 . . . . 0.0 110.575 -178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -56.8 -33.76 67.01 Favored 'General case' 0 C--N 1.327 -0.374 0 O-C-N 121.882 -0.511 . . . . 0.0 110.518 -179.593 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 15.7 m -79.58 -50.91 9.98 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.109 -177.374 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.6 t -76.92 1.44 17.62 Favored 'General case' 0 C--N 1.328 -0.332 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 -176.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.51 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 1.7 t30 47.53 29.18 1.33 Allowed 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.574 178.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 11.2 p -138.46 156.79 47.23 Favored 'General case' 0 C--N 1.332 -0.193 0 N-CA-C 110.403 -0.221 . . . . 0.0 110.403 179.508 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -109.4 153.2 24.33 Favored 'General case' 0 C--N 1.33 -0.278 0 O-C-N 121.725 -0.609 . . . . 0.0 109.95 -179.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -147.31 129.31 15.44 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.741 -177.741 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.798 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -104.74 138.08 41.58 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.495 -0.321 . . . . 0.0 110.209 175.984 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.455 ' N ' ' O ' ' A' ' 64' ' ' SER . 22.0 m -111.58 124.1 51.6 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 121.026 0.441 . . . . 0.0 110.475 174.677 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.436 HG13 HD21 ' A' ' 76' ' ' LEU . 10.3 mt -108.45 128.1 64.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 N-CA-C 109.365 -0.606 . . . . 0.0 109.365 178.494 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.531 ' HA ' HG22 ' A' ' 17' ' ' THR . 79.0 p -104.79 144.57 31.57 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.473 -0.33 . . . . 0.0 110.521 179.182 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 50.31 66.11 2.57 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.018 -0.833 . . . . 0.0 111.018 178.197 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.557 HD22 HG23 ' A' ' 18' ' ' VAL . 1.5 pp -73.11 154.1 40.51 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 121.245 -0.182 . . . . 0.0 110.704 179.874 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 24.8 mtpt -146.05 166.36 26.33 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.638 0.256 . . . . 0.0 110.782 178.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.5 m -59.6 -37.31 78.22 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.717 0.294 . . . . 0.0 111.209 179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 28.2 mt-10 -54.89 -5.41 0.09 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.094 -0.503 . . . . 0.0 110.174 178.446 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.626 ' CG ' HH22 ' A' ' 62' ' ' ARG . 1.9 m-20 -103.71 -7.7 20.45 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 110.076 -0.342 . . . . 0.0 110.076 178.117 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.447 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 23.4 tt0 -53.56 112.98 1.01 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.05 178.932 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.447 ' HB2' ' O ' ' A' ' 86' ' ' GLU . . . 179.42 -167.87 0.09 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.601 0.238 . . . . 0.0 110.414 179.27 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.431 ' O ' ' N ' ' A' ' 39' ' ' GLN . 0.1 OUTLIER -106.06 131.24 53.58 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.053 0.454 . . . . 0.0 110.746 -179.608 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.622 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 12.5 m-85 -93.16 157.61 16.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.839 179.914 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -139.8 149.19 43.22 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.949 178.578 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.2 m -118.44 143.05 46.97 Favored 'General case' 0 N--CA 1.464 0.226 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 179.248 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.577 ' NE2' ' CD1' ' A' ' 37' ' ' TYR . 58.5 mt-30 -135.41 146.54 48.38 Favored 'General case' 0 C--N 1.333 -0.148 0 O-C-N 122.017 -0.427 . . . . 0.0 110.266 174.876 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.681 ' O ' HG22 ' A' ' 101' ' ' VAL . 49.2 p -141.74 166.05 25.8 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.938 0.399 . . . . 0.0 110.229 -179.29 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.451 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 76.2 m-85 -124.62 134.94 52.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.234 -179.135 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 35.1 p-10 -92.84 -167.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.343 -179.667 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 68.5 m -57.93 -40.37 80.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.856 179.627 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.417 ' O ' ' OG ' ' A' ' 97' ' ' SER . 0.1 OUTLIER -86.3 24.9 1.27 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.426 -0.352 . . . . 0.0 110.386 -178.549 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER 45.82 47.76 12.03 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.62 0.724 . . . . 0.0 109.839 178.618 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -91.84 120.55 32.64 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.89 -0.596 . . . . 0.0 109.765 178.052 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.56 HG13 ' O ' ' A' ' 100' ' ' VAL . 12.8 p -71.72 114.91 11.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.101 175.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.681 HG22 ' O ' ' A' ' 93' ' ' SER . 27.1 m -113.93 155.4 15.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.488 -179.396 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 62.4 m-85 -112.39 150.2 31.44 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.09 178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -102.16 174.73 24.4 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 111.163 -0.775 . . . . 0.0 111.163 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -60.72 -33.66 83.51 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.655 -0.978 . . . . 0.0 110.655 -179.09 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.78 165.51 40.88 Favored Glycine 0 CA--C 1.525 0.697 0 N-CA-C 110.974 -0.851 . . . . 0.0 110.974 178.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.3 m -136.65 147.06 46.66 Favored 'General case' 0 C--N 1.33 -0.241 0 N-CA-C 109.914 -0.402 . . . . 0.0 109.914 -178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -100.64 100.69 11.44 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 115.698 -0.683 . . . . 0.0 110.724 177.167 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 55.1 tp -83.44 126.38 32.7 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.967 -0.383 . . . . 0.0 109.967 175.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 43.3 m -120.61 143.36 48.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.0 0.429 . . . . 0.0 110.562 179.003 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.431 HG11 ' HA ' ' A' ' 83' ' ' THR . 70.9 t -118.39 138.9 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.988 179.575 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.88 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.498 0 CA-C-O 118.119 -0.944 . . . . 0.0 109.638 179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 10.7 t30 . . . . . 0 N--CA 1.49 1.528 0 N-CA-C 108.968 -0.753 . . . . 0.0 108.968 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.1 m-85 -81.58 178.04 8.58 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.637 179.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 6.8 mtp -155.37 172.15 18.68 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.091 179.691 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.613 HD23 ' HA2' ' A' ' 24' ' ' GLY . 32.2 mt -115.77 145.5 42.74 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.02 -0.363 . . . . 0.0 110.02 178.853 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.454 HG22 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -117.71 138.31 52.09 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.131 -0.486 . . . . 0.0 109.829 178.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.542 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.4 OUTLIER -146.12 -179.53 0.97 Allowed Pre-proline 0 C--N 1.33 -0.244 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 -176.902 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 5.8 Cg_exo -73.16 152.76 51.04 Favored 'Trans proline' 0 C--N 1.307 -1.63 0 C-N-CA 121.871 1.714 . . . . 0.0 111.615 178.151 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.412 ' O ' ' OG ' ' A' ' 9' ' ' SER . 38.3 m80 -71.23 -44.47 65.26 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.058 -0.519 . . . . 0.0 111.123 179.343 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . 0.412 ' OG ' ' O ' ' A' ' 8' ' ' HIS . 1.5 m -166.03 157.63 13.85 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.534 -178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 6.1 p -165.01 151.63 2.22 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.057 -0.52 . . . . 0.0 110.236 -178.766 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 7.3 t -139.05 160.88 38.72 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.829 0.347 . . . . 0.0 110.552 -178.23 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.54 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.9 tm-20 -156.25 162.26 40.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.087 -0.506 . . . . 0.0 109.99 -178.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.54 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -87.42 146.29 39.41 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.789 -0.449 . . . . 0.0 109.789 -179.451 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -60.53 151.55 74.54 Favored 'Trans proline' 0 C--N 1.307 -1.619 0 C-N-CA 121.227 1.284 . . . . 0.0 111.041 -178.704 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.68 -32.81 5.96 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.431 -1.068 . . . . 0.0 110.431 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.447 ' O ' ' CD2' ' A' ' 81' ' ' LEU . 11.6 mptt -81.02 -164.07 0.69 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 121.057 0.456 . . . . 0.0 110.084 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.626 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.2 p -126.02 157.91 36.69 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 121.365 0.602 . . . . 0.0 111.048 178.723 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 7.7 t -129.27 135.65 61.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.371 -0.832 . . . . 0.0 109.812 177.086 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . 0.42 ' C ' HD12 ' A' ' 20' ' ' ILE . 23.8 m -128.89 118.19 22.27 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.74 -0.664 . . . . 0.0 110.402 177.438 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.538 ' N ' HD12 ' A' ' 20' ' ' ILE . 1.8 mp -101.57 136.45 33.42 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 N-CA-C 109.306 -0.627 . . . . 0.0 109.306 176.492 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 24.4 t -101.25 129.82 47.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.347 178.198 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.542 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.3 m -124.39 117.16 23.84 Favored 'General case' 0 N--CA 1.464 0.235 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -179.632 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.454 ' O ' HG22 ' A' ' 5' ' ' THR . 20.9 m -113.0 136.5 52.62 Favored 'General case' 0 N--CA 1.465 0.305 0 O-C-N 121.997 -0.439 . . . . 0.0 110.727 179.0 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.613 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -105.13 154.03 17.25 Favored Glycine 0 CA--C 1.523 0.543 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 -176.27 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -99.47 2.8 45.31 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.495 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 96.2 p -96.73 -105.6 0.17 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.203 -0.453 . . . . 0.0 110.589 179.763 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.495 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -106.6 -173.1 22.98 Favored Glycine 0 CA--C 1.525 0.678 0 N-CA-C 110.855 -0.898 . . . . 0.0 110.855 -178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.414 ' C ' ' H ' ' A' ' 30' ' ' ALA . 5.8 m -80.66 135.85 36.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.272 0.558 . . . . 0.0 110.998 178.012 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.751 ' CD1' ' H ' ' A' ' 29' ' ' ILE . 0.1 OUTLIER -65.02 3.05 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 115.419 -0.809 . . . . 0.0 111.41 178.15 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.414 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -102.5 -21.58 14.19 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.021 0.439 . . . . 0.0 109.93 177.246 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 11.6 m -85.08 -14.07 48.34 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.539 -0.755 . . . . 0.0 110.777 178.498 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -139.87 162.99 33.83 Favored 'General case' 0 C--N 1.331 -0.237 0 N-CA-C 109.917 -0.401 . . . . 0.0 109.917 -178.016 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 42.0 m-85 -82.64 147.08 28.75 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.222 -0.444 . . . . 0.0 110.778 179.816 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.63 HG13 ' O ' ' A' ' 92' ' ' GLN . 40.7 t -129.0 141.64 46.12 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 N-CA-C 109.671 -0.492 . . . . 0.0 109.671 -179.65 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.483 ' HG2' ' H ' ' A' ' 51' ' ' GLU . 36.9 mt-30 -125.98 154.92 42.21 Favored 'General case' 0 C--N 1.329 -0.293 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.932 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.584 ' CZ3' ' SG ' ' A' ' 91' ' ' CYS . 86.1 m95 -115.54 156.15 26.26 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 121.171 0.51 . . . . 0.0 110.853 -179.251 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.536 ' CE2' HG22 ' A' ' 47' ' ' THR . 49.8 m-85 -144.05 154.43 43.23 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.574 -0.739 . . . . 0.0 109.863 -177.229 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.576 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 1.7 mm-40 -127.74 144.54 51.08 Favored 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 108.665 -0.865 . . . . 0.0 108.665 -179.186 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 1.7 tp60 -116.66 98.64 6.64 Favored 'General case' 0 C--N 1.331 -0.207 0 N-CA-C 109.924 -0.399 . . . . 0.0 109.924 179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 9.1 mtt-85 -87.33 133.43 38.56 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-O 119.368 -0.349 . . . . 0.0 110.099 178.392 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 2.4 Cg_endo -58.54 137.93 82.99 Favored 'Trans proline' 0 C--N 1.309 -1.543 0 C-N-CA 121.025 1.15 . . . . 0.0 110.939 178.791 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 76.71 -3.32 56.1 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.367 -0.693 . . . . 0.0 111.367 176.503 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 15.6 m -132.35 156.85 45.89 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.867 0.365 . . . . 0.0 110.556 -179.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.15 -177.76 0.5 Allowed Pre-proline 0 C--N 1.33 -0.264 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.175 -178.206 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.7 Cg_exo -74.31 148.64 38.98 Favored 'Trans proline' 0 C--N 1.307 -1.618 0 C-N-CA 122.463 2.109 . . . . 0.0 111.57 176.988 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 6.5 p -129.57 133.09 47.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.89 0.376 . . . . 0.0 110.474 177.025 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.536 HG22 ' CE2' ' A' ' 37' ' ' TYR . 32.4 p -65.17 116.91 7.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.078 -0.51 . . . . 0.0 110.603 177.333 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.489 HG13 ' CD2' ' A' ' 63' ' ' PHE . 48.7 t -80.26 -43.15 21.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.212 -0.449 . . . . 0.0 109.867 178.643 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.58 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 3.9 mt -142.43 173.23 7.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 N-CA-C 109.23 -0.655 . . . . 0.0 109.23 178.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.58 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 0.2 OUTLIER -135.01 132.57 38.47 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 115.338 -0.847 . . . . 0.0 110.227 174.741 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.483 ' H ' ' HG2' ' A' ' 35' ' ' GLN . 99.2 mt-10 59.2 21.61 9.73 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 114.414 -1.266 . . . . 0.0 110.971 175.228 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.499 ' OD1' ' NE1' ' A' ' 36' ' ' TRP . 0.4 OUTLIER 46.35 19.38 0.07 Allowed 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.734 -0.469 . . . . 0.0 109.734 177.396 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.458 ' N ' ' C ' ' A' ' 51' ' ' GLU . 14.2 m120 -112.29 -36.83 5.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.514 -178.566 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -176.54 -161.33 0.07 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.163 -176.634 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.637 HH12 ' H ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -151.29 155.14 34.48 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.829 -0.434 . . . . 0.0 109.829 -177.666 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.667 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.1 Cg_endo -53.36 138.54 64.96 Favored 'Trans proline' 0 C--N 1.307 -1.628 0 C-N-CA 121.557 1.505 . . . . 0.0 110.605 -177.129 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 4.3 m -57.75 139.32 54.17 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 119.932 -0.707 . . . . 0.0 109.639 179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 109.79 -35.21 5.01 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 175.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.667 HG22 ' O ' ' A' ' 56' ' ' PRO . 11.4 m -75.9 153.7 84.92 Favored Pre-proline 0 C--N 1.331 -0.237 0 C-N-CA 120.433 -0.507 . . . . 0.0 110.036 178.597 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.535 ' O ' ' NH2' ' A' ' 55' ' ' ARG . 5.2 Cg_exo -57.35 155.2 31.22 Favored 'Trans proline' 0 C--N 1.308 -1.567 0 C-N-CA 121.549 1.499 . . . . 0.0 110.938 -175.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 12.3 p-10 -112.66 28.28 8.91 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.72 179.017 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.555 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 45.6 mtp180 -73.5 -20.05 60.77 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 121.1 -0.24 . . . . 0.0 111.148 -177.5 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.637 ' H ' HH12 ' A' ' 55' ' ' ARG . 0.6 OUTLIER -108.74 147.78 31.47 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.369 -0.604 . . . . 0.0 109.369 -178.333 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.436 ' CB ' ' O ' ' A' ' 77' ' ' THR . 0.6 OUTLIER -135.17 152.89 52.01 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.457 -0.338 . . . . 0.0 110.888 179.107 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -111.52 140.98 16.39 Favored Glycine 0 CA--C 1.526 0.735 0 N-CA-C 110.552 -1.019 . . . . 0.0 110.552 -179.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.52 ' N ' ' O ' ' A' ' 75' ' ' SER . 0.8 OUTLIER -137.82 142.37 40.8 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 117.036 0.418 . . . . 0.0 110.197 177.437 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 31.0 pt -123.54 143.64 35.97 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.482 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.483 ' O ' HD11 ' A' ' 29' ' ' ILE . 9.6 m-20 -124.0 94.46 4.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.732 -0.667 . . . . 0.0 110.566 -178.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 2.3 p -61.97 -24.99 67.35 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.294 -0.562 . . . . 0.0 110.728 178.896 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.4 m -85.96 -51.02 6.63 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.974 -178.067 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.3 t -77.0 -2.61 34.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.248 0.547 . . . . 0.0 109.579 -177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.537 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 5.5 t30 51.77 28.45 4.94 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.309 -0.86 . . . . 0.0 110.287 178.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 22.2 p -135.61 155.73 49.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 121.015 0.436 . . . . 0.0 111.18 178.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.411 ' HB2' HG21 ' A' ' 29' ' ' ILE . . . -109.56 149.35 29.78 Favored 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.219 -0.659 . . . . 0.0 109.219 -179.282 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.52 ' O ' ' N ' ' A' ' 66' ' ' SER . 3.0 m -148.49 134.55 19.21 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.707 -178.134 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.891 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -103.03 136.56 42.62 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.462 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.436 ' O ' ' CB ' ' A' ' 64' ' ' SER . 59.3 m -108.66 122.22 46.66 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-O 121.285 0.564 . . . . 0.0 110.787 174.501 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 63.9 mt -105.3 147.85 10.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.691 -179.378 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.626 ' HA ' HG22 ' A' ' 17' ' ' THR . 85.1 p -139.24 131.7 28.6 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.769 178.74 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 78.67 41.27 15.9 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.097 -0.801 . . . . 0.0 111.097 179.25 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.868 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.2 pt? -67.19 157.4 33.84 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.844 -0.342 . . . . 0.0 110.945 -179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 38.4 mttp -153.21 176.29 12.11 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.653 174.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.5 ' C ' ' H ' ' A' ' 85' ' ' ASP . 73.7 p -60.75 -32.89 72.17 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.927 179.026 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -54.83 -8.95 0.29 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.09 177.53 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.555 ' OD1' ' NH1' ' A' ' 62' ' ' ARG . 0.2 OUTLIER -108.04 -24.66 11.49 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.733 -0.667 . . . . 0.0 110.17 -179.383 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 80.9 tt0 -35.64 101.15 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.174 0 N-CA-C 111.69 0.256 . . . . 0.0 111.69 179.427 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.486 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.82 -167.21 0.17 Allowed 'General case' 0 C--N 1.33 -0.257 0 C-N-CA 120.774 -0.37 . . . . 0.0 110.447 -179.128 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.45 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 1.0 OUTLIER -102.35 152.05 21.54 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 121.329 0.585 . . . . 0.0 111.468 -178.88 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.576 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 48.3 m-85 -118.61 138.71 52.39 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.219 -0.9 . . . . 0.0 110.065 179.285 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 10.8 m-85 -120.85 153.6 36.92 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.187 179.146 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.584 ' SG ' ' CZ3' ' A' ' 36' ' ' TRP . 56.4 m -117.99 143.84 46.05 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 108.413 -0.958 . . . . 0.0 108.413 -176.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.63 ' O ' HG13 ' A' ' 34' ' ' VAL . 71.0 mt-30 -135.9 142.74 44.72 Favored 'General case' 0 N--CA 1.462 0.173 0 O-C-N 121.809 -0.557 . . . . 0.0 110.828 176.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 19.2 p -142.72 161.6 37.66 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.871 0.367 . . . . 0.0 111.008 -178.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 45.6 m-85 -123.79 145.55 48.97 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.344 178.805 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.444 ' OD1' ' N ' ' A' ' 95' ' ' ASP . 2.9 p30 -116.03 -178.34 3.38 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.33 -0.396 . . . . 0.0 110.108 -179.477 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . 0.431 ' C ' ' H ' ' A' ' 98' ' ' ASN . 66.2 m -56.39 -40.64 74.94 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.123 -0.49 . . . . 0.0 110.578 -178.524 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 74.7 m -68.9 4.44 1.5 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.2 -0.455 . . . . 0.0 110.479 179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . 0.431 ' H ' ' C ' ' A' ' 96' ' ' SER . 40.8 m-20 55.76 39.45 30.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.387 179.897 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -105.41 125.63 51.2 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -178.09 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.499 HG13 ' O ' ' A' ' 100' ' ' VAL . 9.8 p -69.02 126.25 28.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.517 -179.455 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 78.6 t -115.05 140.03 38.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 N-CA-C 109.833 -0.432 . . . . 0.0 109.833 179.635 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -119.18 151.87 37.57 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.908 0.385 . . . . 0.0 110.401 -178.045 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -104.72 173.26 20.83 Favored Glycine 0 CA--C 1.525 0.679 0 N-CA-C 110.994 -0.842 . . . . 0.0 110.994 -179.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.38 -33.81 83.16 Favored Glycine 0 CA--C 1.525 0.666 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 178.157 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 100.8 175.06 29.42 Favored Glycine 0 CA--C 1.524 0.65 0 N-CA-C 111.23 -0.748 . . . . 0.0 111.23 178.442 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 68.4 m -143.76 135.01 25.81 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.798 0.332 . . . . 0.0 110.703 -177.501 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 82.8 tttt -90.15 121.6 32.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.307 -0.406 . . . . 0.0 110.716 -179.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 26.4 tp -107.29 129.77 54.85 Favored 'General case' 0 C--N 1.331 -0.233 0 N-CA-C 109.837 -0.431 . . . . 0.0 109.837 178.993 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 99.8 m -122.11 135.04 54.76 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.741 0.305 . . . . 0.0 110.51 179.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 17.8 t -119.88 109.76 27.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.374 -0.375 . . . . 0.0 110.53 -178.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.199 -1.602 0 CA-C-O 117.733 -1.127 . . . . 0.0 109.981 -178.732 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 23.2 m120 . . . . . 0 N--CA 1.49 1.529 0 N-CA-C 109.008 -0.738 . . . . 0.0 109.008 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.513 ' CD2' ' OD1' ' A' ' 95' ' ' ASP . 8.1 m-85 -81.14 143.09 32.64 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.073 -179.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 10.9 mtp -151.02 165.24 34.36 Favored 'General case' 0 C--N 1.33 -0.28 0 N-CA-C 109.832 -0.433 . . . . 0.0 109.832 177.023 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.517 HD23 ' HA2' ' A' ' 24' ' ' GLY . 19.7 mt -129.2 151.14 50.19 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.132 0.492 . . . . 0.0 109.892 178.752 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 22.2 m -125.37 115.35 20.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.797 178.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.585 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 1.2 mt-30 -123.39 159.65 53.99 Favored Pre-proline 0 C--N 1.33 -0.24 0 N-CA-C 109.164 -0.68 . . . . 0.0 109.164 -179.716 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.7 Cg_exo -54.85 147.84 49.28 Favored 'Trans proline' 0 C--N 1.307 -1.636 0 C-N-CA 121.383 1.389 . . . . 0.0 110.851 -179.802 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 38.2 m80 -61.64 -33.8 74.57 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.814 -0.354 . . . . 0.0 110.266 178.629 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 10.3 t 179.88 162.73 1.0 Allowed 'General case' 0 C--N 1.33 -0.246 0 N-CA-C 109.489 -0.559 . . . . 0.0 109.489 -179.149 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 4.5 p -158.46 150.86 7.51 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.206 -176.286 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.9 m -137.08 153.08 50.65 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.0 -0.545 . . . . 0.0 110.422 -178.633 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 52.5 tp10 -155.92 149.72 25.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.026 -0.534 . . . . 0.0 110.387 179.706 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 4.8 t -87.02 155.16 55.36 Favored Pre-proline 0 C--N 1.329 -0.289 0 CA-C-N 116.401 -0.363 . . . . 0.0 110.354 -179.746 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -59.27 153.84 50.53 Favored 'Trans proline' 0 C--N 1.308 -1.586 0 C-N-CA 121.858 1.705 . . . . 0.0 111.34 -179.053 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 90.22 -35.42 3.82 Favored Glycine 0 CA--C 1.524 0.642 0 N-CA-C 110.802 -0.919 . . . . 0.0 110.802 179.478 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.485 ' O ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -76.91 -172.87 2.47 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.329 0.585 . . . . 0.0 110.313 179.463 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.615 HG22 ' HA ' ' A' ' 79' ' ' SER . 26.2 p -120.22 154.7 34.49 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 114.817 -1.083 . . . . 0.0 110.747 177.399 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.713 HG23 HD22 ' A' ' 81' ' ' LEU . 5.6 t -116.02 137.99 47.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 115.293 -0.867 . . . . 0.0 109.912 178.351 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 61.8 m -122.07 115.58 22.72 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 114.963 -1.017 . . . . 0.0 108.995 177.27 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 93.5 mt -105.07 128.22 59.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.27 176.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.4 t -105.75 126.73 52.5 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 0.0 110.038 -179.822 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.585 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.1 m -122.57 116.82 24.52 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 107.168 -1.419 . . . . 0.0 107.168 179.077 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 91.3 m -110.12 139.37 45.34 Favored 'General case' 0 N--CA 1.466 0.328 0 O-C-N 121.685 -0.634 . . . . 0.0 110.304 -178.787 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.517 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.33 160.44 13.14 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 111.202 -0.759 . . . . 0.0 111.202 -176.475 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 6.5 t -133.83 139.18 46.09 Favored 'General case' 0 C--N 1.331 -0.23 0 N-CA-C 109.736 -0.468 . . . . 0.0 109.736 -176.252 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.443 ' CB ' ' O ' ' A' ' 25' ' ' SER . 1.4 t 81.77 0.25 1.53 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.672 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -163.85 154.0 24.67 Favored Glycine 0 CA--C 1.525 0.719 0 N-CA-C 110.809 -0.917 . . . . 0.0 110.809 179.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 3.7 m -94.77 144.34 25.72 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.886 0.375 . . . . 0.0 110.661 179.169 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.592 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.4 OUTLIER -74.11 -5.04 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.643 -178.058 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . . . . . . . . . . . -101.79 -13.1 17.85 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 121.079 0.466 . . . . 0.0 109.844 179.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.494 ' OG ' ' ND2' ' A' ' 32' ' ' ASN . 55.4 p -78.99 -11.77 60.02 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.472 -0.786 . . . . 0.0 111.088 179.486 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' ND2' ' OG ' ' A' ' 31' ' ' SER . 9.5 m-80 -154.04 166.07 34.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 0.0 110.429 -178.548 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 0.0 OUTLIER -80.81 147.22 30.56 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.427 ' O ' ' OD1' ' A' ' 52' ' ' ASP . 92.6 t -128.51 139.19 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 -179.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.481 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 20.3 mp0 -124.57 149.39 47.05 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.28 -0.637 . . . . 0.0 109.28 -178.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.445 ' CD1' ' OD1' ' A' ' 52' ' ' ASP . 80.3 m95 -105.73 146.43 29.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.536 -178.731 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.491 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 24.9 m-85 -138.06 154.39 49.27 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 115.542 -0.754 . . . . 0.0 109.655 -177.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.705 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -130.37 145.52 51.81 Favored 'General case' 0 C--N 1.329 -0.301 0 N-CA-C 108.955 -0.757 . . . . 0.0 108.955 -179.449 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.534 ' N ' ' OE1' ' A' ' 38' ' ' GLN . 81.7 mt-30 -124.74 97.95 5.5 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.12 -178.192 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.443 ' HD3' ' H ' ' A' ' 40' ' ' ARG . 0.1 OUTLIER -86.51 137.59 34.22 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.433 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.8 Cg_exo -53.84 135.65 63.54 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.613 1.542 . . . . 0.0 110.887 -178.621 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 77.39 7.21 86.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 111.005 -0.838 . . . . 0.0 111.005 176.9 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 9.3 t -143.54 145.66 32.72 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.098 0.475 . . . . 0.0 110.38 -178.694 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.422 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.1 OUTLIER -66.77 -176.5 0.24 Allowed Pre-proline 0 C--N 1.33 -0.27 0 CA-C-N 115.814 -0.63 . . . . 0.0 110.282 -177.495 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.422 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.5 Cg_exo -71.73 153.29 59.27 Favored 'Trans proline' 0 C--N 1.308 -1.601 0 C-N-CA 122.05 1.833 . . . . 0.0 111.699 178.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 34.9 m -135.58 133.34 38.22 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 120.71 0.291 . . . . 0.0 110.857 176.641 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.433 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 23.6 m -64.14 127.76 32.86 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.416 -0.356 . . . . 0.0 110.818 177.612 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.403 HG12 HG13 ' A' ' 49' ' ' ILE . 42.7 t -97.91 -42.9 11.79 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.198 0 N-CA-C 109.911 -0.403 . . . . 0.0 109.911 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.601 HG22 ' N ' ' A' ' 50' ' ' TYR . 28.1 mt -142.55 167.63 14.69 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 0.0 110.457 -179.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.601 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.1 OUTLIER -125.31 148.43 48.71 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.126 -179.409 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.446 ' C ' ' N ' ' A' ' 53' ' ' ASN . 6.0 tt0 43.74 20.88 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.108 -0.951 . . . . 0.0 110.403 178.122 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.47 ' N ' ' O ' ' A' ' 50' ' ' TYR . 0.8 OUTLIER 46.21 19.25 0.07 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.734 -0.666 . . . . 0.0 109.826 177.87 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.446 ' N ' ' C ' ' A' ' 51' ' ' GLU . 9.2 m120 -112.45 -27.93 8.07 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.555 -0.293 . . . . 0.0 110.771 179.732 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -176.99 162.12 2.01 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.042 -177.058 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -100.13 159.46 29.75 Favored Pre-proline 0 C--N 1.327 -0.403 0 CA-C-N 115.84 -0.618 . . . . 0.0 109.535 -176.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . 0.597 ' O ' HG22 ' A' ' 59' ' ' VAL . 1.6 Cg_endo -59.3 157.4 30.82 Favored 'Trans proline' 0 C--N 1.306 -1.67 0 C-N-CA 120.997 1.131 . . . . 0.0 110.377 -179.196 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -68.97 139.66 55.03 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 120.402 -0.519 . . . . 0.0 110.052 177.124 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.54 -38.25 3.4 Favored Glycine 0 CA--C 1.526 0.727 0 N-CA-C 111.113 -0.795 . . . . 0.0 111.113 174.72 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.597 HG22 ' O ' ' A' ' 56' ' ' PRO . 22.7 m -72.74 155.03 91.15 Favored Pre-proline 0 C--N 1.329 -0.31 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.077 -178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 4.0 Cg_exo -59.22 156.74 33.4 Favored 'Trans proline' 0 C--N 1.307 -1.656 0 C-N-CA 121.27 1.314 . . . . 0.0 111.056 -176.835 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 21.4 m-20 -103.95 35.73 2.56 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 121.002 0.43 . . . . 0.0 110.634 -179.635 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.546 ' NH1' ' OD1' ' A' ' 85' ' ' ASP . 36.0 mtp-105 -80.38 -17.65 51.27 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.904 -179.205 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.423 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -116.42 146.95 42.13 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 120.841 0.353 . . . . 0.0 110.052 -177.855 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.422 ' O ' ' N ' ' A' ' 77' ' ' THR . 0.3 OUTLIER -143.9 131.69 21.39 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.062 177.876 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.413 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -99.15 140.7 15.14 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 110.513 -1.035 . . . . 0.0 110.513 -179.436 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . 0.438 ' OG ' ' O ' ' A' ' 75' ' ' SER . 1.0 OUTLIER -135.04 150.62 50.32 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.116 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.7 pt -127.16 139.48 51.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-O 121.059 0.457 . . . . 0.0 110.707 -179.815 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -121.82 85.47 2.41 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.686 -0.688 . . . . 0.0 109.87 178.384 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 p -52.02 -30.64 26.28 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.786 -0.643 . . . . 0.0 109.741 177.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 22.1 m -72.27 -51.22 21.9 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.046 178.523 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 2.3 t -79.89 -7.74 58.91 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.0 -0.545 . . . . 0.0 109.733 -176.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.576 ' C ' HD22 ' A' ' 72' ' ' ASN . 0.2 OUTLIER 59.34 37.75 23.28 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 119.463 -0.895 . . . . 0.0 110.255 178.212 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 88.1 p -156.15 161.1 40.37 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.607 -179.701 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -113.42 133.46 55.17 Favored 'General case' 0 C--N 1.331 -0.196 0 N-CA-C 109.692 -0.485 . . . . 0.0 109.692 -176.063 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . 0.438 ' O ' ' OG ' ' A' ' 66' ' ' SER . 57.6 m -125.51 119.66 28.8 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.36 -178.687 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.841 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.0 OUTLIER -95.63 138.0 33.91 Favored 'General case' 0 C--N 1.331 -0.212 0 N-CA-C 109.945 -0.391 . . . . 0.0 109.945 179.364 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.422 ' N ' ' O ' ' A' ' 64' ' ' SER . 49.7 m -110.17 122.23 47.15 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 121.024 0.44 . . . . 0.0 110.569 175.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 6.9 mt -108.12 136.69 42.8 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.218 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.86 -178.869 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.615 ' HA ' HG22 ' A' ' 17' ' ' THR . 1.7 m -111.59 151.43 28.76 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.618 179.574 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 41.07 68.06 0.68 Allowed Glycine 0 CA--C 1.526 0.725 0 N-CA-C 111.6 -0.6 . . . . 0.0 111.6 178.269 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.713 HD22 HG23 ' A' ' 18' ' ' VAL . 2.1 pp -80.43 144.42 32.65 Favored 'General case' 0 C--N 1.33 -0.264 0 O-C-N 122.763 -0.257 . . . . 0.0 110.912 179.259 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 45.7 mtmt -147.97 172.27 14.48 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.395 -0.366 . . . . 0.0 110.645 176.291 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.53 ' C ' ' H ' ' A' ' 85' ' ' ASP . 19.3 p -46.06 -29.65 1.57 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 121.394 0.616 . . . . 0.0 110.853 -178.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 96.2 mt-10 -55.28 -4.7 0.09 Allowed 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 114.931 -1.031 . . . . 0.0 110.284 177.41 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.587 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -110.26 -29.52 8.12 Favored 'General case' 0 C--N 1.33 -0.242 0 N-CA-C 109.533 -0.543 . . . . 0.0 109.533 179.687 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 67.0 tt0 -41.42 95.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.951 -178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.705 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -178.01 -178.82 0.7 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.073 -177.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.432 ' O ' ' OE1' ' A' ' 38' ' ' GLN . 24.7 m-20 -88.81 144.43 26.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.413 -179.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 2.4 m-85 -114.94 134.36 55.23 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.791 -177.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -119.71 151.6 38.49 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.005 178.486 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 58.4 m -117.59 149.93 39.84 Favored 'General case' 0 N--CA 1.463 0.216 0 N-CA-C 106.737 -1.579 . . . . 0.0 106.737 -178.337 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.491 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 23.4 mt-30 -134.35 123.69 24.54 Favored 'General case' 0 C--N 1.331 -0.223 0 O-C-N 121.568 -0.707 . . . . 0.0 110.577 175.599 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . 0.451 ' OG ' HD11 ' A' ' 4' ' ' LEU . 77.6 p -116.87 156.3 27.56 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.901 -0.59 . . . . 0.0 110.419 -179.674 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 6.6 m-85 -116.82 141.25 48.46 Favored 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.513 ' OD1' ' CD2' ' A' ' 2' ' ' PHE . 72.6 m-20 -96.2 169.65 9.8 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.371 -179.697 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 83.0 p -64.0 1.08 0.74 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.62 -179.078 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.459 ' H ' ' C ' ' A' ' 95' ' ' ASP . 6.4 p -111.61 11.81 21.19 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.7 -178.933 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 1.4 m120 62.71 28.92 16.75 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.661 179.042 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 33.0 t-80 -102.49 116.56 32.87 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 -179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 2.5 p -62.26 126.84 21.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.082 -0.508 . . . . 0.0 110.28 -178.718 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 73.4 t -114.67 152.2 16.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.855 179.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 90.6 m-85 -118.57 150.84 38.98 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.716 -178.086 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -105.09 173.93 21.02 Favored Glycine 0 CA--C 1.526 0.724 0 N-CA-C 111.492 -0.643 . . . . 0.0 111.492 -179.255 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -67.04 -28.51 73.81 Favored Glycine 0 CA--C 1.526 0.731 0 N-CA-C 110.904 -0.879 . . . . 0.0 110.904 -178.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 85.21 168.06 44.16 Favored Glycine 0 CA--C 1.524 0.614 0 N-CA-C 111.417 -0.673 . . . . 0.0 111.417 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 25.1 m -139.16 134.53 32.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.491 -0.355 . . . . 0.0 110.275 -178.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 31.6 tttp -82.68 122.58 28.33 Favored 'General case' 0 C--N 1.33 -0.274 0 N-CA-C 109.935 -0.394 . . . . 0.0 109.935 176.249 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 54.7 tp -107.25 127.34 53.44 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.305 -0.628 . . . . 0.0 109.305 175.697 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 87.3 m -116.34 138.11 51.6 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.016 178.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 43.6 t -118.07 123.58 71.85 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.198 -178.016 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 2.4 mt . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 118.025 -0.988 . . . . 0.0 110.457 -178.93 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 6.7 m120 . . . . . 0 N--CA 1.49 1.539 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.502 ' O ' ' CD2' ' A' ' 2' ' ' PHE . 14.5 t80 -103.94 109.86 21.78 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.851 178.283 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.495 ' SD ' ' O ' ' A' ' 2' ' ' PHE . 0.0 OUTLIER -149.64 168.43 23.6 Favored 'General case' 0 C--N 1.33 -0.263 0 N-CA-C 109.458 -0.571 . . . . 0.0 109.458 176.214 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 12.3 mt -107.31 140.38 40.31 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 121.02 0.438 . . . . 0.0 110.756 177.739 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.407 HG23 ' O ' ' A' ' 23' ' ' THR . 0.9 OUTLIER -112.49 127.54 56.08 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 121.414 0.626 . . . . 0.0 109.771 -177.508 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.428 ' CB ' ' CD ' ' A' ' 7' ' ' PRO . 0.0 OUTLIER -146.0 177.91 1.61 Allowed Pre-proline 0 C--N 1.327 -0.381 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.47 179.705 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.428 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 3.1 Cg_exo -72.43 143.81 39.52 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.317 2.011 . . . . 0.0 111.71 176.192 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.762 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 1.5 p80 -71.46 -40.4 70.34 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.21 177.527 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 54.0 m -161.62 158.18 25.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.056 -0.52 . . . . 0.0 109.758 179.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.426 HG22 ' N ' ' A' ' 11' ' ' SER . 3.9 p -161.72 156.5 2.68 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.149 0.5 . . . . 0.0 110.057 -178.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.426 ' N ' HG22 ' A' ' 10' ' ' VAL . 46.2 m -139.51 154.07 47.61 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.797 -0.638 . . . . 0.0 110.17 -179.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 20.8 tp10 -156.05 145.21 20.62 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.249 -0.432 . . . . 0.0 110.566 179.508 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -85.35 154.36 59.68 Favored Pre-proline 0 C--N 1.33 -0.272 0 N-CA-C 110.064 -0.347 . . . . 0.0 110.064 -178.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.0 OUTLIER -59.17 146.22 95.19 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 121.945 1.763 . . . . 0.0 111.007 179.911 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 98.14 -33.71 5.77 Favored Glycine 0 CA--C 1.525 0.703 0 N-CA-C 110.9 -0.88 . . . . 0.0 110.9 177.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 27.8 mmtp -79.86 -163.79 0.58 Allowed 'General case' 0 C--N 1.329 -0.31 0 O-C-N 122.788 -0.242 . . . . 0.0 110.415 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.61 HG22 ' HA ' ' A' ' 79' ' ' SER . 19.8 p -121.99 166.11 14.97 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 120.855 0.36 . . . . 0.0 110.853 -179.199 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.519 HG23 HD22 ' A' ' 81' ' ' LEU . 27.9 t -125.69 134.22 67.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-O 121.69 0.757 . . . . 0.0 109.811 175.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -126.08 123.98 39.57 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 114.968 -1.015 . . . . 0.0 110.464 176.845 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 57.1 mt -110.87 133.29 56.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.294 -0.866 . . . . 0.0 109.953 177.909 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 17.9 t -109.23 119.17 38.69 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 110.36 -0.237 . . . . 0.0 110.36 179.603 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.2 116.3 26.53 Favored 'General case' 0 C--N 1.329 -0.283 0 N-CA-C 108.087 -1.079 . . . . 0.0 108.087 178.397 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . 0.407 ' O ' HG23 ' A' ' 5' ' ' THR . 25.7 m -113.73 142.31 46.2 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 110.183 -0.303 . . . . 0.0 110.183 174.954 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -105.05 154.41 17.25 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 7.7 t -117.04 148.63 41.32 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.896 0.379 . . . . 0.0 110.337 -179.39 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.43 ' O ' ' OG ' ' A' ' 26' ' ' SER . 1.9 t 55.39 13.93 1.02 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.138 -0.483 . . . . 0.0 110.488 -179.61 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -157.52 165.18 33.36 Favored Glycine 0 CA--C 1.525 0.658 0 N-CA-C 111.142 -0.783 . . . . 0.0 111.142 178.633 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 20.5 t -109.23 144.11 37.78 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.083 0.468 . . . . 0.0 110.886 -176.059 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.616 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.3 pp -86.39 -7.52 10.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 115.654 -0.703 . . . . 0.0 110.502 -178.664 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.616 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -103.14 -21.17 13.93 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.556 -0.293 . . . . 0.0 110.459 179.915 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 92.4 p -77.73 -10.99 59.83 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.418 -0.355 . . . . 0.0 110.859 178.478 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -140.32 161.37 37.85 Favored 'General case' 0 C--N 1.328 -0.326 0 N-CA-C 109.171 -0.678 . . . . 0.0 109.171 -179.836 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 54.4 m-85 -88.82 134.41 33.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.151 -0.477 . . . . 0.0 109.944 179.667 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.74 HG13 ' O ' ' A' ' 92' ' ' GLN . 99.3 t -115.68 137.11 50.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 108.631 -0.877 . . . . 0.0 108.631 -178.75 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.463 ' N ' ' CD ' ' A' ' 35' ' ' GLN . 18.4 mp0 -121.61 163.02 19.63 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.059 -0.519 . . . . 0.0 109.839 179.047 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.481 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 86.7 m95 -117.49 155.64 29.37 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.702 -0.681 . . . . 0.0 110.178 -176.846 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 9.4 m-85 -150.57 154.34 37.38 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.09 -175.834 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.62 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.1 tm0? -134.13 135.37 43.1 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 31.6 mt-30 -120.21 97.71 5.72 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.129 -0.693 . . . . 0.0 109.129 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.403 ' HA ' ' HB1' ' A' ' 87' ' ' ALA . 0.0 OUTLIER -91.18 143.48 28.45 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-N 115.13 -0.941 . . . . 0.0 109.558 176.933 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -56.88 143.78 90.41 Favored 'Trans proline' 0 C--N 1.308 -1.593 0 C-N-CA 121.508 1.472 . . . . 0.0 110.936 177.641 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 70.49 6.95 59.83 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.023 -0.831 . . . . 0.0 111.023 176.154 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.0 p -138.47 149.25 45.24 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.956 0.408 . . . . 0.0 110.305 179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.02 162.15 60.57 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.726 -0.67 . . . . 0.0 109.962 179.811 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -59.91 147.37 92.96 Favored 'Trans proline' 0 C--N 1.306 -1.701 0 C-N-CA 121.736 1.624 . . . . 0.0 110.842 -178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . 0.402 ' O ' HG23 ' A' ' 46' ' ' THR . 7.2 t -136.84 126.31 25.11 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.669 0.271 . . . . 0.0 110.609 178.58 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.26 116.07 3.06 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.353 178.07 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 26.2 t -78.03 -43.18 28.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 N-CA-C 109.485 -0.561 . . . . 0.0 109.485 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.643 HG22 ' N ' ' A' ' 50' ' ' TYR . 59.8 mt -144.3 169.25 9.61 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 CA-C-N 116.516 -0.311 . . . . 0.0 110.278 179.779 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.643 ' N ' HG22 ' A' ' 49' ' ' ILE . 26.2 t80 -128.05 152.63 47.72 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.214 0.53 . . . . 0.0 110.275 178.033 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.404 ' N ' ' CD1' ' A' ' 50' ' ' TYR . 9.6 tt0 48.75 22.46 0.54 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.484 -0.78 . . . . 0.0 110.693 178.997 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.491 ' N ' ' O ' ' A' ' 34' ' ' VAL . 0.1 OUTLIER 46.86 20.08 0.1 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.754 -0.657 . . . . 0.0 110.515 178.215 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -110.93 -49.94 2.99 Favored 'General case' 0 C--N 1.329 -0.319 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 -178.14 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -176.93 -173.48 0.48 Allowed 'General case' 0 C--N 1.329 -0.294 0 N-CA-C 109.799 -0.445 . . . . 0.0 109.799 -179.408 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.436 ' NE ' ' O ' ' A' ' 60' ' ' PRO . 9.4 ptm180 -126.9 154.93 76.24 Favored Pre-proline 0 C--N 1.331 -0.233 0 N-CA-C 109.593 -0.521 . . . . 0.0 109.593 -175.153 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 2.7 Cg_endo -51.64 151.74 14.02 Favored 'Trans proline' 0 C--N 1.307 -1.642 0 C-N-CA 121.783 1.655 . . . . 0.0 110.849 -176.662 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 1.9 m -64.58 141.9 58.61 Favored 'General case' 0 C--N 1.328 -0.328 0 C-N-CA 119.962 -0.695 . . . . 0.0 110.085 176.701 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.27 -37.53 3.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.992 -0.843 . . . . 0.0 110.992 175.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.438 HG22 ' H ' ' A' ' 59' ' ' VAL . 0.2 OUTLIER -78.07 157.75 78.22 Favored Pre-proline 0 C--N 1.33 -0.254 0 O-C-N 122.356 -0.496 . . . . 0.0 109.795 177.207 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . 0.436 ' O ' ' NE ' ' A' ' 55' ' ' ARG . 4.9 Cg_exo -49.0 162.72 0.37 Allowed 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.254 1.969 . . . . 0.0 110.992 -177.46 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -126.88 35.15 4.65 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.816 0.341 . . . . 0.0 110.273 178.635 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.548 HH22 ' CG ' ' A' ' 85' ' ' ASP . 41.3 mtp180 -77.16 -15.64 59.44 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.435 -178.785 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.419 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -119.06 145.47 45.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.944 -177.565 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 15.2 t -139.17 123.5 18.15 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.102 177.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . . . . . . . . . . . -97.94 139.92 14.74 Favored Glycine 0 CA--C 1.525 0.66 0 N-CA-C 110.237 -1.145 . . . . 0.0 110.237 -178.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 17.1 p -139.78 158.98 43.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.938 0.399 . . . . 0.0 109.969 178.284 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 34.4 pt -131.56 141.94 44.48 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.046 -0.525 . . . . 0.0 110.654 -178.224 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.456 ' O ' ' N ' ' A' ' 72' ' ' ASN . 32.1 m-20 -119.36 82.75 1.92 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.268 -0.424 . . . . 0.0 110.14 178.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.2 m -53.12 -35.82 60.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.91 -0.586 . . . . 0.0 110.598 179.069 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 73.7 m -65.43 -51.21 61.85 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.294 -0.412 . . . . 0.0 111.077 -180.0 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 8.9 t -81.26 -7.05 59.5 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.986 179.685 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.456 ' N ' ' O ' ' A' ' 68' ' ' ASP . 3.5 t30 59.33 32.93 22.25 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.311 -0.556 . . . . 0.0 110.468 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -142.3 155.95 45.23 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.185 -0.461 . . . . 0.0 110.486 -178.628 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -115.95 152.45 33.45 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.156 -0.475 . . . . 0.0 109.823 -175.472 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 49.6 m -148.59 133.17 17.74 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.795 -0.638 . . . . 0.0 110.974 -179.257 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.764 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -102.98 138.64 39.59 Favored 'General case' 0 C--N 1.332 -0.195 0 N-CA-C 110.059 -0.348 . . . . 0.0 110.059 176.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 88.9 m -113.89 115.04 27.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 121.253 0.549 . . . . 0.0 110.836 175.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 4.9 mt -101.27 144.07 13.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 N-CA-C 109.595 -0.52 . . . . 0.0 109.595 179.118 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.61 ' HA ' HG22 ' A' ' 17' ' ' THR . 2.0 t -126.77 148.11 49.94 Favored 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.943 0.401 . . . . 0.0 110.785 179.046 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 54.24 59.38 10.1 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.229 -0.749 . . . . 0.0 111.229 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.519 HD22 HG23 ' A' ' 18' ' ' VAL . 1.1 pp -73.81 161.19 30.45 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 121.257 -0.177 . . . . 0.0 110.756 179.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.486 ' N ' HD12 ' A' ' 81' ' ' LEU . 40.6 mttp -150.34 170.26 19.45 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.455 174.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.588 ' C ' ' H ' ' A' ' 85' ' ' ASP . 0.6 OUTLIER -59.98 -37.97 81.17 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 121.341 0.591 . . . . 0.0 110.608 -179.53 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 53.7 mt-10 -54.94 0.33 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 115.122 -0.944 . . . . 0.0 110.296 178.598 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.594 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.1 OUTLIER -105.53 -18.56 14.05 Favored 'General case' 0 C--N 1.33 -0.243 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 179.149 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.559 ' O ' ' HB2' ' A' ' 87' ' ' ALA . 19.8 tt0 -51.08 119.85 4.37 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.686 -179.598 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.62 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . 173.55 -168.8 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.608 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.537 ' N ' ' OD1' ' A' ' 88' ' ' ASP . 0.6 OUTLIER -91.89 139.25 30.84 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 121.245 0.545 . . . . 0.0 110.671 -178.735 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -112.43 149.81 32.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.612 179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 29.4 m-85 -137.59 157.79 45.77 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.642 -0.708 . . . . 0.0 110.295 -179.446 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 1.9 t -120.93 142.02 50.12 Favored 'General case' 0 C--N 1.328 -0.349 0 N-CA-C 107.868 -1.16 . . . . 0.0 107.868 -178.549 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.74 ' O ' HG13 ' A' ' 34' ' ' VAL . 18.4 mt-30 -130.94 129.57 42.33 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.906 0.384 . . . . 0.0 110.684 179.565 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 73.2 p -129.99 162.44 28.67 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 115.538 -0.756 . . . . 0.0 110.506 178.687 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 28.6 m-85 -127.35 142.64 51.39 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.427 179.859 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.6 p30 -107.39 -175.75 2.88 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.684 -0.689 . . . . 0.0 110.079 176.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 22.5 p -66.21 -21.73 66.31 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.368 -0.378 . . . . 0.0 110.678 -179.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 38.1 m -77.23 -2.09 32.88 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.516 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 5.6 t-20 57.59 41.63 25.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.062 -0.517 . . . . 0.0 110.352 178.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 11.0 m80 -112.98 137.96 50.58 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 -179.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.505 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.2 p -72.41 115.9 13.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 115.501 -0.772 . . . . 0.0 110.916 -177.237 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 25.5 t -112.97 144.57 20.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 N-CA-C 109.026 -0.731 . . . . 0.0 109.026 -178.567 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 12.1 p90 -122.14 145.27 48.34 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.641 -0.254 . . . . 0.0 110.588 178.872 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -89.19 174.52 42.11 Favored Glycine 0 CA--C 1.525 0.672 0 N-CA-C 111.279 -0.728 . . . . 0.0 111.279 178.412 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -55.26 -26.16 42.61 Favored Glycine 0 CA--C 1.524 0.649 0 N-CA-C 110.535 -1.026 . . . . 0.0 110.535 -178.399 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.81 172.2 45.47 Favored Glycine 0 CA--C 1.524 0.62 0 N-CA-C 110.906 -0.878 . . . . 0.0 110.906 178.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 29.6 m -145.83 152.5 39.6 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.557 0.217 . . . . 0.0 110.824 -179.487 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 73.9 tttt -110.04 117.48 33.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.814 0.34 . . . . 0.0 111.524 179.798 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.407 HD12 ' N ' ' A' ' 109' ' ' THR . 19.2 tp -91.25 124.16 35.24 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.209 175.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . 0.407 ' N ' HD12 ' A' ' 108' ' ' LEU . 52.7 m -112.68 128.44 56.4 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.503 176.255 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 91.3 t -107.56 140.37 26.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-O 120.862 0.363 . . . . 0.0 110.428 179.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.727 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.032 -0.985 . . . . 0.0 109.007 -175.706 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 44.3 m-80 . . . . . 0 N--CA 1.49 1.557 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.4 OUTLIER -72.6 174.22 7.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 109.941 -178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -156.14 170.12 22.94 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.729 175.866 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 7.1 mt -113.47 133.12 55.38 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-O 121.062 0.458 . . . . 0.0 110.48 178.304 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 23.7 m -109.63 122.02 46.53 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.65 -0.704 . . . . 0.0 110.334 -179.88 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.52 HE22 ' HB2' ' A' ' 91' ' ' CYS . 0.0 OUTLIER -139.98 159.86 62.78 Favored Pre-proline 0 C--N 1.33 -0.242 0 N-CA-C 109.554 -0.536 . . . . 0.0 109.554 -179.771 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 4.6 Cg_exo -55.87 134.47 64.28 Favored 'Trans proline' 0 C--N 1.306 -1.664 0 C-N-CA 121.548 1.498 . . . . 0.0 111.381 -179.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -68.13 -43.31 78.62 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.49 179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 3.6 m -163.67 145.5 9.36 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.286 -178.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . . . . . . . . . 5.5 p -157.89 148.74 9.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.175 -177.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 19.6 m -132.19 157.97 42.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.063 -178.485 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.454 ' CD ' ' H ' ' A' ' 13' ' ' SER . 0.4 OUTLIER -156.09 149.66 24.83 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.42 178.768 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.454 ' H ' ' CD ' ' A' ' 12' ' ' GLU . 0.8 OUTLIER -86.58 146.54 41.87 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-N 116.38 -0.373 . . . . 0.0 110.028 -178.096 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 6.2 Cg_exo -58.97 142.61 99.49 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 121.385 1.39 . . . . 0.0 110.592 -177.729 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 115.97 -35.82 4.11 Favored Glycine 0 CA--C 1.526 0.719 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 177.853 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.4 ' O ' HD23 ' A' ' 81' ' ' LEU . 50.5 mmtt -89.48 -157.26 0.44 Allowed 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 110.138 -0.319 . . . . 0.0 110.138 -178.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 81.7 p -122.47 165.49 16.27 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.159 0.504 . . . . 0.0 110.826 179.309 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.693 HG23 HD22 ' A' ' 81' ' ' LEU . 22.6 t -123.72 132.63 71.06 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 115.48 -0.782 . . . . 0.0 109.533 174.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 14.7 m -117.01 122.09 43.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.805 177.047 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 73.1 mt -108.02 121.45 61.01 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 116.06 -0.518 . . . . 0.0 110.182 178.456 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 12.8 m -105.04 125.02 50.53 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.666 -0.243 . . . . 0.0 110.517 179.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.465 ' SG ' ' CD ' ' A' ' 6' ' ' GLN . 0.1 OUTLIER -116.52 116.89 28.47 Favored 'General case' 0 CA--C 1.534 0.361 0 N-CA-C 107.921 -1.14 . . . . 0.0 107.921 178.134 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 5.7 m -111.56 143.07 43.02 Favored 'General case' 0 N--CA 1.464 0.269 0 O-C-N 121.702 -0.624 . . . . 0.0 109.927 -179.05 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -125.29 144.19 14.99 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.168 -0.773 . . . . 0.0 111.168 -179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 40.7 t -101.37 10.9 40.08 Favored 'General case' 0 C--N 1.332 -0.182 0 O-C-N 122.755 -0.262 . . . . 0.0 110.921 178.298 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.502 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.5 p -94.1 -59.83 1.88 Allowed 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.884 0.373 . . . . 0.0 110.724 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.502 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -160.34 -173.61 29.1 Favored Glycine 0 CA--C 1.525 0.682 0 N-CA-C 110.522 -1.031 . . . . 0.0 110.522 -177.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.484 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.5 p -73.28 138.73 45.67 Favored 'General case' 0 C--N 1.329 -0.292 0 C-N-CA 120.785 -0.366 . . . . 0.0 110.108 177.843 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.602 HD12 ' N ' ' A' ' 29' ' ' ILE . 0.3 OUTLIER -63.11 0.64 0.46 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.391 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.978 -177.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.484 ' H ' ' C ' ' A' ' 28' ' ' SER . . . -101.56 -22.62 14.45 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.057 -177.284 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.409 ' OG ' ' O ' ' A' ' 28' ' ' SER . 14.3 p -72.13 -16.29 61.99 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.664 -0.698 . . . . 0.0 110.324 176.435 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.494 ' CB ' ' O ' ' A' ' 94' ' ' TYR . 0.8 OUTLIER -142.23 151.82 42.48 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.566 -0.743 . . . . 0.0 109.067 178.831 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . 0.507 ' CE1' ' OE2' ' A' ' 51' ' ' GLU . 98.2 m-85 -82.33 146.19 29.54 Favored 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 -178.197 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 42.9 t -124.4 146.92 29.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-O 121.023 0.44 . . . . 0.0 110.049 -177.903 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 80.3 mt-30 -129.57 151.01 50.65 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.032 -0.531 . . . . 0.0 109.988 179.059 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.447 ' N ' ' CD1' ' A' ' 36' ' ' TRP . 37.7 m95 -113.4 142.88 45.36 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.311 -177.426 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.406 ' CE1' ' NE2' ' A' ' 92' ' ' GLN . 19.0 m-85 -134.35 154.4 51.36 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.817 0.342 . . . . 0.0 110.131 -176.786 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.619 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.7 OUTLIER -128.94 144.41 51.17 Favored 'General case' 0 C--N 1.331 -0.232 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 178.054 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . 0.464 ' O ' ' HB1' ' A' ' 87' ' ' ALA . 44.6 tt0 -122.51 103.87 8.99 Favored 'General case' 0 C--N 1.333 -0.14 0 C-N-CA 120.645 -0.422 . . . . 0.0 111.132 179.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 18.2 mtp85 -91.33 132.87 32.64 Favored Pre-proline 0 C--N 1.33 -0.247 0 CA-C-N 115.537 -0.756 . . . . 0.0 110.862 -178.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -58.39 143.24 97.87 Favored 'Trans proline' 0 C--N 1.31 -1.454 0 C-N-CA 121.175 1.25 . . . . 0.0 110.92 -178.448 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 67.95 4.71 36.01 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 110.828 -0.909 . . . . 0.0 110.828 178.02 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -139.82 155.66 47.14 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-O 120.736 0.303 . . . . 0.0 110.396 -179.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -74.96 179.18 1.43 Allowed Pre-proline 0 C--N 1.33 -0.282 0 CA-C-N 116.376 -0.374 . . . . 0.0 110.085 -178.612 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 4.5 Cg_exo -73.39 149.92 45.68 Favored 'Trans proline' 0 C--N 1.307 -1.629 0 C-N-CA 122.031 1.82 . . . . 0.0 111.759 179.23 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 66.1 m -128.23 115.06 17.76 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.13 175.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.417 HG21 ' CD2' ' A' ' 50' ' ' TYR . 22.1 m -51.3 123.07 8.82 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 109.606 -0.516 . . . . 0.0 109.606 177.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.452 ' CG1' ' CG ' ' A' ' 63' ' ' PHE . 31.3 t -86.14 -43.27 16.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 N-CA-C 109.559 -0.534 . . . . 0.0 109.559 -179.099 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.693 HG22 ' N ' ' A' ' 50' ' ' TYR . 44.0 mt -145.18 168.88 8.21 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.188 0 CA-C-O 120.943 0.401 . . . . 0.0 111.107 179.625 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.693 ' N ' HG22 ' A' ' 49' ' ' ILE . 0.2 OUTLIER -136.98 154.73 50.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.706 -0.679 . . . . 0.0 109.958 -179.113 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.507 ' OE2' ' CE1' ' A' ' 33' ' ' TYR . 2.0 mm-40 43.85 21.09 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.739 -0.664 . . . . 0.0 109.744 -179.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.493 ' N ' ' O ' ' A' ' 50' ' ' TYR . 3.0 p30 46.27 19.16 0.07 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.738 174.252 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.941 HD22 ' H ' ' A' ' 53' ' ' ASN . 0.0 OUTLIER -112.46 -36.47 5.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.329 -179.705 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . 0.426 ' H ' ' ND2' ' A' ' 53' ' ' ASN . 0.1 OUTLIER -179.62 -174.11 0.28 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.663 -176.816 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -133.03 151.15 77.41 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.356 -0.384 . . . . 0.0 109.966 -177.055 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.1 Cg_endo -50.96 158.98 2.74 Favored 'Trans proline' 0 C--N 1.308 -1.6 0 C-N-CA 121.679 1.586 . . . . 0.0 111.129 -178.084 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 26.5 m -69.63 145.73 52.22 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.382 178.121 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.84 -36.47 4.37 Favored Glycine 0 CA--C 1.526 0.741 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 174.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.453 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.52 160.16 81.79 Favored Pre-proline 0 C--N 1.33 -0.244 0 CA-C-N 117.264 0.532 . . . . 0.0 110.109 178.728 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 2.5 Cg_endo -59.75 145.15 98.94 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 121.933 1.756 . . . . 0.0 111.105 -176.757 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 84.6 m-20 -106.93 22.36 16.09 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 120.75 0.31 . . . . 0.0 110.847 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.568 ' NH2' ' OD2' ' A' ' 85' ' ' ASP . 58.0 mtp180 -68.44 -20.92 64.67 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.666 -177.2 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.486 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.0 OUTLIER -117.51 150.96 38.08 Favored 'General case' 0 C--N 1.331 -0.209 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -178.114 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.4 ' O ' ' N ' ' A' ' 77' ' ' THR . 40.3 t -146.51 131.66 18.36 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.243 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.402 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.17 146.45 18.29 Favored Glycine 0 CA--C 1.526 0.734 0 N-CA-C 110.96 -0.856 . . . . 0.0 110.96 -177.812 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 2.1 p -141.81 152.97 44.19 Favored 'General case' 0 C--N 1.331 -0.234 0 N-CA-C 109.955 -0.387 . . . . 0.0 109.955 175.074 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.477 ' HB ' HD13 ' A' ' 29' ' ' ILE . 4.7 pt -129.3 138.37 54.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.25 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.821 -178.15 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 58.0 m-20 -117.69 84.76 2.22 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.074 0.464 . . . . 0.0 110.627 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -53.87 -26.91 27.0 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.711 -0.677 . . . . 0.0 110.215 -179.922 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 1.5 m -73.46 -51.19 18.06 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 115.602 -0.727 . . . . 0.0 111.06 -179.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 19.4 t -84.0 -6.86 59.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.189 -177.227 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.515 ' ND2' ' O ' ' A' ' 72' ' ' ASN . 0.7 OUTLIER 62.67 39.83 10.83 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.849 -0.614 . . . . 0.0 111.065 179.047 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 21.2 p -152.51 165.82 33.93 Favored 'General case' 0 C--N 1.329 -0.292 0 O-C-N 122.178 -0.326 . . . . 0.0 110.62 -178.648 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.13 155.78 23.34 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.797 0.332 . . . . 0.0 110.423 -179.741 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 5.0 m -147.42 117.5 7.27 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.513 178.346 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.827 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.8 138.08 36.46 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.181 -0.303 . . . . 0.0 110.181 179.884 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.4 ' N ' ' O ' ' A' ' 64' ' ' SER . 63.7 m -106.71 122.48 46.45 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.57 -0.286 . . . . 0.0 110.535 176.123 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.412 HG13 HD21 ' A' ' 76' ' ' LEU . 3.4 mt -112.78 129.4 68.46 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 N-CA-C 109.964 -0.384 . . . . 0.0 109.964 178.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 3.9 t -121.3 120.82 36.22 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.405 -0.816 . . . . 0.0 110.701 178.313 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 93.07 60.01 1.21 Allowed Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.17 -0.772 . . . . 0.0 111.17 178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.693 HD22 HG23 ' A' ' 18' ' ' VAL . 1.3 pp -83.71 136.76 34.06 Favored 'General case' 0 C--N 1.33 -0.269 0 O-C-N 122.577 -0.366 . . . . 0.0 111.342 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.543 ' H ' ' CG ' ' A' ' 85' ' ' ASP . 19.6 mmtt -146.67 175.19 10.79 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-O 120.893 0.378 . . . . 0.0 110.232 -179.071 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.541 ' C ' ' H ' ' A' ' 85' ' ' ASP . 55.8 p -58.31 -34.96 71.16 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 115.959 -0.564 . . . . 0.0 111.169 -179.719 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.415 ' OE1' ' NH1' ' A' ' 62' ' ' ARG . 0.0 OUTLIER -55.32 -4.42 0.09 Allowed 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 115.368 -0.833 . . . . 0.0 109.545 173.994 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.605 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.2 OUTLIER -108.3 -34.97 6.65 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.317 -0.401 . . . . 0.0 110.216 -179.341 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.422 ' C ' ' O ' ' A' ' 85' ' ' ASP . 61.3 tt0 -32.3 101.13 0.02 OUTLIER 'General case' 0 C--N 1.333 -0.15 0 O-C-N 123.314 0.384 . . . . 0.0 111.466 178.694 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.464 ' HB1' ' O ' ' A' ' 39' ' ' GLN . . . -170.68 -170.93 0.96 Allowed 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.014 -0.674 . . . . 0.0 111.419 -179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -107.29 127.84 53.91 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 115.444 -0.798 . . . . 0.0 110.326 178.472 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.619 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 19.9 m-85 -89.86 165.88 13.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.845 -0.616 . . . . 0.0 110.806 178.673 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -139.31 156.83 46.77 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.06 -0.518 . . . . 0.0 109.854 178.19 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . 0.52 ' HB2' HE22 ' A' ' 6' ' ' GLN . 0.1 OUTLIER -127.05 142.02 51.64 Favored 'General case' 0 N--CA 1.465 0.31 0 N-CA-C 106.965 -1.494 . . . . 0.0 106.965 179.986 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.406 ' NE2' ' CE1' ' A' ' 37' ' ' TYR . 84.4 mt-30 -131.22 118.98 21.18 Favored 'General case' 0 C--N 1.332 -0.184 0 O-C-N 121.972 -0.455 . . . . 0.0 109.976 175.509 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 4.3 p -119.71 164.5 15.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.998 0.428 . . . . 0.0 110.81 -179.823 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.494 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 55.0 m-85 -131.36 135.09 46.93 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.677 178.035 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.3 t70 -78.77 164.93 24.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.135 -0.484 . . . . 0.0 110.095 178.697 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.3 t -51.1 -26.52 6.61 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.852 0.358 . . . . 0.0 110.655 179.874 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 1.4 m -79.71 1.08 27.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.627 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 2.0 m120 65.61 47.41 2.2 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.876 -177.509 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 18.4 t-160 -107.38 127.13 53.3 Favored 'General case' 0 C--N 1.33 -0.268 0 N-CA-C 109.961 -0.385 . . . . 0.0 109.961 179.484 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . 0.484 HG13 ' O ' ' A' ' 100' ' ' VAL . 7.2 p -71.11 125.6 29.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 0.0 110.553 -177.614 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 74.3 t -133.61 149.3 30.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 CA-C-O 120.873 0.368 . . . . 0.0 110.17 178.511 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.427 ' CD1' ' N ' ' A' ' 102' ' ' PHE . 24.9 m-85 -115.87 136.84 52.66 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.045 -0.525 . . . . 0.0 109.806 -178.336 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -90.55 174.35 39.63 Favored Glycine 0 CA--C 1.525 0.701 0 N-CA-C 110.813 -0.915 . . . . 0.0 110.813 -178.411 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -59.02 -21.82 53.76 Favored Glycine 0 CA--C 1.525 0.665 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 178.852 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 80.28 -161.54 45.17 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 -178.376 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 31.2 m -156.81 141.91 17.21 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.793 0.33 . . . . 0.0 110.609 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 54.6 tttp -98.98 117.6 33.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.146 -0.479 . . . . 0.0 109.981 177.539 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 31.1 tp -105.7 133.47 50.39 Favored 'General case' 0 C--N 1.331 -0.204 0 N-CA-C 110.359 -0.237 . . . . 0.0 110.359 175.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 98.7 m -125.58 130.99 52.78 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.161 -0.472 . . . . 0.0 109.914 177.377 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.88 117.13 54.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.962 -0.563 . . . . 0.0 110.234 178.431 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 1.055 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.22 -0.473 0 CA-C-O 118.001 -1.0 . . . . 0.0 109.334 -178.277 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 7.8 m120 . . . . . 0 N--CA 1.491 1.587 0 N-CA-C 109.368 -0.604 . . . . 0.0 109.368 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.468 ' C ' ' SD ' ' A' ' 3' ' ' MET . 0.3 OUTLIER -95.34 109.85 21.95 Favored 'General case' 0 C--N 1.33 -0.248 0 N-CA-C 109.894 -0.41 . . . . 0.0 109.894 179.263 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . 0.468 ' SD ' ' C ' ' A' ' 2' ' ' PHE . 2.1 mpt? -154.61 167.28 30.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.249 -0.432 . . . . 0.0 109.92 176.938 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 17.3 mt -119.6 136.37 54.41 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.123 0.487 . . . . 0.0 110.643 179.137 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 2.9 m -108.63 121.36 44.86 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.641 -0.709 . . . . 0.0 109.472 178.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.583 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -137.21 -177.23 0.67 Allowed Pre-proline 0 C--N 1.33 -0.247 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 179.865 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . 0.459 ' CD ' ' CB ' ' A' ' 6' ' ' GLN . 2.8 Cg_exo -72.45 155.41 55.29 Favored 'Trans proline' 0 C--N 1.308 -1.591 0 C-N-CA 122.417 2.078 . . . . 0.0 111.55 178.199 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 8' ' ' HIS . 0.0 OUTLIER -81.51 -45.3 16.15 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.12 -0.491 . . . . 0.0 109.955 177.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 47.7 t -168.61 152.4 5.65 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.436 -0.347 . . . . 0.0 110.563 -178.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.524 HG22 ' N ' ' A' ' 11' ' ' SER . 3.3 p -165.08 159.95 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.452 -177.668 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.524 ' N ' HG22 ' A' ' 10' ' ' VAL . 7.9 t -140.99 161.02 38.82 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.857 0.361 . . . . 0.0 110.81 -179.642 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -156.13 148.19 23.27 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.466 179.835 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 5.3 m -79.53 147.68 68.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 116.367 -0.379 . . . . 0.0 110.18 -178.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 1.6 Cg_endo -61.86 159.07 34.99 Favored 'Trans proline' 0 C--N 1.308 -1.553 0 C-N-CA 121.556 1.504 . . . . 0.0 111.462 179.848 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 95.43 -30.85 7.7 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.852 -0.899 . . . . 0.0 110.852 177.564 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.64 -158.38 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 121.244 0.545 . . . . 0.0 110.317 -179.519 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 70.5 p -129.26 168.24 16.5 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.331 -0.85 . . . . 0.0 110.896 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . . . . . . . . . 9.0 p -144.31 138.58 23.93 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 115.53 -0.759 . . . . 0.0 110.745 177.212 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 7.4 m -119.19 124.97 48.07 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.123 -0.489 . . . . 0.0 109.744 -179.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 31.2 mm -101.45 135.09 39.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.008 179.186 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 91.5 p -108.32 137.01 47.01 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.502 -0.317 . . . . 0.0 110.602 179.146 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.583 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.2 m -134.12 119.79 19.33 Favored 'General case' 0 CA--C 1.532 0.256 0 N-CA-C 107.333 -1.358 . . . . 0.0 107.333 178.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 21.6 m -110.61 139.42 45.89 Favored 'General case' 0 N--CA 1.464 0.237 0 O-C-N 121.657 -0.652 . . . . 0.0 110.437 -179.536 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -111.78 150.23 18.07 Favored Glycine 0 CA--C 1.524 0.656 0 N-CA-C 111.01 -0.836 . . . . 0.0 111.01 -179.445 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.532 ' OG ' ' N ' ' A' ' 26' ' ' SER . 7.7 t -106.89 -177.66 3.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.875 0.369 . . . . 0.0 110.801 -178.74 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.548 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 0.0 OUTLIER 64.36 -72.88 0.06 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.563 179.492 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.548 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -111.25 -172.87 19.6 Favored Glycine 0 CA--C 1.524 0.617 0 N-CA-C 110.482 -1.047 . . . . 0.0 110.482 -177.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.437 ' C ' ' H ' ' A' ' 30' ' ' ALA . 2.2 t -95.04 142.95 26.92 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.936 0.398 . . . . 0.0 109.946 178.503 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.601 HD12 ' N ' ' A' ' 30' ' ' ALA . 1.9 pp -63.86 -1.0 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 115.806 -0.633 . . . . 0.0 109.903 -177.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.601 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -99.9 -11.97 20.24 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.037 179.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 6.1 p -76.7 -8.91 58.19 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.875 -0.602 . . . . 0.0 110.649 178.59 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -148.74 164.47 34.3 Favored 'General case' 0 C--N 1.331 -0.215 0 N-CA-C 109.652 -0.499 . . . . 0.0 109.652 -177.765 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -83.31 148.72 27.19 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.389 -0.369 . . . . 0.0 110.495 178.362 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 61.8 t -128.64 139.28 52.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-O 120.984 0.421 . . . . 0.0 110.737 -179.588 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 5.0 mp0 -128.91 154.52 46.45 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.156 179.072 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 72.6 m95 -107.63 148.42 29.36 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 121.024 0.44 . . . . 0.0 110.955 -179.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . . . . . . . . . 1.6 m-85 -137.82 154.4 49.53 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.712 -0.676 . . . . 0.0 109.625 -179.136 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.573 HE22 ' HB3' ' A' ' 87' ' ' ALA . 1.9 tm0? -134.74 134.51 41.06 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 178.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 55.7 tt0 -120.79 97.91 5.76 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.121 -179.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . 0.408 HH21 ' HB3' ' A' ' 40' ' ' ARG . 13.4 mtp-105 -87.16 127.39 59.42 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-N 115.765 -0.652 . . . . 0.0 110.379 -179.176 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 5.7 Cg_exo -58.35 142.25 97.51 Favored 'Trans proline' 0 C--N 1.309 -1.506 0 C-N-CA 120.969 1.113 . . . . 0.0 110.913 179.192 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.86 -2.34 74.82 Favored Glycine 0 CA--C 1.525 0.7 0 N-CA-C 111.179 -0.768 . . . . 0.0 111.179 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.1 p -140.79 167.02 23.18 Favored 'General case' 0 C--N 1.33 -0.268 0 O-C-N 122.531 -0.393 . . . . 0.0 110.169 178.768 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 81.7 p -82.89 146.45 52.3 Favored Pre-proline 0 C--N 1.33 -0.254 0 CA-C-N 116.16 -0.473 . . . . 0.0 110.24 -179.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -62.3 154.48 63.23 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 121.284 1.322 . . . . 0.0 111.313 -178.372 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 76.4 p -133.09 136.89 46.14 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.773 0.321 . . . . 0.0 110.791 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 18.5 m -63.91 130.45 44.16 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.517 176.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.527 ' CG1' ' CD2' ' A' ' 63' ' ' PHE . 3.3 t -96.55 -41.71 11.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.413 -179.147 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.512 ' CG2' ' N ' ' A' ' 50' ' ' TYR . 4.3 mt -145.0 168.89 8.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.568 -0.531 . . . . 0.0 109.568 175.674 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.512 ' N ' ' CG2' ' A' ' 49' ' ' ILE . 2.2 t80 -144.27 146.41 32.61 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.551 -0.75 . . . . 0.0 110.7 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.469 ' O ' ' N ' ' A' ' 53' ' ' ASN . 87.5 mt-10 51.08 21.81 1.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.925 -178.369 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . . . . . . . . . 4.9 p-10 46.39 19.9 0.08 Allowed 'General case' 0 C--N 1.327 -0.383 0 CA-C-O 121.128 0.489 . . . . 0.0 110.415 177.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.469 ' N ' ' O ' ' A' ' 51' ' ' GLU . 1.3 m-80 -108.06 -39.94 5.36 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.814 -0.63 . . . . 0.0 109.899 -179.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -176.87 -179.66 0.97 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.406 -179.355 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.464 HH21 ' HA ' ' A' ' 64' ' ' SER . 0.0 OUTLIER -109.2 155.61 40.73 Favored Pre-proline 0 C--N 1.329 -0.304 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.219 -179.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 5.5 Cg_endo -57.84 154.49 37.75 Favored 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 121.6 1.533 . . . . 0.0 111.324 178.749 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 3.6 m -69.0 140.69 55.01 Favored 'General case' 0 C--N 1.329 -0.317 0 C-N-CA 120.394 -0.522 . . . . 0.0 110.253 178.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 108.23 -37.54 3.76 Favored Glycine 0 CA--C 1.526 0.745 0 N-CA-C 111.087 -0.805 . . . . 0.0 111.087 175.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.442 HG22 ' H ' ' A' ' 59' ' ' VAL . 2.5 m -75.05 155.83 86.27 Favored Pre-proline 0 C--N 1.329 -0.303 0 N-CA-C 109.811 -0.44 . . . . 0.0 109.811 178.335 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.1 Cg_exo -52.05 165.99 0.76 Allowed 'Trans proline' 0 C--N 1.307 -1.647 0 C-N-CA 121.836 1.691 . . . . 0.0 111.06 -178.306 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -123.51 35.09 4.93 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.716 -0.22 . . . . 0.0 110.736 -178.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.649 HH22 ' CG ' ' A' ' 85' ' ' ASP . 1.2 mtm-85 -89.6 2.23 54.96 Favored 'General case' 0 C--N 1.33 -0.28 0 C-N-CA 120.707 -0.397 . . . . 0.0 110.365 178.823 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD2' ' CG1' ' A' ' 48' ' ' VAL . 13.8 m-85 -115.04 145.38 42.35 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 110.271 -0.27 . . . . 0.0 110.271 -177.872 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.464 ' HA ' HH21 ' A' ' 55' ' ' ARG . 3.2 t -144.17 124.4 13.75 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.558 178.529 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.454 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -96.77 142.5 16.2 Favored Glycine 0 CA--C 1.526 0.722 0 N-CA-C 110.73 -0.948 . . . . 0.0 110.73 -178.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 9.3 t -145.8 143.23 29.54 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.648 0.261 . . . . 0.0 110.391 178.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . . . . . . . . . 32.8 pt -119.55 142.6 34.15 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.398 -0.364 . . . . 0.0 110.765 -179.243 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 3.4 m-20 -124.13 89.82 3.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.191 -0.458 . . . . 0.0 110.627 179.939 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 5.0 p -59.29 -37.73 78.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.931 0.396 . . . . 0.0 110.285 -179.196 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.2 m -65.31 -51.0 63.52 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.931 -179.553 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.5 t -79.81 -7.03 58.44 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.799 -0.637 . . . . 0.0 109.768 -178.872 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER 58.13 37.03 26.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.878 -0.601 . . . . 0.0 110.289 176.687 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 6.1 p -149.68 143.74 25.67 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 121.142 0.496 . . . . 0.0 111.277 -178.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -107.7 143.37 36.3 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 -175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 4.9 m -148.05 139.56 23.67 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.701 -175.12 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.886 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -107.91 138.11 44.75 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.017 -0.538 . . . . 0.0 110.555 177.988 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.445 ' N ' ' O ' ' A' ' 64' ' ' SER . 18.4 m -107.26 123.98 49.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.922 0.391 . . . . 0.0 110.543 172.694 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.62 HG13 HD21 ' A' ' 76' ' ' LEU . 5.2 mt -106.33 123.91 61.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 N-CA-C 109.636 -0.505 . . . . 0.0 109.636 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.408 ' O ' ' C ' ' A' ' 80' ' ' GLY . 20.0 m -86.4 142.55 28.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.679 178.951 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.408 ' C ' ' O ' ' A' ' 79' ' ' SER . . . 33.45 76.24 0.05 OUTLIER Glycine 0 CA--C 1.527 0.793 0 CA-C-N 116.478 -0.328 . . . . 0.0 112.527 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.3 pt? -70.1 159.12 34.47 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 120.853 -0.339 . . . . 0.0 110.734 178.504 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 23.9 mtpp -140.44 163.48 32.69 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.014 177.011 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -46.0 -33.17 3.2 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.989 0.423 . . . . 0.0 110.809 179.161 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 23.7 tt0 -54.97 -14.2 1.4 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.225 -0.898 . . . . 0.0 110.222 -177.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.649 ' CG ' HH22 ' A' ' 62' ' ' ARG . 12.0 m-20 -89.9 -11.58 41.42 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.459 -0.337 . . . . 0.0 110.453 177.87 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 83.2 tt0 -52.47 95.89 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 C-N-CA 120.13 -0.628 . . . . 0.0 110.189 178.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.573 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -176.98 -172.93 0.44 Allowed 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.959 179.995 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -96.03 148.44 22.66 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.024 -179.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.415 ' O ' ' CD1' ' A' ' 90' ' ' TYR . 19.3 m-85 -113.34 159.4 19.44 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.427 -179.59 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . 0.415 ' CD1' ' O ' ' A' ' 89' ' ' TYR . 42.0 m-85 -150.4 153.36 35.84 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.086 -0.506 . . . . 0.0 110.524 179.134 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 21.1 m -118.72 148.4 42.82 Favored 'General case' 0 CA--C 1.533 0.314 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 -178.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 25.9 mt-30 -134.17 121.21 21.08 Favored 'General case' 0 N--CA 1.464 0.239 0 O-C-N 121.46 -0.775 . . . . 0.0 110.8 178.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.6 p -122.95 166.79 14.49 Favored 'General case' 0 C--N 1.332 -0.174 0 CA-C-O 120.671 0.272 . . . . 0.0 110.842 -179.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 30.0 m-85 -122.24 142.12 50.78 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 121.029 0.443 . . . . 0.0 110.322 178.651 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -96.22 161.05 14.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.255 179.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 8.0 p -55.54 -22.67 22.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.433 179.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 23.0 p -73.89 1.71 10.1 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.526 179.076 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 67.96 33.14 4.77 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.867 -0.606 . . . . 0.0 110.574 -179.333 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 13.5 t60 -113.33 141.67 46.76 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.355 -0.384 . . . . 0.0 110.318 178.358 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 10.8 p -80.05 145.26 9.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.639 179.714 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.496 HG12 ' N ' ' A' ' 102' ' ' PHE . 96.7 t -129.7 157.37 42.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.246 -178.854 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.496 ' N ' HG12 ' A' ' 101' ' ' VAL . 13.3 m-85 -129.83 149.12 51.71 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.378 -0.374 . . . . 0.0 110.695 -179.582 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -103.38 170.6 19.61 Favored Glycine 0 CA--C 1.525 0.71 0 N-CA-C 111.131 -0.788 . . . . 0.0 111.131 179.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.61 -33.84 88.32 Favored Glycine 0 CA--C 1.525 0.669 0 N-CA-C 111.012 -0.835 . . . . 0.0 111.012 179.115 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 87.21 176.58 48.89 Favored Glycine 0 CA--C 1.525 0.715 0 N-CA-C 111.212 -0.755 . . . . 0.0 111.212 179.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 1.9 m -133.15 148.52 52.1 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 109.796 -0.446 . . . . 0.0 109.796 -179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 86.4 tttt -98.83 101.89 13.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.645 178.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . . . . . . . . . 13.0 tp -88.55 129.1 35.55 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.419 177.22 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 52.1 m -121.04 138.6 54.1 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 115.524 -0.762 . . . . 0.0 110.069 177.676 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 53.3 t -114.83 127.44 72.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-O 120.974 0.416 . . . . 0.0 110.458 -179.473 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.414 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.9 OUTLIER . . . . . 0 C--O 1.217 -0.63 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.558 179.9 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 . . . . . 0 N--CA 1.49 1.559 0 N-CA-C 109.312 -0.625 . . . . 0.0 109.312 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.489 ' CG ' ' O ' ' A' ' 2' ' ' PHE . 20.4 p90 -98.12 125.7 43.25 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.361 178.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -156.07 169.59 24.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.517 -0.765 . . . . 0.0 109.797 179.134 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . 0.661 HD23 ' HA2' ' A' ' 24' ' ' GLY . 28.2 mt -117.12 140.95 48.88 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-O 121.234 0.54 . . . . 0.0 110.098 177.58 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 41.0 m -108.83 113.19 25.92 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.586 -0.734 . . . . 0.0 110.224 179.098 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.596 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -139.11 159.41 66.75 Favored Pre-proline 0 C--N 1.329 -0.301 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 -178.383 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 3.4 Cg_exo -54.16 127.96 27.91 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 121.786 1.657 . . . . 0.0 110.884 -179.991 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 27.9 t60 -70.75 -25.41 62.9 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.359 178.729 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 21.9 t -170.12 151.95 4.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.356 -179.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.433 ' CG2' ' N ' ' A' ' 11' ' ' SER . 1.4 p -164.26 157.69 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 115.931 -0.577 . . . . 0.0 109.562 -178.214 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.433 ' N ' ' CG2' ' A' ' 10' ' ' VAL . 32.7 m -135.72 158.13 45.14 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.057 -0.519 . . . . 0.0 110.341 -177.945 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.466 ' O ' HD12 ' A' ' 111' ' ' LEU . 15.1 tp10 -155.92 145.99 21.45 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.99 -0.55 . . . . 0.0 110.371 -178.277 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 19.1 m -78.28 143.89 65.61 Favored Pre-proline 0 C--N 1.328 -0.352 0 C-N-CA 120.831 -0.347 . . . . 0.0 110.21 -178.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 2.8 Cg_endo -57.49 125.9 20.24 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.385 1.39 . . . . 0.0 110.858 -178.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 117.69 -34.61 4.44 Favored Glycine 0 CA--C 1.526 0.766 0 N-CA-C 111.291 -0.723 . . . . 0.0 111.291 176.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . 0.602 ' O ' HD23 ' A' ' 81' ' ' LEU . 31.2 mmtp -80.9 157.83 25.49 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 109.695 -0.483 . . . . 0.0 109.695 179.657 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . 0.585 HG22 ' HA ' ' A' ' 79' ' ' SER . 24.7 p -83.98 163.02 20.22 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 121.353 0.596 . . . . 0.0 110.949 179.126 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.412 HG21 HD11 ' A' ' 81' ' ' LEU . 17.3 t -123.32 135.96 61.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 CA-C-N 115.099 -0.955 . . . . 0.0 110.366 178.172 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 21.6 m -117.49 117.99 30.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.364 -0.834 . . . . 0.0 109.771 175.513 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . . . . . . . . . 29.7 mm -107.3 121.8 60.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.228 177.552 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 8.6 m -107.11 122.75 47.1 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.395 -179.009 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.596 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 1.4 m -113.89 116.91 30.04 Favored 'General case' 0 CA--C 1.534 0.337 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 179.761 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 92.6 m -110.24 143.0 41.06 Favored 'General case' 0 N--CA 1.465 0.319 0 O-C-N 121.374 -0.829 . . . . 0.0 110.659 -178.16 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . 0.661 ' HA2' HD23 ' A' ' 4' ' ' LEU . . . -113.9 156.19 15.8 Favored Glycine 0 CA--C 1.524 0.616 0 N-CA-C 111.391 -0.684 . . . . 0.0 111.391 -177.932 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -98.38 -73.37 0.62 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.773 0.321 . . . . 0.0 110.278 -179.683 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -97.04 -3.02 42.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.325 -0.398 . . . . 0.0 110.426 -178.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . -109.37 113.74 3.77 Favored Glycine 0 CA--C 1.524 0.634 0 N-CA-C 110.587 -1.005 . . . . 0.0 110.587 179.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -77.91 126.4 30.79 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 121.081 0.467 . . . . 0.0 110.087 179.032 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.571 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.5 pp -74.76 -3.14 4.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.551 -178.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.571 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -108.79 -28.93 8.92 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.779 0.323 . . . . 0.0 110.449 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . 0.526 ' O ' ' ND2' ' A' ' 32' ' ' ASN . 92.1 p -79.02 -9.06 59.43 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.899 179.696 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . 0.526 ' ND2' ' O ' ' A' ' 31' ' ' SER . 4.3 m120 -145.43 163.97 32.98 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.35 -0.386 . . . . 0.0 110.333 -178.06 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 72.3 m-85 -84.08 146.88 27.68 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.429 -178.559 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . . . . . . . . . 55.2 t -129.07 138.51 54.32 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.846 -0.427 . . . . 0.0 109.846 -179.857 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . 0.606 HE21 ' N ' ' A' ' 35' ' ' GLN . 0.0 OUTLIER -125.03 155.13 40.21 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.1 -0.5 . . . . 0.0 109.827 178.872 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . . . . . . . . . 69.8 m95 -106.54 154.94 20.14 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.346 -0.388 . . . . 0.0 110.373 -178.693 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.439 ' CZ ' ' OG1' ' A' ' 47' ' ' THR . 3.3 m-85 -143.19 154.39 43.82 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.215 -0.448 . . . . 0.0 109.879 -177.162 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.551 HE22 ' HB3' ' A' ' 87' ' ' ALA . 2.2 tm0? -131.45 139.16 49.31 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 108.971 -0.752 . . . . 0.0 108.971 179.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 85.1 mt-30 -115.66 97.58 6.21 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-O 121.053 0.454 . . . . 0.0 109.82 177.083 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -100.27 139.07 20.4 Favored Pre-proline 0 C--N 1.33 -0.239 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.72 178.985 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -58.44 148.3 81.26 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 121.375 1.383 . . . . 0.0 111.226 178.438 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 79.87 -11.96 31.97 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 110.979 -0.848 . . . . 0.0 110.979 177.142 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 4.5 t -138.58 145.1 40.19 Favored 'General case' 0 C--N 1.33 -0.252 0 O-C-N 122.673 -0.31 . . . . 0.0 110.316 179.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . 0.404 ' CB ' ' CD ' ' A' ' 45' ' ' PRO . 0.6 OUTLIER -71.57 179.56 0.94 Allowed Pre-proline 0 C--N 1.329 -0.323 0 N-CA-C 109.94 -0.393 . . . . 0.0 109.94 -178.552 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . 0.404 ' CD ' ' CB ' ' A' ' 44' ' ' SER . 5.9 Cg_exo -72.13 138.34 30.54 Favored 'Trans proline' 0 C--N 1.306 -1.662 0 C-N-CA 122.326 2.017 . . . . 0.0 111.748 177.822 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 35.8 p -132.17 149.7 52.33 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.562 177.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . 0.439 ' OG1' ' CZ ' ' A' ' 37' ' ' TYR . 14.5 m -68.6 129.67 40.61 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.599 178.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 11.4 t -93.51 -32.03 4.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 O-C-N 121.964 -0.46 . . . . 0.0 110.635 179.452 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.463 HG22 ' N ' ' A' ' 50' ' ' TYR . 7.2 mt -144.79 161.47 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 N-CA-C 109.105 -0.702 . . . . 0.0 109.105 177.438 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.463 ' N ' HG22 ' A' ' 49' ' ' ILE . 11.2 t80 -126.91 148.54 50.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.587 -0.733 . . . . 0.0 109.505 -177.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . 0.532 ' O ' ' ND2' ' A' ' 53' ' ' ASN . 10.1 tt0 45.78 25.43 0.28 Allowed 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.516 179.367 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.448 ' C ' HD22 ' A' ' 53' ' ' ASN . 0.5 OUTLIER 46.81 20.28 0.11 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.929 0.395 . . . . 0.0 110.631 179.05 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . 0.532 ' ND2' ' O ' ' A' ' 51' ' ' GLU . 1.0 OUTLIER -108.76 -49.86 3.09 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.86 -179.032 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.0 pt20 -160.82 177.24 10.61 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.887 0.375 . . . . 0.0 110.705 -177.518 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.509 ' NH1' ' OD1' ' A' ' 61' ' ' ASP . 2.8 ptp85 -110.61 156.11 41.06 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.377 -178.553 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -58.59 163.9 10.13 Favored 'Trans proline' 0 C--N 1.309 -1.551 0 C-N-CA 121.59 1.527 . . . . 0.0 111.144 179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 5.5 m -71.83 141.32 49.63 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.54 -0.464 . . . . 0.0 110.738 177.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.67 -36.88 4.1 Favored Glycine 0 CA--C 1.526 0.763 0 N-CA-C 111.169 -0.772 . . . . 0.0 111.169 175.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.4 m -72.53 153.63 91.75 Favored Pre-proline 0 C--N 1.33 -0.266 0 N-CA-C 109.847 -0.427 . . . . 0.0 109.847 -179.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 3.2 Cg_exo -61.37 156.33 46.86 Favored 'Trans proline' 0 C--N 1.308 -1.595 0 C-N-CA 121.582 1.521 . . . . 0.0 111.045 -177.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.509 ' OD1' ' NH1' ' A' ' 55' ' ' ARG . 7.5 m-20 -105.39 40.59 1.51 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.458 -0.337 . . . . 0.0 110.593 179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.521 ' NH2' ' O ' ' A' ' 80' ' ' GLY . 11.2 mtm180 -91.05 -0.95 57.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.86 179.915 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.457 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.1 OUTLIER -124.77 145.89 49.49 Favored 'General case' 0 C--N 1.331 -0.218 0 N-CA-C 109.966 -0.383 . . . . 0.0 109.966 -179.533 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.9 t -145.87 127.5 15.18 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.399 -0.52 . . . . 0.0 110.664 176.145 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.427 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -97.19 147.37 18.64 Favored Glycine 0 CA--C 1.526 0.73 0 N-CA-C 111.495 -0.642 . . . . 0.0 111.495 -179.669 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -146.65 165.22 30.22 Favored 'General case' 0 C--N 1.331 -0.236 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 175.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.445 ' N ' HD13 ' A' ' 67' ' ' ILE . 0.1 OUTLIER -134.71 144.68 34.14 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-O 121.032 0.444 . . . . 0.0 111.061 -175.825 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.491 ' O ' ' N ' ' A' ' 72' ' ' ASN . 42.2 m-20 -123.95 91.37 3.45 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.687 -0.688 . . . . 0.0 110.356 -179.003 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 74.0 p -60.78 -42.53 97.72 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.922 0.391 . . . . 0.0 110.64 -178.743 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 25.5 m -58.33 -50.61 73.02 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 115.884 -0.598 . . . . 0.0 110.568 179.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 36.6 t -84.08 -8.99 58.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.314 -179.437 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.491 ' N ' ' O ' ' A' ' 68' ' ' ASP . 20.2 t30 57.66 35.84 26.05 Favored 'General case' 0 C--N 1.33 -0.281 0 C-N-CA 120.48 -0.488 . . . . 0.0 110.782 179.21 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 7.1 p -139.14 156.86 46.83 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.316 -0.402 . . . . 0.0 110.208 -178.023 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . . . . . . . . . . . -112.99 136.21 52.92 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 110.032 -0.359 . . . . 0.0 110.032 -176.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 73.6 m -130.04 127.16 39.36 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.707 -176.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.839 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -105.1 138.19 41.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.787 0.327 . . . . 0.0 110.832 177.341 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . . . . . . . . . 53.5 m -107.91 120.96 43.76 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-O 121.083 0.468 . . . . 0.0 110.579 174.482 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . . . . . . . . . 2.0 mt -109.36 148.77 12.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 109.586 -0.524 . . . . 0.0 109.586 179.467 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . 0.585 ' HA ' HG22 ' A' ' 17' ' ' THR . 57.2 p -133.17 128.81 36.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.033 -0.531 . . . . 0.0 110.87 176.48 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . 0.521 ' O ' ' NH2' ' A' ' 62' ' ' ARG . . . 93.93 76.71 1.34 Allowed Glycine 0 CA--C 1.525 0.716 0 N-CA-C 110.929 -0.868 . . . . 0.0 110.929 178.702 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.602 HD23 ' O ' ' A' ' 16' ' ' LYS . 2.6 mm? -78.54 130.2 35.69 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 121.028 0.442 . . . . 0.0 110.391 179.516 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . 0.463 ' N ' ' OD2' ' A' ' 85' ' ' ASP . 34.4 mttp -152.99 160.42 43.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.718 -0.674 . . . . 0.0 110.596 179.897 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.459 ' C ' ' H ' ' A' ' 85' ' ' ASP . 47.2 p -57.76 -34.88 70.01 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.047 -178.644 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 60.5 mm-40 -54.89 -9.32 0.34 Allowed 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.329 -0.85 . . . . 0.0 109.445 176.794 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.478 ' O ' ' N ' ' A' ' 87' ' ' ALA . 8.8 m-20 -100.51 -30.07 12.01 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 115.975 -0.557 . . . . 0.0 110.601 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . . . . . . . . . 66.3 tt0 -39.6 92.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.252 0 CA-C-O 120.903 0.382 . . . . 0.0 111.643 179.114 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . 0.551 ' HB3' HE22 ' A' ' 38' ' ' GLN . . . -168.83 -169.72 1.05 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.925 -0.58 . . . . 0.0 110.384 -178.662 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.26 151.8 21.8 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 121.243 0.544 . . . . 0.0 110.012 -179.32 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . . . . . . . . . 3.0 m-85 -116.78 142.16 47.28 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.481 -0.781 . . . . 0.0 110.219 178.331 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -123.15 149.55 44.43 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.82 178.344 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 33.2 m -118.31 147.8 43.11 Favored 'General case' 0 CA--C 1.533 0.29 0 N-CA-C 107.312 -1.366 . . . . 0.0 107.312 178.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -136.32 127.78 28.57 Favored 'General case' 0 C--N 1.332 -0.189 0 O-C-N 121.513 -0.742 . . . . 0.0 110.965 175.737 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 91.4 p -126.62 161.07 28.91 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.311 -0.404 . . . . 0.0 110.776 -178.036 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . 0.446 ' O ' ' CB ' ' A' ' 32' ' ' ASN . 22.3 m-85 -121.4 142.76 49.69 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-O 121.109 0.48 . . . . 0.0 110.172 179.289 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 17.5 m-20 -89.39 177.13 6.66 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.319 179.836 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 12.5 p -58.41 -29.36 66.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.244 -0.434 . . . . 0.0 110.698 178.951 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . . . . . . . . . 30.8 p -83.9 11.55 7.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.539 178.972 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 3.6 m120 58.3 50.11 10.11 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.685 179.856 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . . . . . . . . . 1.9 t-80 -112.72 122.01 46.4 Favored 'General case' 0 C--N 1.331 -0.217 0 N-CA-C 109.752 -0.462 . . . . 0.0 109.752 -179.169 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 9.3 p -60.94 136.56 24.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.277 -179.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . 0.442 HG12 ' N ' ' A' ' 102' ' ' PHE . 86.7 t -127.29 156.32 38.81 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.799 0.333 . . . . 0.0 110.259 179.146 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . 0.442 ' N ' HG12 ' A' ' 101' ' ' VAL . 3.2 m-85 -117.39 144.91 44.48 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.299 -0.41 . . . . 0.0 110.042 -179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -96.76 172.19 28.24 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -63.52 -33.2 86.6 Favored Glycine 0 CA--C 1.525 0.709 0 N-CA-C 110.793 -0.923 . . . . 0.0 110.793 -178.322 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 97.82 161.81 31.02 Favored Glycine 0 CA--C 1.524 0.644 0 N-CA-C 110.816 -0.914 . . . . 0.0 110.816 -179.537 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 21.2 m -138.42 134.88 34.66 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.762 0.315 . . . . 0.0 110.226 -179.405 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 43.1 tttm -98.99 101.82 13.34 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 120.97 0.415 . . . . 0.0 110.51 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.426 HD12 HG13 ' A' ' 10' ' ' VAL . 11.6 tp -92.2 120.48 32.82 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.259 178.157 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 72.1 m -116.97 129.22 55.89 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.092 179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . . . . . . . . . 7.3 t -102.9 120.56 52.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.928 -0.578 . . . . 0.0 110.207 179.548 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . 0.877 ' H ' HD12 ' A' ' 111' ' ' LEU . 0.0 OUTLIER . . . . . 0 C--O 1.236 0.368 0 CA-C-O 117.64 -1.171 . . . . 0.0 109.411 -177.476 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ASN . . . . . 0.479 ' O ' ' CB ' ' A' ' 26' ' ' SER . 22.6 m-20 . . . . . 0 N--CA 1.49 1.569 0 N-CA-C 109.01 -0.737 . . . . 0.0 109.01 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.516 ' CG ' ' OD2' ' A' ' 95' ' ' ASP . 5.7 m-85 -147.54 116.11 6.69 Favored 'General case' 0 C--N 1.329 -0.317 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 177.747 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' MET . . . . . . . . . . . . . 8.2 mtt -148.89 163.91 36.05 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.981 -0.554 . . . . 0.0 109.856 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' LEU . . . . . . . . . . . . . 11.5 mt -121.97 150.94 41.33 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 121.078 0.466 . . . . 0.0 110.635 178.799 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 5.2 m -127.91 121.79 30.84 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.826 -0.624 . . . . 0.0 109.761 179.61 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.665 ' NE2' ' SG ' ' A' ' 22' ' ' CYS . 0.0 OUTLIER -144.56 165.37 23.38 Favored Pre-proline 0 C--N 1.33 -0.253 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 -177.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' PRO . . . . . . . . . . . . . 6.1 Cg_exo -54.53 152.83 25.45 Favored 'Trans proline' 0 C--N 1.306 -1.665 0 C-N-CA 122.26 1.974 . . . . 0.0 111.193 -179.635 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' HIS . . . . . . . . . . . . . 23.3 t60 -88.14 -36.64 16.74 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.317 -0.401 . . . . 0.0 111.183 178.27 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' SER . . . . . . . . . . . . . 24.5 m -162.92 145.58 10.58 Favored 'General case' 0 C--N 1.33 -0.264 0 C-N-CA 120.604 -0.438 . . . . 0.0 110.506 -177.656 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' VAL . . . . . 0.526 HG13 HD12 ' A' ' 108' ' ' LEU . 1.7 p -162.02 150.88 4.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.087 -179.588 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.2 m -134.56 154.21 51.57 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.201 -0.454 . . . . 0.0 110.455 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.538 ' OE1' ' N ' ' A' ' 13' ' ' SER . 1.1 tm-20 -156.07 150.91 26.17 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.479 -179.547 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.538 ' N ' ' OE1' ' A' ' 12' ' ' GLU . 0.1 OUTLIER -90.73 151.89 44.24 Favored Pre-proline 0 C--N 1.331 -0.215 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.611 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' PRO . . . . . . . . . . . . . 3.0 Cg_exo -62.97 156.93 51.44 Favored 'Trans proline' 0 C--N 1.308 -1.596 0 C-N-CA 121.555 1.504 . . . . 0.0 111.497 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLY . . . . . . . . . . . . . . . 96.15 -23.48 34.47 Favored Glycine 0 CA--C 1.525 0.685 0 N-CA-C 110.686 -0.966 . . . . 0.0 110.686 178.703 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' LYS . . . . . . . . . . . . . 57.9 mmtt -96.05 -161.02 0.83 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.768 0.318 . . . . 0.0 110.266 177.886 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' THR . . . . . . . . . . . . . 69.8 p -125.61 160.43 29.64 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 121.322 0.582 . . . . 0.0 111.203 179.01 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' VAL . . . . . 0.478 HG23 HD13 ' A' ' 81' ' ' LEU . 13.7 t -124.92 135.35 64.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.438 176.769 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' THR . . . . . . . . . . . . . 22.2 m -118.88 123.67 45.25 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.32 -0.854 . . . . 0.0 109.783 177.282 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ILE . . . . . 0.505 HG12 HD22 ' A' ' 76' ' ' LEU . 43.8 mm -105.35 122.62 58.9 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 115.973 -0.558 . . . . 0.0 109.897 177.083 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.2 m -102.22 124.49 47.91 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 -179.487 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' CYS . . . . . 0.665 ' SG ' ' NE2' ' A' ' 6' ' ' GLN . 10.0 m -127.81 116.7 20.59 Favored 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 178.047 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' THR . . . . . . . . . . . . . 3.6 m -113.17 136.93 52.19 Favored 'General case' 0 N--CA 1.465 0.307 0 O-C-N 121.806 -0.559 . . . . 0.0 110.288 177.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' GLY . . . . . . . . . . . . . . . -99.57 167.63 21.23 Favored Glycine 0 CA--C 1.524 0.635 0 N-CA-C 111.114 -0.794 . . . . 0.0 111.114 179.913 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . 0.443 ' O ' ' CB ' ' A' ' 26' ' ' SER . 7.7 t -128.26 142.7 51.07 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.821 0.343 . . . . 0.0 110.589 -179.21 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.513 ' OG ' ' N ' ' A' ' 27' ' ' GLY . 1.0 OUTLIER 79.52 -61.52 0.31 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 115.972 -0.558 . . . . 0.0 110.327 179.846 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . 0.513 ' N ' ' OG ' ' A' ' 26' ' ' SER . . . -95.88 169.72 27.18 Favored Glycine 0 CA--C 1.526 0.747 0 N-CA-C 110.877 -0.889 . . . . 0.0 110.877 -178.608 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 5.3 m -103.21 140.85 36.83 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.685 0.279 . . . . 0.0 110.354 179.669 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ILE . . . . . 0.608 HD12 ' N ' ' A' ' 30' ' ' ALA . 2.4 pp -74.36 -2.76 3.94 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.511 -179.399 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ALA . . . . . 0.608 ' N ' HD12 ' A' ' 29' ' ' ILE . . . -102.36 -19.39 15.0 Favored 'General case' 0 C--N 1.329 -0.308 0 N-CA-C 109.761 -0.459 . . . . 0.0 109.761 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 82.3 p -78.95 -9.09 59.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.699 -0.682 . . . . 0.0 110.989 178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -146.32 162.93 37.07 Favored 'General case' 0 C--N 1.33 -0.251 0 N-CA-C 110.057 -0.349 . . . . 0.0 110.057 -176.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' TYR . . . . . . . . . . . . . 55.2 m-85 -86.38 145.01 27.05 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.354 -0.385 . . . . 0.0 110.57 -178.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' VAL . . . . . 0.538 ' O ' ' N ' ' A' ' 52' ' ' ASP . 16.7 t -124.52 141.87 43.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 N-CA-C 109.446 -0.575 . . . . 0.0 109.446 179.536 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLN . . . . . . . . . . . . . 1.4 mp0 -124.18 160.91 26.82 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.009 0.433 . . . . 0.0 110.025 177.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' TRP . . . . . 0.53 ' NE1' ' OD1' ' A' ' 52' ' ' ASP . 19.4 m95 -129.72 141.56 50.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.955 -0.566 . . . . 0.0 110.156 -177.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TYR . . . . . 0.656 ' HA ' HG23 ' A' ' 48' ' ' VAL . 0.8 OUTLIER -148.65 154.44 39.68 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 109.695 -179.521 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' GLN . . . . . 0.62 ' NE2' ' CE1' ' A' ' 89' ' ' TYR . 0.5 OUTLIER -119.14 146.7 44.92 Favored 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 -175.363 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLN . . . . . . . . . . . . . 15.5 tt0 -113.99 97.78 6.59 Favored 'General case' 0 C--N 1.332 -0.184 0 C-N-CA 120.343 -0.543 . . . . 0.0 109.661 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ARG . . . . . . . . . . . . . 1.9 ttp180 -93.25 122.31 63.46 Favored Pre-proline 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.332 -178.649 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' PRO . . . . . . . . . . . . . 3.3 Cg_exo -56.3 135.5 70.44 Favored 'Trans proline' 0 C--N 1.308 -1.562 0 C-N-CA 120.98 1.12 . . . . 0.0 110.805 -178.568 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 86.54 -4.4 86.19 Favored Glycine 0 CA--C 1.525 0.717 0 N-CA-C 111.327 -0.709 . . . . 0.0 111.327 177.831 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -137.25 147.82 46.02 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 110.286 -0.264 . . . . 0.0 110.286 179.43 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' SER . . . . . . . . . . . . . 1.3 p -68.71 152.55 96.65 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.245 -0.434 . . . . 0.0 109.83 -178.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' PRO . . . . . . . . . . . . . 2.0 Cg_endo -60.16 144.23 99.5 Favored 'Trans proline' 0 C--N 1.307 -1.654 0 C-N-CA 121.797 1.665 . . . . 0.0 110.669 -178.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' THR . . . . . . . . . . . . . 3.2 t -128.54 130.59 47.64 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.9 0.381 . . . . 0.0 110.66 179.402 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -57.13 124.15 17.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.905 -0.589 . . . . 0.0 109.958 178.924 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . 0.656 HG23 ' HA ' ' A' ' 37' ' ' TYR . 21.4 t -84.56 -40.04 14.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.363 178.301 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ILE . . . . . 0.522 ' CD1' ' N ' ' A' ' 65' ' ' GLY . 4.2 mt -144.49 155.09 14.8 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-O 121.139 0.495 . . . . 0.0 109.969 178.721 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' TYR . . . . . 0.42 ' C ' ' N ' ' A' ' 52' ' ' ASP . 40.7 m-85 -110.59 142.82 41.9 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.439 -0.801 . . . . 0.0 110.744 179.419 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLU . . . . . . . . . . . . . 23.6 mt-10 44.01 22.8 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.828 -0.624 . . . . 0.0 110.73 178.575 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ASP . . . . . 0.857 ' OD2' HG23 ' A' ' 67' ' ' ILE . 33.7 t70 50.16 19.88 0.55 Allowed 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.77 -0.65 . . . . 0.0 111.046 178.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASN . . . . . . . . . . . . . 31.4 m120 -112.16 -34.24 5.99 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.537 -0.301 . . . . 0.0 110.564 -179.068 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLN . . . . . . . . . . . . . 2.1 pt20 178.73 -172.25 0.14 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 109.863 -0.421 . . . . 0.0 109.863 -179.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . 0.451 ' CZ ' ' O ' ' A' ' 48' ' ' VAL . 0.1 OUTLIER -134.11 158.66 74.82 Favored Pre-proline 0 C--N 1.33 -0.241 0 N-CA-C 110.055 -0.35 . . . . 0.0 110.055 -179.196 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' PRO . . . . . . . . . . . . . 1.4 Cg_endo -52.96 163.35 2.12 Favored 'Trans proline' 0 C--N 1.308 -1.597 0 C-N-CA 121.841 1.694 . . . . 0.0 111.621 -177.893 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' SER . . . . . . . . . . . . . 2.8 m -71.71 143.48 49.64 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.003 -0.544 . . . . 0.0 110.745 176.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 106.17 -37.78 3.64 Favored Glycine 0 CA--C 1.525 0.657 0 N-CA-C 110.845 -0.902 . . . . 0.0 110.845 175.636 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . 0.41 ' H ' HG22 ' A' ' 59' ' ' VAL . 0.3 OUTLIER -74.95 151.16 86.3 Favored Pre-proline 0 C--N 1.33 -0.276 0 C-N-CA 120.372 -0.531 . . . . 0.0 109.872 -179.121 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' PRO . . . . . . . . . . . . . 1.7 Cg_endo -60.05 158.15 31.2 Favored 'Trans proline' 0 C--N 1.308 -1.579 0 C-N-CA 121.761 1.641 . . . . 0.0 110.684 -177.58 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.9 t0 -112.2 26.82 10.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.616 0.246 . . . . 0.0 110.83 -179.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ARG . . . . . 0.513 ' NH2' ' OD1' ' A' ' 85' ' ' ASP . 56.0 mtp180 -63.67 -12.48 34.41 Favored 'General case' 0 C--N 1.329 -0.325 0 C-N-CA 120.809 -0.356 . . . . 0.0 110.41 -177.624 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PHE . . . . . 0.527 ' CD1' ' N ' ' A' ' 63' ' ' PHE . 0.2 OUTLIER -121.64 145.54 47.89 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 109.721 -0.474 . . . . 0.0 109.721 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.449 ' O ' ' HA ' ' A' ' 76' ' ' LEU . 0.3 OUTLIER -139.56 130.74 26.59 Favored 'General case' 0 C--N 1.331 -0.213 0 C-N-CA 120.086 -0.646 . . . . 0.0 110.189 174.411 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' GLY . . . . . 0.522 ' N ' ' CD1' ' A' ' 49' ' ' ILE . . . -94.99 142.7 16.19 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 110.847 -0.901 . . . . 0.0 110.847 179.683 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.91 140.38 31.14 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.69 0.281 . . . . 0.0 110.249 178.446 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ILE . . . . . 0.857 HG23 ' OD2' ' A' ' 52' ' ' ASP . 5.1 pt -115.01 142.05 29.36 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-O 121.644 0.735 . . . . 0.0 110.789 -179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . 0.557 ' O ' ' N ' ' A' ' 72' ' ' ASN . 14.6 m-20 -118.33 80.4 1.52 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 114.456 -1.247 . . . . 0.0 109.817 -179.085 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.3 m -51.57 -30.94 22.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.988 0.423 . . . . 0.0 109.88 179.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' SER . . . . . . . . . . . . . 4.3 m -70.74 -51.23 28.59 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.816 -179.442 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.9 t -84.28 -7.12 59.43 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.874 -0.603 . . . . 0.0 109.895 -179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ASN . . . . . 0.557 ' N ' ' O ' ' A' ' 68' ' ' ASP . 53.9 t-20 58.73 38.05 24.96 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.066 -0.515 . . . . 0.0 111.007 -179.596 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' SER . . . . . . . . . . . . . 5.1 p -139.87 166.33 24.91 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.889 0.376 . . . . 0.0 110.719 -178.86 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ALA . . . . . 0.459 ' HB1' ' HZ2' ' A' ' 36' ' ' TRP . . . -120.92 117.64 27.85 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.7 -176.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' SER . . . . . . . . . . . . . 67.8 m -116.71 121.13 40.73 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.535 -0.757 . . . . 0.0 110.187 -176.262 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' LEU . . . . . 0.779 ' O ' HD23 ' A' ' 76' ' ' LEU . 0.1 OUTLIER -98.68 138.29 36.06 Favored 'General case' 0 C--N 1.33 -0.281 0 N-CA-C 109.927 -0.398 . . . . 0.0 109.927 179.285 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' THR . . . . . 0.447 ' N ' ' O ' ' A' ' 64' ' ' SER . 36.4 m -107.7 117.04 33.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 121.263 0.554 . . . . 0.0 110.981 175.097 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ILE . . . . . 0.629 HG13 HD21 ' A' ' 76' ' ' LEU . 3.9 mt -103.17 142.52 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 O-C-N 121.802 -0.561 . . . . 0.0 109.533 178.271 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -131.72 138.99 48.87 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.058 -0.519 . . . . 0.0 110.503 178.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' GLY . . . . . . . . . . . . . . . 60.22 53.94 41.45 Favored Glycine 0 CA--C 1.526 0.748 0 N-CA-C 111.254 -0.738 . . . . 0.0 111.254 177.751 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.837 ' H ' HD23 ' A' ' 81' ' ' LEU . 2.4 pt? -71.58 150.03 45.11 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.71 -0.396 . . . . 0.0 110.814 177.332 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -135.96 177.3 7.94 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.948 -0.39 . . . . 0.0 109.948 175.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 85' ' ' ASP . 1.1 m -53.65 -34.05 57.31 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.084 0.469 . . . . 0.0 110.174 179.722 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . . . . . . . . . 55.5 mm-40 -54.87 -8.17 0.24 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.529 -0.76 . . . . 0.0 109.474 179.841 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' ASP . . . . . 0.548 ' OD1' ' N ' ' A' ' 85' ' ' ASP . 0.4 OUTLIER -95.93 -13.17 24.09 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 115.819 -0.628 . . . . 0.0 110.066 179.296 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' GLU . . . . . 0.45 ' HG3' ' H ' ' A' ' 110' ' ' VAL . 1.8 tt0 -58.73 101.07 0.08 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.073 -0.512 . . . . 0.0 110.567 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' ALA . . . . . . . . . . . . . . . -175.66 -165.83 0.18 Allowed 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.731 -0.388 . . . . 0.0 111.096 -179.835 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . 0.434 ' C ' ' OE1' ' A' ' 38' ' ' GLN . 55.0 m-20 -106.97 126.75 52.73 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-O 121.404 0.621 . . . . 0.0 111.139 176.746 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' TYR . . . . . 0.62 ' CE1' ' NE2' ' A' ' 38' ' ' GLN . 33.8 m-85 -91.3 162.05 14.77 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.302 -0.863 . . . . 0.0 110.422 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' TYR . . . . . . . . . . . . . 59.7 m-85 -149.69 152.03 34.67 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.823 179.796 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' CYS . . . . . . . . . . . . . 12.0 m -117.75 144.78 44.99 Favored 'General case' 0 N--CA 1.465 0.304 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -178.148 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' GLN . . . . . 0.533 ' O ' HG13 ' A' ' 34' ' ' VAL . 7.2 mt-30 -126.42 144.62 50.78 Favored 'General case' 0 N--CA 1.463 0.215 0 O-C-N 121.297 -0.877 . . . . 0.0 110.995 177.674 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' SER . . . . . . . . . . . . . 82.5 p -146.18 159.53 43.18 Favored 'General case' 0 C--N 1.332 -0.192 0 O-C-N 122.101 -0.374 . . . . 0.0 111.213 177.695 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' TYR . . . . . . . . . . . . . 38.8 m-85 -118.95 152.67 35.92 Favored 'General case' 0 C--N 1.331 -0.199 0 CA-C-O 121.053 0.454 . . . . 0.0 110.344 179.618 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.516 ' OD2' ' CG ' ' A' ' 2' ' ' PHE . 37.1 m-20 -111.03 164.32 12.94 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.809 -0.632 . . . . 0.0 110.654 -179.254 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 3.0 p -60.67 -25.13 66.13 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 115.882 -0.599 . . . . 0.0 110.809 -179.506 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' SER . . . . . 0.42 ' O ' ' ND1' ' A' ' 99' ' ' HIS . 5.5 p -75.76 0.04 19.29 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.948 0.404 . . . . 0.0 110.286 -179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' ASN . . . . . . . . . . . . . 14.0 t30 69.46 37.58 1.96 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.948 -0.569 . . . . 0.0 110.53 178.954 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' HIS . . . . . 0.42 ' ND1' ' O ' ' A' ' 97' ' ' SER . 1.8 m80 -113.27 142.71 45.5 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.935 0.397 . . . . 0.0 110.575 178.817 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' VAL . . . . . . . . . . . . . 1.2 p -80.09 141.66 14.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 115.92 -0.582 . . . . 0.0 109.996 179.508 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' VAL . . . . . . . . . . . . . 46.8 t -136.43 151.49 28.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-O 120.943 0.401 . . . . 0.0 109.938 177.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' PHE . . . . . . . . . . . . . 33.2 m-85 -124.63 156.16 37.96 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.847 178.685 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' GLY . . . . . . . . . . . . . . . -99.89 164.93 19.71 Favored Glycine 0 CA--C 1.524 0.64 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.719 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -58.45 -34.16 74.2 Favored Glycine 0 CA--C 1.525 0.694 0 N-CA-C 110.659 -0.976 . . . . 0.0 110.659 -179.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 86.64 170.66 47.09 Favored Glycine 0 CA--C 1.524 0.639 0 N-CA-C 111.28 -0.728 . . . . 0.0 111.28 177.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' THR . . . . . . . . . . . . . 2.0 m -131.05 128.78 40.96 Favored 'General case' 0 C--N 1.33 -0.273 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 -173.925 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' LYS . . . . . . . . . . . . . 44.3 tttm -81.4 114.25 20.03 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.198 -0.456 . . . . 0.0 110.345 175.223 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' LEU . . . . . 0.526 HD12 HG13 ' A' ' 10' ' ' VAL . 9.0 tp -105.04 133.67 49.42 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 121.004 0.43 . . . . 0.0 110.728 177.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' THR . . . . . . . . . . . . . 1.2 m -120.84 142.26 49.8 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.627 -0.715 . . . . 0.0 109.935 177.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' VAL . . . . . 0.45 ' H ' ' HG3' ' A' ' 86' ' ' GLU . 59.2 t -112.87 131.38 64.61 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.258 178.825 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.223 -0.323 0 CA-C-O 117.545 -1.217 . . . . 0.0 109.955 -176.652 . . . . . . . . 1 1 . 1 stop_ save_